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Abstract 
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Orthotopic liver transplantation has become the preferred treatment for a variety of 
end-stage  liver d i s e a s e .  As  competency  and  survival  rates  increase,  so  does 
increasing demand, which puts greater strain on a static donor pool. This increases 
pressure to accept more marginal grafts, e.g. non-heart-beating and steatotic donors. 
However,  graft  dysfunction  post-transplantation  contributes c o n s i d e r a b l y  t o  
postoperative morbidity and mortality.  
Proton nuclear magnetic resonance (
1HNMR) spectroscopy is a powerful technique to 
explore the biochemical composition of biological fluids; it is rapid, non-invasive, non-
destructive and it can detect metabolites at millimolar concentrations. In this study, 
1HNMR assessed the changes in bile composition during liver ischaemia/reperfusion. 
The  primary  hypothesis  was  that  bile  composition  changes  during  liver  ischaemia 
reperfusion  injury  (IRI).  The  aims were to document these changes, identify biliary 
markers for liver IRI using 
1HNMR, validate these markers using known modulators, 
determine  if  the  same  was  true  for  steatotic  livers a n d  a t t e m p t  t o  u n d e r s t a n d  t h e  
mechanisms by which these changes happen in relation to the redox state of the liver.  
Materials  and  methods:  A  rabbit  model  of  hepatic  lobar  IRI  was  used.  In  most 
experiments 3 groups were used (n=6): Sham group (laparotomy alone), I/R group 
(1hr ischaemia and 6hrs reperfusion), and a modulation group similar to I/R with the 
addition of N-acetylcysteine (I/R+NAC: 150mg/kg of NAC) and glycine (I/R+glycine: 
5mg/kg glycine). Steatosis was induced by feeding with a 2% cholesterol diet for 8 
weeks. Experiments were repeated on steatotic animals with Sham, I/R, I/R+NAC and 
IPC+I/R  (5min  ischaemia  followed  by  10min o f  r e p e r f u s i o n  b e f o r e  p r o l o n g e d  
ischaemia  was  induced)  groups.  The  following  parameters  were  measured:  portal 
blood  flow,  bile  flow ( B F )  a n d  b i l e  
1HNMR  spectroscopy,  hepatic  microcirculation, 
intracellular tissue oxygenation, serum ALT, AST and ICG clearance were measured 
at 1, 2, 5 and 7 hours following reperfusion.  
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Results:  Bile  spectroscopy  demonstrated  significant  changes  in  bile  composition 
following I/R and alterations with NAC, glycine and IPC. These changes are evident 
despite a constant post-reperfusion rate of BF. They were also present in steatotic 
livers, and were modulated by NAC and IPC. 
In experiment 1: BF, COX and biliary acetate decreased following I/R while AST, 
ALT, biliary PC and lactate increased along with PMN accumulation in sinusoids, KC 
hypertrophy, necrosis and apoptosis in normal livers. 
In experiment 2: BF, COX and biliary acetate decreased following I/R while ALT, PC, 
conjugated bile acids and lactate increased in the I/R group in normal livers. NAC 
administration attenuated the increase in ALT and lactate following I/R in the NAC+I/R 
group compared to the I/R group. Changes in conjugated bile acids seem to reflect 
changes in BF.  
In experiment 3: I/R+glycine was associated with increased BF, bile acid, acetate, 
pyruvate, glucose, acetoacetate, and decreased bile lactate and PC levels in normal 
livers.  
In  experiment  4:  NAC a d m i n i s t r a t i o n  i n  s t e a t o t i c  l i v e r s  reduced  the  extent  of  IRI, 
increased portal blood flow and liver parenchymal perfusion. NAC increased BF, biliary 
acetate and pyruvate and reduced acute liver injury, ALT and biliary PC.  
In experiment 5: IPC protected the steatotic liver from IRI and maintained hepatic 
oxygenation,  tissue  perfusion  and  mitochondrial r e d o x  s t a t e .  C O X  a c t i v i t y  was 
decreased by IRI in the fatty liver, but can was protected by IPC. 
Conclusions: This thesis has demonstrated changes in bile composition during warm 
normal  liver  I/R  and  its  modulation  with  NAC  and  glycine.  It  has  
4 
also demonstrated changes in bile composition during warm steatotic liver I/R and its 
modulation with NAC and IPC. It has noted several metabolites that are consistently 
changed,  as  well  as  the  bile  redox  ratio  of  metabolites  that  provides  a  clearer 
indication of liver redox state than individual metabolites.   
5 
1  Introduction 
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In  the  past  two  decades,  orthotopic  liver  transplantation  (OLT)  has  become  the 
preferred therapy for a variety of causes of end-stage organ disease and is a routinely 
applied p r o c e d u r e .  As  liver  transplantation  becomes  the  treatment  of  choice  in  an 
ever-widening spectrum of indications, greater strain is put on a static donor pool in 
the UK (figure 1), with the result of increasing numbers of patients spending longer on 
waiting lists and dying on these lists
1. The availability of organs during that same time 
period  has  increased  much  more  slowly  and  appears  to  have  plateaued a t  
approximately 5,000 liver grafts per year in the US
2.  
This has put increasing pressure on surgeons and physicians to accept more marginal 
grafts  including  those  from  non-heart-beating  and  steatotic  donors.  However,  graft 
dysfunction  after  liver  transplantation  continues  to  contribute  considerably  to 
postoperative morbidity and mortality with a primary graft nonfunction rate of 6-8% and 
initial  poor  function  in  15-16%
3,4.  Improvements  in  graft  preservation  and  anti-
reperfusion therapeutics are required to cope with the increase in the use of marginal 
grafts. 
This disparity between demand and supply has led to a large expansion in the United 
Network for Organ Sharing liver transplant waiting list in the US and a 5-fold increase 
in deaths while still awaiting OLT
2. During this period, several developments have led 
to any improvement in the survival rate in transplanted patients: more stringent criteria 
for  the  selection  of  suitable  donors  and  recipients;  a  better  understanding  of  the 
rejection  process  and  of  the  modalities  to  interfere  with  rejection  (prevention  and 
treatment); improvements in the diagnosis and treatment of infectious complications; 
and better monitoring of transplanted patients
5.  
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Figure 1: Comparison between liver transplants and patients on waiting list  
 
 
Disparity between number of liver transplants and number of patients on the transplant 
waiting list in the UK (as of 31
st of March for each year cited) 
Source: UK Transplant
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Certainly, the success rate of solid organ transplantation, in terms of recipient actuarial 
survival,  has  dramatically  increased  since  the  introduction  of  cyclosporine  and 
immunosuppressive  therapies  that  can  manage  acute  rejection,  however,  chronic 
rejection remains the major complication. This involves both the reaction of the host to 
the graft (mainly T-cell mediated and B-lymphocyte-driven) and reactions in the graft 
towards  injury  (vasculopathy  or  graft  vessel  disease).  The  first  reaction  requires 
improved immunosuppressants including tolerance-inducing approaches, the second 
for  interventions  to  protect  the  graft  (e.g.  endothelial  cells)  from  damage  like 
ischaemia/reperfusion injury or for treatment of vessel disease
5,7.  
MR spectroscopy has obviously lagged behind the development of MRI for several 
reasons, one of it being the enormous technical demands, however, clinical MRS is 
entering  the  realm  of  possible,  with  it  becoming  almost  routine  in  several  fields, 
particularly  the  brain  and  breast.  As  further  technological  improvements  can  be 
expected  in  the  coming  years,  spectroscopic  applications  will  increase.  It  can  be 
expected that MRS will slowly become establish as a tool in individual diagnostics, 
initially in some niche specialities, and later more generally. The improvements that 
are needed for this to happen are unspectacular yet necessary such as establishing 
standards and reference values. The wealth of metabolic data offered by MRS may 
uncover  pathways  in  ischaemia  reperfusion  that  have  not  previously  been 
investigated. 
In  recent  years,  high  resolution  proton  nuclear  magnetic  resonance  (
1HNMR) 
spectroscopy has been established as a powerful technique to explore the biochemical 
composition of biological fluids such as plasma, bile, seminal and synovial fluids, in 
various  pathological  conditions
8.  This  technique  is  rapid,  non-invasive  and  non-
destructive and can detect metabolites present at the millimolar concentrations and 
can be applied to detect unexpected compounds in biological fluids
9. In bile, it has 
been used to confirm the hydrophobic association in micelles of conjugated bile acids  
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and biliary lipids
10,11. It has also been used to assess micelle formation
12, the effects of 
cholesterol on the fluidity of human gallbladder bile
13, the amount of conjugated bile 
acids in bile
14 and to identify the lipid content of plasma membranes
15. NMR has also 
been used to assess hepatic glutamine metabolism
16, hepatic energetic status after 
warm  ischaemia
17,  and  to  study  effects  of  ischaemia r e p e r f u s i o n  (I/R)  on  liver  cell 
membranes
18. A preliminary study of 
1HNMR analysis of bile after liver transplantation 
has been reported by Powell et al in 1990, suggesting that this technique might help to 
distinguish  ischaemia f r o m  r e j e c t i o n  p o s t -transplant  by  detecting  large  resonance 
peaks  for  lactate  and  acetate
18.  More  recently  there  has  been  growing  interest  in 
attempting  to  predict  graft  function  by  analysing  bile  production  immediately  after 
transplantation
18.  
In this study MRS will be used to assess the changes in bile composition during liver 
ischaemia/reperfusion. The aim is to determine readily recognizable markers for liver 
IRI  using  MRS  and  also  attempt  to  understand  the  mechanisms  by  which  these 
changes happen.  
The  clinical  application  of  this  approach  would  be  as  a  non-invasive  assessment 
modality of graft suitability prior to transplantation, and subsequently, assessment of 
post-transplantation graft viability. The importance of this study is underlined by the 
continuing advances taking place in clinical MRI scanners where bile composition may 
be analysed in vitro non-invasively through MRI voxel analysis
19,20. MRS is coming of 
age, but without the research to lend its focus on clinical questions, it will remain a 
research tool.  
The  advantages  of  a  non-invasive  modality  that  reveals  some  of  the  chemical 
composition of the object studied is very attractive. Moreover, the documentation of 
these changes after IRI may allow for the identification of markers of injury. Some may 
be detectable by MRS techniques, but others may be more easily detected by simpler  
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techniques once they are identified. Briefly, the aims of this study were:  
•  To determine if bile composition changed during IRI. 
•  To determine markers of this change, that may predict IRI in organs. 
•  To  observe  the  changes  in  these  markers  when  IRI  is  suppressed  through 
pharmacological  modulation,  using  agents  known  to  modulate  or  ameliorate 
IRI. 
•  To determine if bile composition is different in IRI of steatotic livers. 
•  To observe the changes in these markers when I/R injury in steatotic livers is 
suppressed  through  pharmacological  modulation  or  the  use  of  ischaemic 
preconditioning 
•  To correlate the changes in bile composition to changes in the redox state of 
the liver. 
The hypothesis of this thesis being that since bile requires active, energy dependant, 
secretion, changes during I/R will affect its composition, and the energy state of the 
liver may be detected through detecting these changes. 
 
Due  to  unusual  personal  circumstances,  the  experimental  work  in  this  thesis  was 
carried  out  from  2001-2003  but  it  was  examined  in  2013.  Interestingly,  certain 
advances have been made in both experimental model and MRS analysis and their 
relevance to this thesis is discussed in sections 3.1, 3.9, 3.11 and 3.12. This is an 
attempt to do justice to the fact that the thesis is being examined in 2013, and if the 
experimental  work  were  more  contemporary,  this  is  how  it  would  have  been 
investigated. 
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2  Review of literature  
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2.1  Physiology of Bile secretion and composition 
Bile  formation  is  an  osmotic  filtration-driven  process  that  depends  on  the  proper 
function  of  transport  systems  in  both  the  basolateral  and  apical  or  canalicular 
membranes of hepatocytes
21,22. Bile secretion is driven by active excretion of organic 
solutes into the bile canaliculus, followed by passive inflow of water, electrolytes, and 
non-electrolytes from hepatocytes and across semi-permeable tight junctions
22.  
Liver  ischaemia r e d u c e s  e n e r g y  d e p e n d a n t  t r a n s p o r t  p r o c e s s e s  a n d  i s  t h e r e f o r e  
associated with reduced Bile flow (BF)
23. BF recommences on reperfusion, and has 
thus been considered to be a marker of liver function and used to assess clinical liver 
transplantation studies
8,9,11. However the changes in bile composition during ischaemia 
and reperfusion have not been widely investigated. 
2.1.1  Bile acids and bile flow 
Bile acids are quantitatively the major component of human bile and their hepatic flux 
markedly  influences  BF  and  the  concentrations  of  other  biliary  lipids,  particularly 
phospholipids and cholesterol
24. Hepatic bile formation is an active secretory process 
involving bile salt-dependent and -independent mechanisms
25, it occurs at two levels, 
canalicular and ductular. Canalicular BF is mainly dependent on bile acid secretion, 
bile acid-dependent BF, and accounts for 70% to 85% of the total canalicular flow. Bile 
acid-independent  BF  is  probably  driven  by  inorganic  ion  transport
26 a n d  i s  b o t h  
canalicular  and  ductular.  Apparent  choleretic  activity  (ACA)  is  a  concept  that 
expresses the relationship between the bile acid secretion rates and the BF and is 
calculated from the equation of a positive slope of a linear regression, indicating that 
more  bile  acid  secretion  produces  more  BF  (bile  acid-dependent  BF).  Bile  acid-
independent BF is calculated from the estimated intercept of the slope
27,28. More than 
95% of the bile acids entering the duodenum are absorbed from the intestinal lumen 
and returned to the liver via the portal vein to be re-secreted at the canalicular level, 
which  is  termed  the  enterohepatic  circulation  (EHC).  Bile  acid  uptake  by  the  
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hepatocytes is very efficient, with a high first-pass extraction rate, but bile acids can 
still be found in systemic blood bound mainly to albumin
27. Serum bile acids had been 
considered a simple but reliable method for assessing hepatic function in liver disease, 
and it can help to understand the dynamics of bile acid metabolism
29. 
2.1.2  Bile secretion 
Bile acids are a major component of bile and have a significant influence on BF and 
the secretion of biliary lipids such as phosphatidylcholine (PC; also known as lecithin) 
and  cholesterol
30.  The  hepatocyte  is  a  secretory  epithelial  cell  with  a  basolateral 
(sinusoidal and lateral) and apical (canalicular) membrane
31. Bile is formed by several 
energy dependant mechanisms, and secretion is relatively independent of perfusion 
pressure
32. The passage of bile salts into the biliary canaliculus is the most important 
factor  promoting  bile  formation.  This  bile  acid-dependent  flow  accounts  for 
approximately  50%  of  canalicular  BF.  Water  follows  osmotically  and  there  is  an 
excellent correlation between BF and bile salt secretion
33. Bile salts are transported 
across the canalicular membrane in a primary active adenosine triphosphate (ATP)-
dependent fashion
24,25 which is mediated by the bile salt export pump (BSEP)
26. BSEP 
is  a  genuine  ATP-binding  cassette  (ABC)  transporter  similar  to  ABC  transporters 
expressed  in  many  tissues  and  involved  in  active  outward  transport  of  molecules 
across the plasma membrane
23. 
2.1.3  Bile studies 
Developments in liver transplantation over the past 4 decades has fuelled a parallel 
interest in bile studies
24. However, in vivo analysis of bile secretory function in humans 
is far from easy, and many measurement techniques have been described, including 
those of BF and bile acid concentrations of hepatic bile per se, bile secretion using 
duodenal aspirates or markers of water fluxes, and more indirectly, the measurement 
of bile acid concentrations in serum. Liver ischaemia and reperfusion has been shown 
to decrease BF in vivo
25,34 and in vitro
35. BF has been considered to be a marker of  
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liver  function
25,36-44 a n d  h a s  b e e n  u s e d  t o  a s s e s s  t h e r a p e u t i c  a n d  p r e s e r v a t i o n  
strategies in liver transplantation
45,46. 
2.1.4  Post-transplant biliary obstruction 
Studies of bile production after liver transplantation were initially plagued with biliary 
obstruction. Javitt et al., in 1971, were among the first to recognize the potential of bile 
measurements to monitor liver function after transplantation
47. A T-tube placed in the 
common bile duct allowed the collection of bile from one patient during the first 20 
days after transplantation found a rapid increase in bile salt synthesis within the first 24 
hours which was attributed to the loss of bile salt through the T-tube, such as occurs 
when  the  EHC  is  interrupted  by  an  external  biliary  drainage,  ileal  bypass,  or 
administration of cholestyramine. Deoxycholate was still present for several days after 
transplant,  indicating  that  not  all  the  bile  was  diverted  by  the  T-tube,  despite  the 
authors’ suggestion that this represented residual bile salt left within the donor biliary 
tree at the time of organ retrieval
47. 
As the number of liver transplants increased, biliary tract obstruction caused by bile 
cast formation became recognized as a major postoperative complication. Abnormal 
bile composition was suggested as a cause—bile supersaturated with cholesterol—
possibly potentiated by infection and mucosal damage
48,49. It was also suggested to be 
a surgical problem related to bile duct reconstruction
50. New surgical techniques were 
developed to try to reduce the incidence of biliary complications, including Roux-en-Y 
anastomosis to the gallbladder and the gallbladder conduit
51, but these modifications 
did  not  resolve  the  problem.  It  was  discovered  that  during  the  first  days  post-
transplantation, bile supersaturated with cholesterol was primarily attributable to low 
levels of bile acids following interruption of the EHC and depletion of the bile acid 
pool
52,53.  However,  there  was  poor  correlation  between  the  development  of 
supersaturated bile and biliary obstruction
52,53. The primary mechanism of bile sludge 
formation was shown to be necrosis of donor bile duct mucosa caused by ischaemic  
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injury  and  the  presence  of  bile  within  the  biliary  tree  during  the  period  of  cold 
preservation
54. Flushing of the biliary tree during organ retrieval was introduced, with 
resolution of the problem
54. 
2.1.5  Bile flow and composition studies 
It was recognised that the composition of bile produced by the transplanted liver was 
determined not only by the metabolic state of the recipient, but also by that of the 
donor
55. Low levels of both cholesterol and bile acids were detected in T-tube bile, 
which were thought to be due to cholestasis following early severe acute rejection. 
These  findings  contradicted  earlier  reports  of  supersaturation  of  bile  with 
cholesterol
48,52,53 and may be explained by the introduction of intrabiliary flushing during 
organ  retrieval.  Nevertheless,  attention  was  directed  toward  the  ability  of  the 
transplanted liver to secrete bile; in a preliminary report, Shiffman et al. introduced the 
idea of measurement of BF, bile acid concentration, and bile acid output as potentially 
useful  parameters  for  assessing  graft  function  and,  in  particular,  acute  rejection
56. 
Using  a  Soloway  T-tube,  which  preserves  the  EHC,  BF  was  found  to  be  initially 
depressed after orthotopic liver transplantation (OLT) but then increased significantly 
over the next few days
57. Furthermore, one patient was noted to have a fall in BF, 
which  signalled  the  development  of  hepatic  artery  thrombosis.  Using  the  same 
Soloway T-tube, persistent supersaturation of bile with cholesterol in the first week 
after transplantation was demonstrated when bile acids were depleted
58. Of their six 
patients, three developed choledocholithiasis 15 to 42 months later; however, there 
was no correlation between the degree of cholesterol saturation after surgery and later 
development of biliary stones. In 1996, Tisone et al. used daily monitoring of biliary 
bile acids and lipid composition to try to differentiate patients with PNF from those with 
moderate  graft  dysfunction  or  normal  function
59.  They  showed  that  patients  with 
primary  nonfunction  had  lower  bile  acid  concentrations  and  higher  biliary  lecithin 
concentrations compared with patients with normal graft function in whom there was a  
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rapid increase in the bile secretion of primary bile acids. They concluded that it is 
possible to recognize primary nonfunction; however, the use of T-tube bile and the 
small number of patients (n=16) studied limit the value of this study. 
2.1.6  Apparent choleretic activity studies 
Based  on  earlier  studies,  Ericzon  et  al.,  using  T-tube  bile  samples  taken  from  10 
patients  with  liver  grafts  retrieved  from  nonheartbeating  donors,  demonstrated  a 
significant correlation between BF and bile acid output, ACA, and applied, for the first 
time in OLT, the concept of bile acid-independent BF
59. Total BF, concentration of bile 
acids, phospholipids, and cholesterol were low during the first week after transplant, 
reflecting graft recovery from the preservation, ischaemia, and reperfusion. Analysis of 
bile  acid  composition  was  not  reliable  because  of  EHC  interruption,  and  although 
changes in biliary lipid composition occurred rapidly with graft dysfunction, it did not 
provide more information than standard liver function tests. They did, however, detect 
improved bile lipid concentrations following successful anti-rejection treatment. 
In carefully selected patients considered to have healthy hepatic grafts, with a normal 
pattern of recovery, and who were considered to provide a baseline of adequate BF, a 
linear relationship was found between BF and bile salt output
60, which represents the 
bile salt-dependent flow, and they described two phases of graft recovery over a 10- to 
12-day period: an early phase with rapid increase of bile salt concentration and a later 
phase  with  more  prolonged  recovery  of  bile  salt  output,  suggesting  that  bile  salt-
independent  flow  recovered  more  slowly  than  bile  salt-dependent  flow.  They 
suggested  that  variations  in  the  ACA  may  be  related  to  alterations  in  the 
hydrophobicity and structure of the bile salt pool and that the presence of increased 
BF was associated with hypoxia following donor organ retrieval and vagal denervation 
of  the  transplanted  graft
60.  The  ACA  in  patients  with  interruption  of  the  EHC  was 
measured and showed a linear correlation between BF and bile acid output with a 
markedly  elevated  ACA  value  and  a  low  concentration  of  bile  acids  following  
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transplantation
28.  This  anomalous  choleresis  may  suggest  the  presence  of  an 
increased  proportion  of  other  osmotically  active  solutes  in  bile  probably  due  to 
impaired biliary epithelial cell function, and they drew attention to the influence of such 
factors  as  the  removal  of  the  circulating  bile  acid  pool,  graft  dysfunction  and 
denervation on BF
28. 
2.1.7  Other procedures for the assessment of bile flow 
EHC interruption by use of a T-tube for varying periods and at different times after 
transplant renders interpretation and comparison of the results of the above studies of 
bile secretion difficult. Measurement of biliary bile acid secretion without interruption of 
EHC  was  performed  by  Theilman  et  al.,  in  1991,  using  duodenal  perfusion  with  a 
nonabsorbable marker in patients at least 6 weeks after transplant
61. Biliary secretion 
was assessed at hourly intervals, and the mean biliary output of bile acids was higher 
in comparison with their controls. In the bile of the transplant recipients, the majority of 
bile  acids  were  cholate  and  chenodeoxycholate  with  only  low  percentages  of 
deoxycholate and lithocholate, presumably because of changes in intestinal bacterial 
flora secondary to perioperative antibiotics
61. 
A  linear  relationship  was  found  between  BF  and  the  clearance  of  the 
3H-labeled 
polyethylene  glycol,  a  marker  of  water  fluxes,  3-6  weeks  after  OLT
62.  A  reduced 
canalicular flow was noted (including a reduced bile acid-independent BF), despite the 
patients  receiving  ursodeoxycholic  acid,  which  has  a  well-defined  choleretic  effect. 
They suggested that these findings were related to immunological, preservation, or 
reperfusion injury. 
2.1.8  Bile studies and immunosuppressive drugs 
Cyclosporin A (CsA) was noted to have an apparent cholestatic effect and inhibit bile 
acid  secretion  in  vivo a n d  in  vitro
63,64,  and  tacrolimus  has  been  related  with 
hepatotoxicity  when  administered  at  higher  doses  in  animals
65.  In  humans, 
McCashland et al. found decreased bile acid secretion and BF in patients receiving  
18 
either  CsA  or  tacrolimus  and  described  a  reduction  in  chenodeoxycholic  acid 
biosynthesis  related  only  to  patients  receiving  CsA
28.  However,  Ericzon  et  al. 
concluded  that  patients  with  tacrolimus  showed  a  more  rapid  recovery  of  biliary 
secretion
66,67, and this observation was supported by Sauer et al., using a duodenal 
perfusion method, 3-6 weeks after transplantation
68. In patients receiving tacrolimus, 
there  was  complete  recovery  of  biliary  secretion,  despite  the  presence  of  elevated 
serum alkaline phosphatase and γ-glutamyl transferase levels
68. The effect of CsA on 
the kinetics of primary bile acids at 6-20 months after transplantation using isotope 
dilution  to  measure  pool  size,  synthesis,  and  turnover  rates  of  cholic  and 
chenodeoxycholic acids showed no change 
69. 
Recently, Ericzon et al., using T-tube bile samples, showed that bile secretion and 
composition  were  not  different  in  patients  receiving  either  CsA  or  tacrolimus  after 
transplantation
70. The ACA assessment showed that bile acid-dependent BF was lower 
in the tacrolimus group than in the CsA group. This was interpreted as evidence of a 
more rapid recovery of bile secretion capacity in the first group and may due to a lower 
incidence  of  acute  rejection  or  a  greater  hepatotrophic  effect  of  tacrolimus  as 
compared with CsA. 
2.1.9  Serum bile acid studies 
In 1987, Mora et al., along with Codoceo et al. and Herrera et al. later, investigated the 
potential value of monitoring serum total bile acids (STBA) as a guide to early graft 
function
71-73. They found that STBA levels increased during the anhepatic phase of liver 
transplantation and were rapidly corrected after revascularization. Kohlhaw et al. noted 
a prompt drop of STBA levels after reperfusion in 24 of 30 post-transplant patients, 
which correlated with good early graft function
74. The other six patients showed either 
no fall or a rise in STBA and all subsequently lost their graft. Although STBA levels 
failed  to  correlate  with  other  parameters  of  liver  function,  such  as  serum 
transaminases,  bilirubin,  and  coagulation  factors,  they  concluded  that  STBA  
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monitoring could be helpful in assessing early graft function
74. Muraca et al. extended 
this work and suggested that STBA measurement could be used as a sensitive and 
specific indicator of hepatic graft dysfunction, particularly during graft rejection when 
levels increased 3.6-fold and as a marker of successful anti-rejection therapy when 
levels fell rapidly 
75. Azer et al. also suggested that individual serum bile acids are 
highly sensitive and specific in assessing graft function, and changes in the added 
serum  concentration  of  glycocholic  and  glycodeoxycholic  acids  and  the 
taurocholic/taurodeoxycholic  ratio  usually  antedated  more  traditional  biochemical 
indicators of graft rejection
76. These studies demonstrated the value of STBA levels in 
liver  transplantation;  however,  their  routine  use  has  not  been  adopted  in  clinical 
practice  probably  because  of  the  lack  of  reliable  and  automated  measuring 
techniques. 
2.1.10  Combined serum and biliary bile acid studies 
STBA levels in liver transplant recipients were found to fall progressively in serum with 
concomitant  increases  in  bile  acids  in  bile  after  transplantation
77,78.  The  effect  of 
marked  depletion  of  the  bile  acid  pool  and  the  use  of  T-tube  diversion  was  only 
reversed by day 15 after transplantation, when normal concentrations of bile acids 
were  achieved.  Determination  of  STBA  and  biliary  bile  acid  levels  could  be  used 
simultaneously to detect graft dysfunction 1-3 days earlier than would be indicated by 
other standard liver function tests
77,78. 
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2.2  Modulation of ischaemia reperfusion injury 
 
2.2.1  N-acetylcysteine  
2.2.1.1  Reactive oxygen species  
Reactive oxygen species (ROS) are produced primarily by the mitochondria in cells as 
a  by-product  of  normal  metabolism  during  conversion  of  molecular  oxygen  (O2)  to 
water (H2O).  These include superoxide radical, O2
•-,
  hydrogen peroxide, H2O2,  and 
hydroxyl radical (
•OH). A “radical” is defined as any atom or biomolecule that contains 
unpaired  electrons
79.  These  unpaired e l e c t r o n s   influence  the  chemical  reactivity, 
making the radical more reactive than the corresponding nonradical. Transfer of an 
electron  to  oxygen  by  cytochrome  oxidase  c  (COX)  and  flavin  enzymes  results  in 
production of O2
•-
. The enzyme superoxide dismutase (SOD) converts it into H2O2 and 
O2. Besides normal cells, phagocytes combat microorganisms with oxidative burst of 
ROS.  Peroxisomes  produce  H2O2  during  fatty  acid  degradation.  H2O2  is  mostly 
degraded into water by catalase, but some may also escape into the cell
80.  
Cells have several antioxiodant defence mechanisms. These include vitamins C and 
E, and enzymes such as SOD, catalase and glutathione peroxidase
81. Oxidative stress 
is generated when there is an imbalance between oxidants and antioxidants. ROS can 
modify  or  damage  macromolecules  in  cells  including  oxidation  and  peroxidation  of 
DNA, proteins and lipids
82,83. Trace amounts of metals ions (principally iron or copper) 
react with H2O2 in what is known as the Fenton reaction to produce the toxic radical 
•
OH
84. T h i s  r a d i c a l  c a n  c l e a v e  c o v a l e n t  b o n d s  i n  p r o t e i n s  a n d  c a r b o h y d r a t e s  a n d  
destroy cell membranes. ROS at low concentrations can also serve as mediators for a 
variety  of  signal  transduction  pathways  and  ultimately  gene  expression
85,86.  Both 
oxidants and antioxidants have a profound impact on the expression of genes
87-89.   
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The  body  has  developed  major  antioxidant  defense  mechanisms  to  protect  it  from 
damage from free radicals. An antioxidant is any substance that when present at low 
concentrations, compared with those of an oxidizable substrate, significantly delays or 
prevents oxidation of the substrate
90. The endogenous antioxidants mainly are small 
molecular weight substances that are able to prevent initiation of oxidative damage or 
to limit its propagation and enzymes that convert and detoxify ROS.
89 
Cellular redox balance is in normal circumstances under tight control. However, when 
ROS are produced at levels that cannot be counteracted by endogenous antioxidant 
systems, an imbalance takes place, called oxidative stress
91. This condition can lead to 
the damage of lipids, proteins, carbohydrates, and nucleic acids. Hepatocytes tend to 
be resistant to injury by ROS, since they contain high intracellular concentrations of 
glutathione (GSH), SOD, catalase, and lipid soluble antioxidants
89. 
The antioxidant system is very important for the living species and has allowed them to 
use O2 for energy production, without being exposed to the deleterious effects of O2. 
The composition of antioxidant defences differs in different cells, tissues, and organs. 
Different organs contain different concentrations of antioxidants, and for this reason 
there  is  variability  in  organ  resistance  to  I/R.  However,  there  is  evidence  that  the 
antioxidants operate as a balanced and coordinated system and each relies on the 
action of the others
92,93. 
One of the antioxidant defences in cells is endogenous thiols (sulfhydryl containing 
compounds) such as GSH and thioredoxin
94. 
One of the main systems that can break down H2O2 is the glutathione peroxidases.  
This group includes 4 different isoforms—cellular, gastrointestinal, extracellular, and 
phospholipids
95. They have a major role in removing hydrogen peroxide generated by 
SOD with the oxidation of GSH to its oxidized form, glutathione  disulphide (GSSG) 
(equation 1):  
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2GSH + H2O2 → GSSG + 2H2O (1) 
Glutathione reductase is also an important enzyme in this system. It expresses its 
action through the regeneration of GSH from glutathione disulphide using nicotinamide  
adenine dinucleotide phosphate
96. 
GSH is a tripeptide present in millimolar concentrations in virtually all cells. It is an 
important component of the endogenous antioxidant system. GSH’s main function is to 
act  as  a  cosubstrate  of  glutathione  peroxidase    to  reduce  intracellularly  generated 
peroxides.  GSH also scavenges directly ROS and RNS. GSH is involved in many 
other  metabolic  processes  including  prevention  of  oxidation  of  protein  sulfhydryl 
groups and chelation of copper ions. GSH is also present in the extracellular fluids in 
very small concentrations
89,97. 
Sulphydryl (-SH) groups exert their antioxidant action through the oxidation of the thiol 
(sulfhydryl) group of cysteine. Furthermore, they have a central role as mediators to 
the majority of redox-sensitive cell signaling mechanisms
93,98. The main representative 
in  this  group  is  GSH.  It  serves  as  a  substrate  for  glutathione  peroxidase  and  also 
scavenges ROS directly
99,100. Glutathione peroxidase is the major defense system of 
the cell against ROS found in the cytosol and mitochondria and detoxifies H2O2 very 
effectively. The main problem is that its efficacy is dependent on the availability of 
intracellular GSH and the ability of the cell to re-reduce the oxidized form, glutathione 
disulphide
101. 
N-acetylcysteine ( N A C )  i s  a  t h i o l -containing  compound  used  successfully  in  the 
management of fulminant liver failure after acetaminophen overdose
102,103. NAC enters 
the cell and is hydrolysed to L-cysteine, a reduced-glutathione precursor capable of 
rapidly replenishing depleted intracellular reduced glutathione concentrations
102. NAC 
is a source of sulfhydryl groups in cells and a scavenger of free radicals as it interacts 
with ROS and reactive nitrogen species directly
104.  
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The administration of GSH or its precursors could be expected to be effective if the 
compounds are supplied at the time of declining tissue GSH levels.  Although initial 
experimental studies with GSH administration in liver I/R have not shown a protective 
effect
105, recent studies in rats have shown that intravenous  administration of GSH in 
doses over 100 µmol/h/kg offers significant protection from both warm and cold liver 
ischaemia
106,107. Exogenous GSH administration has limited cellular uptake, due to its 
large  molecular  size.  This  may  limit  its  value  in  situations  associated  with  severe 
intracellular oxidative stress
101. Glutathione precursors such as N-acetylcysteine (NAC) 
can enter cells more easily due to its smaller size. 
2.2.1.2  Pharmacology of N-acetylcysteine 
The  diversity  in  the  pharmacological  uses o f  N A C  i s  d u e  t o  t h e  m u l t i p l e  c h e m i c a l  
properties of the cysteinyl thiol of the molecule. These include its nucleophilicity and 
redox reactions. The main mechanism of action of NAC is through the metabolism to 
cysteine in vivo and synthesis of GSH
108. NAC can also act as a chemical antioxidant. 
In  vitro  studies  show  that  the  interaction  with  free  radical  species  results  in  the 
intermediate formation of NAC thiyl radicals, with NAC disulphide as the major end 
product
109.  
NAC is a well documented substance in medicine. Its defined volume of distribution is 
0.33  L/kg,  its  renal  clearance  is  0.21  L/hr/kg,  and  its  elimination  half-life  is  2.27 
hours
110. Originally, NAC has been used to liquefy mucus in bronchi; NAC is also the 
antidote  for  paracetamol  poisoning.  It  should  also  be  mentioned  that  cysteine 
derivatives have been intensively investigated in military medicine because of their 
protective effects against radiation and that NAC has been investigated as a modulator 
of radiographic contrast agent-induced nephrotoxicity
111-113. 
It is important that NAC is readily hydrolyzed to cysteine. Cysteine is a precursor of 
glutathione.  By  itself,  cysteine  has  no  significant  hemodynamic  effects;  but,  when 
combined  with  nitrates—the  indication  being  either  enhancement  of  the  nitrate  
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mechanism or elimination of nitrate tolerance through -SH donation—it may cause a 
decrease  in  blood  pressure  and,  possibly,  headache  via  intracranial  blood  bed 
dilation
114.  These  findings  were  made  in  a  study  addressing  the  management  of 
unstable angina pectoris and comparing the effects of intravenous nitroglycerin versus 
a  combination  of  intravenous  nitroglycerin  and  NAC
114.  New  combinations  of  NAC 
action  under  pathophysiologic  conditions,  particularly  in  ischaemia-reperfusion 
situations, continue to emerge. The effects of NAC in I/R are summarised in table 1. 
Table 1: Postulated roles for NAC in ischaemia-reperfusion injury  
•  Direct protection against effects of ROS 
•  Redox mechanism cysteine-cystine 
•  Relation to glutathione 
•  Indirect protection against ROS, formation of mixed disulfides with –SH groups 
of membrane peptide/enzymes 
•  Effect on modulating processes and factors 
•  Effect on platelet function 
•  Action under low pH (ischaemic) conditions 
•  Interaction with neutrophils 
•  NAC induced ACE inhibition 
•  Modulation of coagulation 
•  Effect on adhesion processes (via adhesion molecules)  
Modified after Sochman
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2.2.1.3  Role of N-acetylcysteine in endothelial function  
Since  superoxide  can  react  with  the  vasorelaxant  NO  to  produce  peroxynitrite—a 
strong  oxidant—increased  production  of  superoxide  can  inhibit  the  vasorelaxation 
properties  of  a  vessel  by  decreasing  the  level  of  available  NO  and  certain 
epidemiological  studies  suggest  a  beneficial  role  of  antioxidants  for  cardiovascular 
diseases
116. Thus, there is a role for NAC to improve the vasorelaxant properties of a 
vessel  by  suppressing  the  endogenous  levels  of  ROS,  including  superoxide,  and 
thereby  increasing  the  bioavailability  of  NO.  Cytokines  such  as  TNF-α a n d  I L -1, 
among  others,  stimulate  the  expression  of  VCAM-1,  ICAM-1  and  E-selectin  in 
endothelial cells (ECs).  Antioxidants,  NAC  and  pyrrolidine  dithiocarbamate  (PDTC),  
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suppressed  the  cytokine-stimulated  expression  of  VCAM-1  (90%)  by  inhibiting  the 
binding of nuclear factor-κβ (NF-κβ) to the κβ motif of VCAM-1 promoter
117. Under the 
same conditions antioxidants did not affect the expression of ICAM-1
117. Furthermore, 
PDTC was also shown to inhibit VCAM-1-mediated cellular adhesion, suggesting that 
the adhesiveness of endothelium can be inhibited by antioxidants
118. It has also been 
suggested  that  several  radical-generating  systems  are  involved  in  the  induction  of 
VCAM-1 by TNF-α and that NAC and PDTC can inhibit the adhesion of monocytic 
cells to TNF-α treated human umbilical vein ECs (HUVECs)
119. In another report, the 
IL-1-stimulated expression of both VCAM-1 and E-selectin was shown to be inhibited 
by  NAC.  However,  NAC  inhibited  the  expression  of  these  genes  through  different 
mechanisms.  
2.2.1.4  The molecular basis of N-acetylcysteine action 
2.2.1.4.1  The effect of N-acetylcysteine on adhesion 
NAC inhibited the expression of VCAM-1  by  inhibiting  the  binding  of  NF-κβ t o  t h e  
VCAM-1 κβ motif as mentioned above. Under the same conditions, NAC did not inhibit 
the  binding  of  NF-κβ t o  t h e  E -selectin  -κβ m otif,  suggesting  that  NAC  inhibits  E-
selectin expression through a different mechanism
120. Since NF-κβ has been shown to 
be necessary for the cytokine-stimulation of expression of VCAM-1, ICAM-1 and E-
selectin,  the  differential  effect  of  NAC  on  the  binding o f  N F -κβ t o  t h e  -κβ m o t i f  o f  
different adhesion molecule genes suggests that multiple NF-κβ complexes may be 
involved in regulating the expression of these adhesion molecules and that the activity 
of NF-κβ that regulates the expression of VCAM-1 is redox sensitive. The ability of 
NAC to inhibit TNF-α -induced ROS production suggests an involvement of ROS in 
NF-κβ activation and ICAM-1 and E-selectin expression
121,122. It is possible that adhe-
sion  molecule  genes  in  HUVEC  and  pulmonary  artery  ECs  have  differential  redox 
sensitivity. In another study with HUVEC, however, NAC had no impact on cytokine-
induced E-selectin expression, while several protein thiol-modifying agents inhibited  
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it
123. In a study investigating the mechanisms of diabetes-associated atherosclerosis, 
advanced glycation end products were found to augment NF-κβ activity and VCAM-1 
expression that were inhibited by NAC, affirming the role of ROS in the development of 
diabetic vasculopathy
124. NAC specifically prevented TNF-activated inhibitor of NF-κβ 
(I-κβ) kinase-mediated I-κβα phosphorylation and degradation without affecting β and 
θ I-κβs 
125. This agent was utilized to demonstrate that preconditioning of ECs against 
ischaemia via induction of adhesion molecules (ICAM-1, E-selectin), NF-κβ activation 
and subsequent protection was oxidative stress dependent
126. NAC and catalase also 
abolished  the  endothelial  induction  of  ICAM-1  (70%)  and  VCAM-1  (100%), 
respectively,  by  cyclic  strain  and  by  oscillatory  shear  stress,  suggesting  redox 
sensitivity  of  the  signal  transduction  mechanisms
127,128.  The  role  of  the  extracellular 
signal-related kinase (ERK) pathway and ROS in the signalling of cyclic strain-induced 
early growth response-1 gene expression was demonstrated by their suppression with 
NAC
128.  This  agent  also  completely  blocked  IL-4  -induced  oxidative  stress  and 
downstream  activation  of  Sp1  transcription  factor  and  VCAM-1  expression
129.  By 
increasing  glutathione  levels  via  NAC  treatment,  many  harmful  effects  of  TNF-α 
related  to  endothelial  dysfunction  could  be  partially  overcome
130.  NAC  reduced 
GTPase Rac-1-induced superoxide production and blocked cytoskeletal reorganization 
in  ECs 
131.  Although  under  TNF-induced  proinflammatory  conditions  NAC  blocks 
ICAM-1 and VCAM-1 expression, under noninflammatory conditions (without TNF-α), 
this agent increased expression of these genes in HUVEC and human aortic cells in 
some studies
132. Pretreatment of HUVEC with NAC decreased heme-induced oxidative 
stress  and  ICAM-1  expression  by  37%
133,134.  Leptin,  which  is  associated  with  the 
human obesity and atherosclerosis, induced oxidative stress mediators such as ROS, 
INK  and  NF-κβ a c t i v a t i o n ,  a n d  N A C  c o m p l e t e l y  i n h i b i t e d  t h e s e  e v e n t s ,  t h e r e b y  
demonstrating redox-sensitive signaling of hyperleptinemia
135. Induction of the major 
endothelial mitogen, vascular endothelial growth factor (VEGF) by H2O2 (a prominent  
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ROS and a second messenger) was suppressed by NAC in rat heart ECs
136.  
2.2.1.4.2  Effect of N-acetylcysteine on nitric oxide synthase 
The decrease in cardiovascular mortality by antioxidants in epidemiological studies 
may be partly due to the ability of NAC to enhance three-fold the endothelial nitric 
oxide synthase (eNOS) expression and NO bioactivity, a potent vasodilator, which is 
reduced in hypertension and atherosclerosis
137. NAC-mediated increase in glutathione 
levels resulted in the induction of inducible NOS (iNOS) gene transcription and mRNA 
expression
138. By increasing cellular glutathione, NAC was able to attenuate TNF-α-
induced  p38  mitogen-activated protein kinase (MAPK) activity in human pulmonary 
vascular ECs, suggesting redox regulation of p38 MAPK pathway and protective role 
of antioxidants in lung injury
139. While investigating the mechanisms of hyperglycemia-
induced proatherogenic changes in ECs, NAC was shown to block glucose-stimulated 
ERK5 activity
140.  
2.2.1.4.3  Effect of N-acetylcysteine on heme oxygenase  
Induction of heme oxygenase (HO-1) by TNF-α and IL-1 in ECs is also partly ROS 
dependent that can be inhibited by NAC
141. Peroxynitrite generated by interaction of 
NO and superoxide anion leads to the formation of hydroxyl radical, induction of HO-1 
and  EC  apoptosis.  NAC  completely  abolished  HO-1  increase  and  activity
142.  This 
protein may have a protective role against apoptosis. Oscillatory shear- and laminar 
shear stress-induced HO-1 upregulation could be inhibited by NAC in ECs; however, 
the former induced a sustained pro-oxidant response while the latter also activated 
antioxidant defenses
127. Shear flow-induced c-Fos gene expression was mediated by 
ROS as this response was inhibited by NAC
143. NAC inhibited shear-induced tyrosine 
phosphorylation  in  bovine  ECs,  which  is  mediated  by  Rac-l-dependent  ROS 
production. Overall, these studies suggest that NAC could improve endothelial function 
and  may  attenuate  vascular  inflammatory  disease  by  antagonizing  the  effects  of 
intracellular ROS generation, by increasing the bioavailability of nitric oxide and by  
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reducing  leukocyte  adhesion  to  the  endothelium.  Furthermore,  NAC  may  also  be 
beneficial  for  treating  obesity-related  endothelial  dysfunction  and  for  attenuating 
ischaemia-reperfusion  injury  that  remains  to  be  studied  in  patients  with  these 
disorders. 
2.2.1.5  N-acetylcysteine in the liver 
Oxidative  stress  generated  by  various  conditions  activates  hepatic  stellate  cells 
(HSCs)  and  constitutes  a  possible  link  between  chronic  liver  damage  and  hepatic 
fibrosis  ultimately  leading  to  cirrhosis.  NAC  administration  in  rats  reduced  di-
methylnitrosamine (a profibrotic agent) -induced fibronectin deposit
144. At the molecular 
level, NAC arrested HSCs at the G1 phase of the cell cycle by modifying the redox 
status of cysteines in Raf-1, MEK and ERK signalling proteins, resulting in sustained 
activation of ERK-MAPK, induction of the cell cycle inhibitor p21Cip1 and increased 
Sp1 phosphorylation. These actions of NAC were related to its reducing activity 
145. 
Co-administration of NAC with toxic cadmium in rats diminished lipid peroxidation and 
gave protection against hepatic toxicity, suggesting the role of oxidative stress in the 
toxicity
146. Administration of NAC within 10-18 hours in patients with acetaminophen 
overdose  and  alcoholism  prevents  liver  damage  and  significantly  reduces 
mortality
147,148. The possible mechanisms of antitoxicity include improved liver blood flow, 
glutathione replenishment and free radical scavenging
149. Cocaine-induced mitochondrial 
damage in hepatocytes was partially reduced by NAC
150. Liver injury by oxidative stress 
during reperfusion of liver transplantation can be significantly reduced by NAC treatment 
through  downregulation  of  α-glutathione  S-transferase  and  circulating  adhesion 
molecules, sICAM-1 and sVCAM-1 in the donor liver
151. NAC treatment of ischaemia and 
reperfusion-injured rat livers blocked NF-κβ activity and iNOS expression
152. Hepatocyte 
apoptosis induced by transplantation related cold storage of rat liver could be diminished 
by NAC treatment, and its addition before rewarming may be beneficial for successful 
transplantation
153. Hepatitis C virus nonstructural protein 5A or hepatitis B virus X protein  
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generate oxidative stress in the liver and activate NF-κβ and STAT3 transcription factors 
that can be eliminated by NAC
154. NAC and related agents such as S,N-diacetylcysteine 
monoethyl  ester  could  improve  the  status  of  protective  -SH  compounds  such  as 
glutathione in rat liver
155. Glutathione levels depleted by acetaminophen overdose in HIV 
infected patients can be replenished by NAC. Thus, NAC has therapeutic potential for 
liver  against  oxidative  stress,  transplantation-related  damage,  fibrosis,  hepatitis, 
acetaminophen overdose, chronic alcoholism and heavy metal toxicity. 
2.2.1.6  Role of N-acetylcysteine in liver ischaemia-reperfusion injury 
NAC  has  only  recently  been  recognized  to  protect  the  liver  from  warm  and  cold 
IRI
156,157 w h e r e  i t  w a s  u s e d  a s  a  g l u t a t h i o n e  d o n o r
158 a s  i t  i n c r e a s e d  r e d u c e d  
glutathione  levels  in  the  liver  after  reperfusion
159.  It  was  also  seen  to  enhance 
sinusoidal  perfusion  by  intravital  microscopy  on  reperfusion
160 and t r ans pl an tation
45. 
Improvement  in  microcirculation  was  observed  with  NAC  increasing  acinar  and 
sinusoidal  perfusion,  on  I/R  and  on  transplantation,  and  reducing  neutrophil 
sequestration,  on  transplantation
161.  Its  use  during  preservation  revealed  reduced 
sinusoidal o x i d a t i v e  s t r e s s ,  a n d ,  u n d e r  a  g l u t a t h i o n e -depleted  conditions,  reduced 
hepatocellular and sinusoidal oxidative stress
162. The use of NAC-pretreatment in a 
large  animal  transplantation  model  showed  that  NAC  less  cytolysis,  transaminase 
elevation, better coagulation, it reduced the incidence of graft dysfunction and primary 
non-function
163 although this is still controversial
164. NAC was also observed to reduce 
remote  lung  injury  following  liver  I/R
165,166.  Further  investigation  the  mechanisms  by 
which NAC was able to produce these effects revealed that it inhibited TNF-α and IL-
10
167,  maintained  tissue  glutathione  levels,  reduced  the  rise  in  malondialdehyde, 
glutathione  peroxidase  and  superoxide  catalase,  following  I/R,  and  increased 
glutathione reductase activities
168,169. The effect of oxidative stress on NF-κβ and iNOS 
was elucidated when NAC was seen to inhibit the expression of iNOS mRNA and 
block upregulated NF-κβ binding activity on reperfusion
152. NAC was seen to inhibit the  
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kinase JNK1/SAPK1, a member of MAPK family, which regulates cell adaptation to 
stressful conditions
170. 
2.2.1.7  Role of N-acetylcysteine in clinical liver transplantation 
In  the  first  reported  trial  in  clinical  liver  transplantation,  NAC  failed  to  show  any 
beneficial effect of the intraoperative administration of NAC on hemodynamics and 
graft  function  in  liver  transplantation  in  cirrhotic  patients
171.  However  it  was  later 
reported to produce a distinct reduction in IRI and improved liver function with less 
elevated  peak  transaminases,  better  macrocirculation,  improved  liver  synthetic 
function  and  a  lower  incidence  of  PNF
172.  NAC  was  observed  to  increase  selectin 
shedding following OLT
173. Furthermore, it was observed to inhibited the increase in 
circulating ICAM-1 and VCAM-1 24 hr after reperfusion in OLT and reduced the rise in 
alpha-glutathione S-transferase after reperfusion of the donor liver
151. Although not all 
the effects of NAC observed in OLT were beneficial
174. 
In  summary,  NAC  can  scavenge  ROS,  increase  glutathione  levels,  undergo a u t o -
oxidation (and produce H2O2)  and  serve  as  reducing  agent.  Activation  of  NF-κβ i n 
response to a variety of signals (IL-1, TNF, H2O2) can be inhibited by NAC, suggesting 
ROS as common signalling modulators. NAC has been an extensively utilized tool for 
investigating redox sensitivity of biological or pathological processes. However, due to 
multiple activities of NAC and the possibility of direct modification of certain signals 
and signalling proteins, caution is warranted in interpretations. Such putative redox-
sensitive  mechanisms  should  be  confirmed  by  additional  approaches  such  as 
overexpression  of  antioxidant  enzymes  and  proteins.  In  liver,  NAC  diminishes 
oxidative stress by various agents, and gives some protection against fibrosis, viral 
infections and toxicity
117.  
2.2.2  Glycine 
Several process have been implicated in the cascade of events that contribute to IRI, 
including  the  generation  of  ROS
101,  generation  of  pH  paradox  with  mitochondrial  
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permeability transition
175, generation of inflammatory cytokines
176 and microcirculatory 
failure, no reflow
177 and the reflow paradox
178. Complement activation is related to KC 
and  neutrophil  activation,  with  inflammatory  and  endothelial  cell  activation  further 
aggravating microcirculatory failure and hepatocytic injury
179. 
Since  the  mechanisms  of  IRI  are  diverse,  interventions  at  multiple  sites  may  be 
necessary to achieve reduction in IRI
180. Thus, the earlier in the cascade the blockade 
is achieved, the more effective it may be. In this respect, in addition to microcirculation, 
blocking activation of KCs and neutrophils provides an important pathway to modulate 
IRI
179.  
2.2.2.1  Kupffer cell activation in I/R 
The role of Kupfer cells (KCs) and neutrophils in IRI is pivotal and has been previously 
reviewed
179-182.  In  brief, t h i s  involves  production  of  redox  stress,  inflammatory 
cytokines,  chemokines  and  proteases.  KCs  produce  a  burst  of  SO d u r i n g  
reperfusion
183,184, as well as cytokines such as TNFα and IL-1. KCs are responsible for 
the  initial  burst  of  redox  stress  and  organ  injury
185 w i t h  n e u t r o p h i l s  r e s p o n s i b l e  f o r  
injury  in  the  late  phase
186.  Blocking  KC  activation  reduces  injury  in  both  phases, 
possibly through blocking the chemotactic effect of KCs on neutrophils
187. Inflammatory 
cytokines produced by activated KCs result in local injury through caspase activation 
and  are  also  implicated  in  activation  and  expression  of  cell  adhesion  molecules. 
Neutrophils, once activated, contribute to the injury through ROS production
188 as well 
as protease secretion
189.  
To  achieve  modulation  of  hepatic  IRI  requires  targeting  of  several  parts  of  the 
inflammatory cascade. Glycine is a particularly good candidate as it is non-toxic at 
doses that can block KC, neutrophil and possibly lymphocyte activation
190. In addition 
glycine provides and broad non-specific cytoprotective effect. Glycine is part of the 
normal human diet. The body is able to synthesize glycine in the absence of dietary 
intake,  from  serine  and  in  the  central  nervous  system  from  threonine,  and  it  is  
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therefore classified as a non-essential amino acid. The average daily diet provides up 
to 2 grams of glycine, as it is the second most common amino acid found in proteins, 
with fish, meat, beans and dairy products being rich sources
190.  
2.2.2.2  Anti-inflammatory action of glycine 
Glycine is an inhibitory neurotransmitter in the central nervous system where it hyper-
polarizes the post synaptic spinal motor neurons
191 and has been used therapeutically 
in central nervous disorders. In 1987, Weinberg et al discovered that the cytoprotective 
effect of glycine on hypoxic cultured renal tubule cells was equivalent to glutathione
192. 
In 1991 Marsh et al reported on the cytoprotective effects of glycine on cold stored rat 
hepatocytes
193, and later that it protected hepatocytes from mitochondrial inhibitors
194. 
In  1994,  Nichols  et  al  made  progress  in  elucidating  the  mechanism  of  this 
cytoprotection  when  they  demonstrated  that  glycine  inhibited  extra  cellular  Ca
+2 
dependent non-lysosomal proteolysis in anoxic hepatocytes
195.  
Intracellular  calcium  is  confined  to  the  endoplasmic  reticulum
196 k e e p i n g  t h e  
concentration of free cytoplasmic calcium (Caf) low while the extracellular fluid has a 
relatively higher concentration of calcium. Mammalian cells express two types of Ca
+2 
channels, voltage gated and receptor (agonist/antagonist) gated. Cell injury leads to 
an  increase  in  intracellular  Caf b y  o p e n i n g  v o l t a g e  g a t e d  C a
+2 c h a n n e l s
197,198. 
Membrane voltage gated channels are activated by membrane depolarization. How 
this membrane depolarization is triggered in IRI and other inflammatory conditions is 
not clearly understood
199, but their activation results in cytoplasmic influx of Ca
+2 along 
the concentration gradient. Glycine has been shown to reduce this rise in intracellular 
Ca
+2.  This  is  achieved  by  through  glycine  receptor  (GlyR)  activation  resulting  in 
increased  intracellular  Cl
-1,  which  hyperpolarizes  the  cell  membrane,  protecting  it 
against  IR-induced  depolarization  thereby  preventing  voltage  gated  Ca
+2 c h a n n e l  
activation
200.  Resultant  reduced  cellular  influx  of  extracellular  calcium  may  be 
beneficial in preventing calcium mediated cell injury. Voltage gated Ca
+2 channels are  
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present in the membranes of a variety of immune and other cells, and may be involved 
in the pathogenesis of cell injury
201. Glycine induced movement of radiolabled Cl in 
alveolar  and  splenic  macrophages  as  well  as  hepatocytes  and  peritoneal 
neutrophils
202-204 has been used to provide evidence for glycine receptors in these cells, 
and glycine has been shown to reduce intracellular Caf following lipopolysaccharide 
(LPS) stimulation in a variety of cell types. This reduced influx of Ca
+2 by glycine has 
been shown to reduce production of inflammatory mediators and increase production 
of anti-inflammatory mediators. 
KCs are known to contain voltage sensitive Ca
+2 channels and an increase in the free 
intracellular  Ca
+2  (Caf)  concentration  is  known  to  be  essential  for  LPS-mediated 
inflammatory  cytokine  secretion  by  activated  KCs
190.  In  1997,  Ikejima  et  al 
demonstrated that KC membranes also expressed glycine sensitive Cl
-1 channels, and 
showed that glycine produces hyperpolarisation of the KC membranes and reduces 
LPS-induced  TNF-α p r o d u c t i o n  b y  i n h i b i t i n g  C a
+2 i n f l u x .  I n  1 9 9 9 ,  W h e e l e r  e t  a l  
provided  evidence  for  the  presence  of  glycine  sensitive  Cl
-1 c h a n n e l s  o n  a l v e o l a r  
macrophage cell membranes, and glycine mediated suppression of TNF-α and LPS-
induced ROS production
204. 
Recently  further  evidence  has  accumulated  rapidly  that  glycine  has  significant 
cytoprotective  and  anti-inflammatory  activity.  These  effects  depend  on  special 
structural  characteristics,  which  glycine  shares  with  other  agents  such  as  alanine, 
taurine and strychnine
205. 
2.2.2.3  Glycine receptors 
Glycine receptor (GlyR) stimulation produces hyperpolarisation of the cell membrane 
by Cl
-1 influx and consequent inhibition of excitation under inflammatory stimuli. GlyR 
were  originally  discovered  in  the  CNS,  where  glycine  acts  as  an  inhibitory 
neurotransmitter, later GlyR were found to be present on peripheral cells
206.  
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2.2.2.3.1  Central Glycine receptors 
Glycine is an inhibitory neurotransmitter in the spinal cord and brainstem
207, and is 
responsible for the reciprocal inhibition necessary for spinal cord reflexes and muscle 
tone
208. This inhibitory effect is mediated by GlyR, which are primarily localized at the 
post synaptic membrane in the spinal cord, brain stem, caudal brain and retina
209. The 
receptor consists of a glycine gated chloride channel.  
In  the  brain,  glycine  acts  as  the  principal  mediator  of  fast  inhibitory 
neurotransmission
210. Fast synaptic transmission involves conversion of an electrical 
signal  into  a  chemical  signal  at  the  pre-synaptic  terminal.  The  neurotransmitter  so 
released causes postsynaptic ion channel opening. Opening of cationic channels (Na
+ 
and Ca
+2) by nicotinic acetylcholine, glutamate or serotonin receptors leads to post-
synaptic membrane depolarisation and neuronal firing whereas activation of anionic 
(Cl
-1 and bicarbonate) channels by glycine and gamma aminobutyric acid, respectively, 
causes post synaptic membrane hyperpolarisation and suppression of neuronal firing. 
Activation of the GlyR makes the cells resistant to stimulatory neurotransmitters
190. 
2.2.2.3.2  Peripheral Glycine receptors 
Peripheral GlyR are present in almost all cell types studied including white cells i.e. 
Kupffer cells
211, alveolar macrophages (AMs)
211, splenic macrophages
211, monocytes
212, 
neutrophils
203,211, lymphocytes
213, epithelial cells such as hepatocytes
214 and ECs
215.  
Use of Ca
+2 sensitive dye has shown that glycine inhibits LPS-induced increase in Caf 
in KCs
200, AMs
204, splenic macrophages
202, peritoneal neutrophils (PNs)
203, rat T-cells
213, 
and VEGF induced increase in Caf in ECs
215 and phenylephrine and prostaglandin E2 
mediated Caf  increase in hepatocytes
214. 
Glycine  causes  a  dose  dependent  influx o f  r a d i o l a b e l l e d  C l
-1  in  AMs
204,  splenic 
macrophages
202 a n d  i n  P N s
203.  The  effect  of  glycine  on  Caf i s  d e p e n d e n t  o n  
extracellular Cl
-1 in AMs
204, PNs
203, and ECs
215, while the LPS-induced rise in Caf is  
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independent  of  extracellular  Cl
-1 i n  A Ms
204 a n d  i n  PNs
203.  This  suggests  that  under 
some conditions the effect of glycine is directly related to increased intracellular Cl
-1 
flux, but under other conditions, other mechanisms of action may be involved
190. 
Molecular  evidence  for  the  presence  of  GlyR  on  peripheral  cells  is  based  on  the 
demonstration of mRNA and protein expression of GlyR subunits in KCs and AMs
211. 
Yamashina et al provided evidence for the presence of GlyR β subunit on ECs using 
Western Blot analysis
215. 
2.2.2.4  Cytoprotective action of glycine 
The  cytoprotective  effect  of  glycine  has  been  shown  to  be  independent  of  Ca
+2 
homeostasis and Cl
-1 conductance in cultured cells
216. Calcium has been shown as the 
final common pathway leading to cell death induced by toxic influences
217, and rise in 
intracellular Ca
+2 is a common feature between apoptotic and necrotic mechanisms of 
cell  death
218.  Glycine  can  still  provide  cytoprotection  despite  allowing  a  rise  in 
intracellular Ca
+2 and can prevent  l ysi s i n cel l s cul t ured i n l ow Ca
+2 medi um
190. As 
opposed to it’s anti-inflammatory GlyR-mediated blunting of the intracellular Ca
+2 rise, 
the cytoprotective effect is possibly mediated by blocking pre-lytic opening of large cell 
membrane  pores  (death  channels),  which  would  normally  allow  large  molecules  to 
leak into, or out of the cell and lead to cell lysis. Glycine prevents the cell membrane 
bleb dilatation in response to increasing membrane permeability
190. 
After  exposure  to  toxin  or  ATP  depletion,  cell  permeability  increases
219,  eventually 
leading  to  cell  lysis.  Evidence  has  accumulated  suggesting  the  opening  of  glycine 
responsive cell membrane channels, as a terminal mechanism of cell lysis. Although 
the  presence  of  glycine  in  the m e d i u m  d o e s  n o t  i n f l u e n c e  t h e  e a r l y  c h a n g e s  i n  
molecular permeability, or the morphological changes occurring after toxic injury or 
ATP depletion, it does prevent the terminal changes and cell lysis
219. 
Hepatic  IRI  leads  to  cellular  ultrastructural  changes  such  as  the  vesicular  
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development,  alterations  of  junctional  complexes  and  the  development  of  electron 
densities
220. Cell swelling and bleb formation has also been described in hepatocytes 
after  cold  and  warm  IRI
221,222.  Estacion  et  al  have  shown  that  glycine  containing 
medium, added to bovine aortic endothelial cells blocked cell permeability to large 
molecules,  prevented  dilatation  of  blebs  and  cell  lysis,  providing  evidence  of 
cytoprotection independent of the presence of GlyR
219.  
 
2.2.3  Steatosis 
Hepatic steatosis is a common problem in Western countries, with an incidence of 6-
11% in autopsies of accidental deaths
223,224 and is as high as 20% in hepatic resection 
patients 
225 and 26% in potential donors for liver transplantation
226,227 (possibly due to 
population selection, poor nutritional status and prolonged intensive care units)
228,229. 
2.2.3.1  Steatosis in liver transplantation 
There  is  an  association  between  severe  donor  steatosis  and  primary  nonfunction 
(PNF)
230 o r  d y s f u n c t i o n
231.  In  a  multivariate  analysis  including  227  patients,  severe 
steatosis was identified as an important significant risk factor for primary graft non- or 
dysfunction
3.  This  has  been  confirmed  by  others
232-234 a n d  e s t i m a t e d  t h a t  s e v e r e  
steatosis is associated with a 60% risk of PNF
234. Moderate steatosis has no impact on 
graft  or  patient  survival
234,235,  but  primary  graft  dysfunction  (e.g.,  elevated  serum 
transaminases)  was  uniformly  more  frequent  in  the  steatotic  groups  which  is 
associated with decreased 1-year survival of patients
4,229,236. 
2.2.3.2  Steatosis in liver resection 
There is also an increased risk of complications for liver resections in fatty livers
237 with 
a mortality rate up to 14% in patients undergoing major hepatic resections
238. There is 
currently  a  consensus  in  the  hepatobiliary  and  transplant  community  that  steatosis 
increases  the  risk  of  postoperative  complications  and  patient  death  following  liver 
transplantation and major liver resection. Until recently most transplant centres refused  
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to accept steatotic livers with more than 20% steatosis. With increasing demand for 
livers and a static donor pool, the interest in steatotic donors has increased
229.  
2.2.3.3  Impaired microcirculation 
During liver resection, hepatic inflow occlusion (Pringle manoeuvre) is often used to 
minimize blood loss. In addition, cold preservation, rewarming, and warm ischaemia 
are inherent in liver transplantation procedures. Impaired microcirculation has been 
proposed as an important factor in the decreased tolerance of the steatotic liver to 
ischemic injury. Fat accumulation in the cytoplasm of the hepatocytes is associated 
with  an  increase  in  the  cell  volume
239,240 w h i c h  m a y  r e s u l t  i n  p a r t i a l  o r  c o m p l e t e  
obstruction of the hepatic sinusoidal space
239-241. The impaired microcirculation may 
amplify the negative effects of additional ischemic insults. Ischaemia and reperfusion 
injuries also cause cell swelling and adherence of platelets and leukocytes
242,243, which 
in combination with pre-existing reduced sinusoidal space may lead to a more severe 
injury. Sinusoidal flow has been shown to decrease by half in rat livers containing 30 to 
60% steatosis compared with controls
244,245. 
2.2.3.4  Steatosis and hepatic energy metabolism 
Steatosis of different aetiologies leads to an accumulation of nonesterified fatty acids 
which have an inhibitory effect on the β-oxidation system resulting in a decrease of 
acetyl-coenzyme  A  (CoA)  production.  Acetyl-CoA  is  an  important  precursor  for  the 
Krebs  cycle  and  gluconeogenesis.  Thus  important  energy  sources  for  the  liver,  β-
oxidation and gluconeogenesis, are decreased in steatosis
229,246-249.  
2.2.3.5  Other mechanisms of injury in steatotic livers 
Steatosis  increased  neutrophil a d h e s i o n  f o l l o w i n g  6 0  m i n u t e s  o f  n o r m o t h e r m i c  
ischaemia
37,250. Others have suggested KC dysfunction as a factor involved in poor 
outcome in the fatty liver
250.  
A feature of ischemic liver injury is apoptosis, an active energy-requiring type of cell 
death. In apoptosis, unwanted cells are transformed into smaller apoptotic bodies that  
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are removed with minimal inflammation. The amount of apoptotic hepatocytes after I/R 
correlates  with  liver  injury  and  survival
251,252.  Antiapoptotic  strategies  are  highly 
protective  against  ischemic  injury  of  the  liver
253-256.  Steatotic  livers  have  shown  a 
dysfunction of the apoptotic pathway
256. Massive hepatocyte necrosis occurred in fatty 
rats after 60 minutes of ischaemia, whereas only minimal necrosis was present in the 
lean  control  group,  blocking  apoptosis  significantly  reduced  ischemic  injury  in  lean 
animals but had no effect in steatotic rats
229,256. 
Steatosis  is  associated  with  decreased  hepatic  microcirculation,  a  dysfunction  of 
mitochondrial ATP generation, and impaired apoptosis as the physiologic form of cell 
death is impaired in fatty hepatocytes, resulting in the necrotic form of cell death with 
the release of cytoplasmic contents, which further aggravates inflammation and liver 
injury.  Finally,  liver  regeneration  is  reduced  in  steatosis  and  tissue  loss  cannot  be 
restored
229,257. 
As a period of ischaemia is often necessary in liver surgery, and is inevitable in organ 
retrieval  and  transplantation,  pharmacological  modulation  could  potentially  protect 
steatotic livers, minimizing the detrimental effects of IRI.  
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2.2.4  Ischaemic preconditioning 
 
Murry et al. first described IPC on observing that brief periods of ischaemia improves 
the tolerance to subsequent, prolonged ischaemia in various organ systems
258.  IPC 
has been shown to decrease liver injury after warm IR
34,259-261  as well as after cold 
ischemic storage
262-264. IPC is protective against IRI in normal
261-264 and fatty liver
265. The 
benefit  of  IPC  has  also  been  proven  in  human  liver  resection  surgery
260.  Recent 
studies show that IPC increases the tolerance of fatty livers to IRI in animal model of 
steatosis
265,266. 
IPC  significantly  improves b l o o d  f l o w  i n  t h e  m i c r o c i r c u l a t i o n  d u r i n g  t h e  r e p e r f u s i o n  
phase
267 in a rat IRI model and NIRS showed that preconditioned livers exposed to 
hypoxia  maintained  their  COX r e d o x  s t a t e
268.  There  is  growing  evidence  that 
mitochondria are a major target of IRI
269.  
The mechanism of ischemic preconditioning is uncertain, but it is considered to be a 
biphasic event. The early stage of protection lasts about 2 hours after the trigger, while 
a second phase of protection occurs during the following 24 hours. As the effects can 
be observed shortly after the stimulus, the mechanisms involved might be related to 
pre-existing  molecules  as  effectors  of  natural  defense  events  against  subsequent 
ischemic injury
270. 
IPC modulates oxidative stress by limiting the accumulation of xanthine, and through 
reducing  the  conversion  of  xanthine  dehydrogenase  to  xanthine  oxidase  (XO).  XO 
requires molecular oxygen introduced on tissue reperfusion to convert hypoxanthine to 
xanthine  with  SO  release.  IPC  inhibits  XO-derived  oxidant  stress  thus  limiting  this 
pathway of oxidative injury
271. 
IPC reduces oxidative stress by suppression of ROS released by KCs, because IPC 
has  no  benefit  on  Kupffer  cell-depleted  rat  livers
272.  Ischemic  pre-conditioning 
decreases endothelial adhesion molecule expression (P-selectin) in warm IRI of the  
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rodent liver, thereby diminishing the neutrophil adhesion and resulting in decrease of 
oxidative neutrophil-mediated damage
243,272. 
In case of sustained oxygen deficit, ATP is rapidly consumed to generate energy for 
cellular  metabolism,  thereby  resulting  in  adenosine  production.  At  some  stage  in 
reperfusion,  adenosine  is  washed  out  of  the  tissues,  causing  adenosine  depletion. 
Moreover, adenosine is transformed to hypoxanthine and xanthine leading to ROS 
production. Adenosine-related mechanisms during IPC seem to be mediated by A2 
receptors,  because  their  blockade  results  in  inhibition  of  NO  production  and 
subsequent cessation of protective effects of IPC
272,273. 
Adenosine activates eNOS, resulting in NO synthesis. It is widely accepted that NO is 
an important mediator of IRI associated with improvement of liver microcirculation and 
tissue  oxygenation  by  attenuating  neutrophil  adherence  and  inhibiting  platelet 
aggregation. NO inhibits the release of endothelins—a member of a family of potent 
and  long-acting  vasoconstrictive  mediators
274.  Inhibition  of  NO  synthesis  blocks  the 
protective effect of IPC
275,276. IPC stimulates the activity of various intracellular kinases 
via activation of cell membrane receptors by adenosine and other effectors. Protein 
kinase C (PKC) and p38 mitogen-activated protein kinase have been shown to reduce 
hepatocyte  injury.  This  is  mainly  due  to  activation  of  another  intracellular  kinase 
(protein  kinase  B;  Akt/PKB),  which  has  antiapoptotic  effects  and  stimulates  NO 
synthesis via eNOS
277,278. 
IPC of an organ may protect others organs from IRI. This mechanism is recognized as 
remote  IPC.  It  was  first  described  in  a  model  of  canine  of  heart  ischaemia,  and 
involves  the  release  of  effectors  into  systemic  circulation.  Liver  preconditioning-
induced  resistance  to  IRI d a m a g e  i n  r e m o t e  o r g a n s  i s  t h o u g h t  t o  b e  e l i c i t e d  b y  
decreased hepatic TNF-α release. 
Recently, it was shown that remote ischemic preconditioning of the hind limb reduces  
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warm  ischaemia-reperfusion  injury  in  the  livers  of  rabbits  and  rats.  Although  the 
mechanism  of  remote  ischemic  preconditioning  remains  poorly  understood—
adenosine, bradykinin, and opioids are released in systemic circulation after sublethal 
ischemic injury seems to be involved in the process
279,280. 
Delayed  ischemic  preconditioning  onsets 2 4  h o u r s  a f t e r  r e p e r f u s i o n  a n d  p r o t e c t i o n  
may persist for several days. Gene expression and synthesis of proteins have been 
investigated in delayed ischemic preconditioning. The activation of NF-kβ and other 
transcription  factors  can  induce  the  synthesis  of  iNOS,  heat-shock  proteins,  and 
antioxidants. Heat-shock proteins contribute to the diminishment of TNF-α synthesis 
and reduce inflammatory injury in livers subjected to IPC
259,281. 
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2.3  Magnetic resonance  
2.3.1  Introduction 
In this chapter I would like to review the history of magnetic resonance (MR) and its 
applications in medicine. I would like to focus on magnetic resonance spectroscopy 
(MRS) and its growing importance in medical applications. 
It is difficult for those from a medical background to understand MR applications, to 
follow MR literature, and to interpret the MR specific terminology. Extensive use of 
mathematical treatment of the MR effect and its applications is thus avoided in this 
thesis.  
Clinicians will most likely encounter MR through looking at a diagnostic MR images 
(MRI) displaying anatomy with excellent contrast and resolution. When the first human 
MR images became available, radiologists and clinicians were already familiar with 
sectional images of the body through the advent of computer tomography (CT). To 
relate MRI as an extension of CT, ultrasound (US) or other morphological imaging 
modalities  would  be  a  great  injustice.  CT  is  modulated  through  only  one  major 
parameter, the energy of X-rays, and displays only one measured parameter, X-ray 
absorption. In contrast, MR images are determined by multiple parameters and the 
way  an  image  is  acquired  can  change  the  appearance  of  the  picture  and  the 
information  content  completely.  The  physics  of  image  acquisition  manipulates  the 
contrast and resolution of the image and is used to render other parameters such as 
flow, oxygenation, chemical environment, and many other characteristics determined 
by the molecular structure of tissue
282. 
Very  briefly  MR  is  produced  when  nuclei  with  a  nuclear  spin  (with  non-zero  spin 
numbers) are subjected to a strong magnetic field, they are split into a set with the 
sum of their spin aligned parallel to the magnetic field and a set whose sum spin are 
anti-parallel.  The  nuclei  spin  (precess)  around  the  axial  magnetic  field.  While  the 
proportion is nearly equal, slightly more are oriented at the low energy angle. The  
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frequency with which the dipole moments precess is called the “Larmor frequency”. 
The  nuclei  are  then  briefly  exposed  to  pulses  of  electromagnetic  radiofrequency 
energy  (RF)  in  a  plane  perpendicular  to  the  magnetic  field,  causing  some  of  the 
magnetically aligned nuclei to assume a temporary non-aligned high-energy state. The 
frequency  of  the  pulses is governed by the “Larmor equation”. As the high-energy 
nuclei relax and realign, they emit energy at rates, which are recorded to provide a 
wealth of information about their environment.  
One of the most informative parameters encoded in the magnetic resonance signal is 
the “chemical shift”. While this information is only partially used in MRI, it is the very 
basis  of  magnetic  resonance  spectroscopy  and  of  the  applications  in  physics, 
chemistry, and biology. An MR spectrum represents signals of different metabolites 
ordered in a plot along a chemical shift axis. MR spectroscopy is a representation of 
the  different  metabolites  in  the  tissue  or  liquid  being  analysed.  The  wealth  of 
information recorded in a spectrum makes this method rather difficult and demanding 
to interpret. Single proteins or other macromolecules can be characterized perfectly in 
well-defined solutions, even allowing the analysis of their three-dimensional structure. 
In  vivo,  MR  spectra  are  generated  by  a  complicated  mixture  of  elements  and 
metabolites  in  tissue,  making  the  interpretation  of  the  crowded  spectra  difficult. 
However, it represents a unique tool to obtain a chemical “snap shot” non-invasively 
and from living tissue
282. 
2.3.2  Historical perspective 
While MRI has become established and well known in medicine, only a few specialists 
really know that the effect of nuclear magnetism has its roots in physics. This would 
only  be  of  historical  interest  if  the  development  of  MR  in  medicine  had  been 
completed. However, looking at the history of MR and at its applications in different 
fields reveals the flexibility of this modality and gives an indication to the potential of 
this  method
282-284.  In  this  respect,  looking  back  at  the  history  of  MR  may  help  in  
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understanding its future. 
2.3.2.1  Scattered beginnings 
The  beginning  of  MR  as  we  know  it  today  can  be  traced  back  to  the  famous 
experiment of Stern and Gerlach in 1921. Stern and Gerlach passed a beam of silver 
atoms  through  an  inhomogeneous  magnetic  field  and  observed  that  two  distinct 
beams were formed instead of a homogeneously spreading one
285. This observation 
was  repeated  in  a  subsequent  experiment  in  Stern”s  laboratory  in  1933  using 
hydrogen molecules
286. The fact that a discrete number of beams were formed could 
not at the time be explained by classical physics. It required the theoretical basis of 
quantum  mechanics  to  reveal  that  these  beams  were  formed  due  to  the  angular 
momentum, i.e., the “spin” of a nucleus or an electron, and magnetic moment, they are 
strongly related to each other and exist in a limited number of allowed states only. 
These  first  experiments  that  lead  eventually  to  the  discovery  of  MR  were  initially 
designed  to  understand  quantum  mechanics  and  the  characteristics  of  nuclei  and 
electrons. Otto Stern was subsequently awarded the Nobel Prize in Physics in 1943
282. 
A  series  of  experiments  of  several  groups  followed,  still  aimed  at  an  exact 
determination of the magnetic properties of the nuclei. One of these scientists was 
Isidor Isaac Rabi who published a one page report on “A new method of Measuring 
Nuclear Magnetic Moment” using oscillating fields to reorient the nuclear spins
287. Rabi 
received the 1944 Nobel Prize in Physics for this discovery; however, not all ingenious 
experiments  lead  to  success  and  awards.  We  know  of  at  least  two  scientists  who 
contributed significantly to the field but failed in one way or the other. It seems that 
Zavoisky, a scientist in Kazan/Russia, observed an NMR effect in 1941 but was not 
able to reproduce it, mainly due to the war
284. Gorter, attempted to measure nuclear 
paramagnetism, but failed several times
288,289, however he inspired Rabi”s group for 
their successful experiment
282,287. 
Although World War II diverted recourses away from theoretical physics, it promoted  
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the  development  of  radar  and s u b s e q u e n t l y  i m p r o v e d  r a d i o -transmitters  and 
amplifiers, which were necessary for the discovery of magnetic resonance. At the end 
of the war, Purcell, Torrey, and Pound
290 published a report on NMR effects in solids in 
1946. At the same time, Bloch, Hansen, and Packard
291,292 made a similar attempt to 
measure what they called “Nuclear Induction”. It seems that it was not immediately 
clear that the two independent groups described the same effect. These reports were 
important as they transferred knowledge about Rabi”s work in molecular beams into 
an effect that had been observed in bulk matter. The scientific world recognized the 
importance  of  this  work  that  led  to  the  discovery  of  modern  NMR  and  Bloch  and 
Purcell received the 1952 Nobel Prize in Physics
282.  
Thus far, NMR contributed almost exclusively to the development of nuclear physics 
and  the  aim  of  the  research  in  this  field  still  was  to  characterize  materials  and  to 
measure nuclear parameters. A major step forward from measuring nuclear properties 
to  the  more  detailed  characterization  of  matter  came  in  1948  in  the  form  of  the 
landmark paper of Bloembergen, Purcell, and Pound (“B.P.P. theory”) on relaxation 
effects and the influence of motion
293.  
2.3.2.2  The chemistry revealed 
The development of NMR has gone hand in hand with the development of related 
technologies. The next achievement was only made possible by the improvement in 
the strength and homogeneity of the magnets used in the experiments in the early 
1950s. The phenomenon of a chemical shift was observed when stronger and more 
uniform  magnetic  fields  were  used.  Up  to  then,  different  parts  of  the  sample 
experienced very different magnetic field strengths, and the observed signal of the 
sample was a mixture of responses. In homogeneous magnets, all parts of the sample 
experience the same field strength and, therefore, it was expected that the response 
would occur at a single frequency. However, instead of observing a single resonance 
line in a spectrum, various groups separately began to observe multiple resonance  
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lines when they improved their magnets
283,284.  
Arnold  et  al.  observed  that  the  relative  position  of  the  left-most  resonance  in  the 
spectrum was temperature dependent
294. Liddel and Ramsey explained this effect by 
hydrogen bonds between the molecules and a chemical exchange of these groups
295. 
Proctor and Yu observed an additional effect that was still hidden in Arnold’s ethanol 
spectrum–the  spin-spin  coupling
296.  Spin-spin  coupling  is  a  direct  consequence  of 
chemical  bonds  and  the  multiplicity  of t h e  l i n e s  c a n  b e  u s e d  t o  i d e n t i f y  c h e m i c a l  
groups. The observation of spin-spin coupling in liquids required a continuation of the 
improvements in magnet technology since the separation of the coupled lines was 
much smaller than typical chemical shift differences
282. 
With  chemical  shift,  spin-spin  coupling,  and  chemical  exchange,  three  new  and 
exciting molecular aspects of NMR have been discovered in the early 1950s. At this 
stage in the early 1950s, chemists started to become more interested in NMR to NMR 
started to used it for the characterization of chemical substances and reactions rather 
than the physicists who wanted to characterize nuclear properties
282.  
2.3.2.3  Radiofrequency pulses and Fourier techniques 
In the early years of NMR, a spectrum was measured by a continuous irradiation with 
radiofrequency  (RF)  waves.  This  procedure  was  called  continuous  wave  detection 
(CW), meaning that every frequency response had to be detected separately. Torrey 
showed in 1949 that signals could be observed after excitation with a radiofrequency 
pulse and subsequent detection without irradiation
297.  In parallel, Erwin Hahn worked 
on the signal that was called “free induction decay” (FID)
298. In 1950, he showed that 
these decaying NMR-signals could be partially refocused by a series of following RF-
pulses,  in  a  landmark  paper,  resulting  in  so-called  “spin  echoes”
298.  Modern  NMR 
techniques and in particular magnetic resonance imaging rely heavily on spin-echoes 
and would not exist without this fundamental paper. These techniques were extended 
by Carr and Prucell in 1954 and Meiboom and Gill in 1958 and effectively laid the  
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basis of modern spin echo trains
299,300. They considered also diffusion of the molecules, 
another molecular effect that influences NMR signals
282. 
The following years interest in NMR increased rapidly. In the mid 1960s, Ernst and 
Anderson  realized  that  in  this  FID,  the  whole  information  of  a  spectrum  was 
encoded
301. They applied a widely used mathematical treatment, developed in the 18th 
century by Jean Baptiste Fourier, to the FID to improve the signal-to-noise ratio and 
experimental  flexibility,  thus  introducing  the  “Fourier  technique”  into  NMR  and  the 
analysis of the data acquired in an FID or a spin echo. However, the new method 
required a considerable computer power, which was not available those early days. 
Fourier spectroscopy required the advent of computer technology and had to wait two 
decades  before  it  became  practicable.  Fourier  spectroscopy  showed  its  enormous 
advantages  over  conventional  CW  techniques  and  founded  modern  NMR 
spectroscopy, including multidimensional data acquisition
302. This was closely followed 
by the development of two-dimensional NMR spectroscopy
303,304 which is also the basis 
for modern imaging techniques
305 in medicine
282.  
In 1991, Richard Ernst was awarded the Nobel Prize in Chemistry for “his contributions 
to the development of the methodology of high resolution NMR spectroscopy”. 
2.3.2.4  The formation of MR imaging  
The early 1970s was the start of MR research being integrated to develop an imaging 
modality.  Lauterbur  published  a  landmark  paper  about  the  use  of  magnetic  field 
gradients to form images of protons (
1H) in water
306. This paper gave the most explicit 
suggestion at the time of how NMR can be used to obtain images. Lauterbur based his 
concept on the method CT generates images
307. He suggested the acquisition of a 
series of projections, similar to the projections obtained by X-rays in CT, followed by a 
“projection reconstruction”
306. This concept has been replaced by the Fourier technique 
suggested by Ernst”s group
305 and refined by Edelstein et al. in the so-called spin-warp 
technique
308.  Other suggestions were made on how images could be obtained
283,284  
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however,  all  the  different  pulse  sequences  developed  in  the  following  years  were 
based on the Fourier principles
282. 
The  possibility  to  obtain  images  from  an  intact  body  was  crying  out  for  medical 
applications.  However,  several  problems  had  to  be  resolved  first,  primarily  the 
construction of magnets large enough for the human body fuelling the advancement of 
the technology in the following years. As it entered the clinical arena, a new problem 
arose when NMR had to be explained to patients, the term “nuclear” led to confusion 
with methods known from “nuclear medicine” which have the disadvantage of using 
radioactive  isotopes  and  ionizing  radiation.  Since  NMR  does  not  generate  ionizing 
radiation,  a  better  differentiation  was  desirable  and  “NMR”  lost  the  “nuclear”  and 
mutated to “MR”. Thereafter, a convenient yet not strict nomenclature evolved: NMR 
was used for in vitro experiments, while MR characterized mainly in vivo examinations, 
separated into MRI and MRS to describe the different sub-specialties
282. 
2.3.2.5  The separation of high resolution NMR and medical applications 
NMR  in  chemistry  and  biophysics  became  increasingly  important  as  a  routine 
analytical method. Commercial spectrometers became available, providing magnetic 
fields of about 8T in the middle of 1970s and almost 20T in the late 1990s. The growth 
of computer power allowed increasingly complex experiments and data analysis.  The 
spectral  resolution  of  analytical  NMR  systems  was  extremely  high  and  led  to  the 
acronym “High resolution NMR” in contrast to applications in solid state physics that 
were at a much lower resolution. Early on, NMR laboratories began using conventional 
electromagnets with horizontal field lines and a gap between two poles, but eventually 
superconducting technology was required to provide the enormous field strength of 
modern  magnets.  “High  resolution  spectra”  were  acquired  in  small  bore,  vertical 
magnets from samples within a tube of typically 5mm diameter. The tube with the 
solution examined rotated at very high speed (“spinning”) to equalize the stabilized 
(“locked”) magnetic field strength. “High resolution NMR” developed with an increasing  
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pace  and  a  number  of  sub-specialties  were  created.  Chemists  were  able  to 
characterize  small  yet  very  complex  molecules  in  detail  and  followed  chemical 
reactions
309-311. Biophysicists on the other hand increased the size of the biomolecules 
observed and began to elucidate the three-dimensional conformation of proteins and 
nucleic acids
282,312-315. 
Lauterbur”s publication on image formation
306 coupled with Damadian”s observation 
that tumours had different relaxation times compared to healthy tissue
316  generated a 
demand to develop magnets and systems capable of imaging the human body. This 
sparked  a  race  to  develop  an  MR  imaging  system  that  started  in  the  1970s  and 
ongoing.  The  medical  field  demanded  a  whole-body  magnet w i t h  a  b o r e  o f  a b o u t  
100cm and equipped with gradient coils. At the beginning, these magnets had quite a 
low field strength of typically 0.05 or 0.1T. Damadian et al were the first to produce an 
image of the human chest in such a large magnet
317, by moving the focused region of 
interest through the body. Mansfield et al followed soon after with an image of the 
abdomen
318 and a group at EMI (Electric and Musical Industries Ltd, Central Research 
Laboratories in Hayes, Middlesex, UK) using what was then called the “EMI scanner”, 
presented the first image of a human head
319. A race for higher field strength began 
and  eventually,  whole  body  magnets  with  field  strengths  of  1.5T  were  widely 
available
282. 
A new problem was generated when NMR had to be explained to patients—the term 
“nuclear'’ led to some confusion with methods known from “nuclear medicine”. While 
some of these methods, in particular positron emission tomography (PET) and single 
photon emission computer tomography (SPECT), are extremely elegant to measure 
the  distribution  of  much  diluted  metabolites,  they  have  the  disadvantage  of  using 
radioactive isotopes and ionizing radiation. Since NMR leaves the nucleus intact and 
does not generate ionizing radiation, a better differentiation was desirable and “NMR” 
lost the “nuclear” and mutated to “MR”. In the following, a convenient yet not strict  
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nomenclature  evolved:  NMR  was  used  for  in  vitro  experiments,  while  MR 
characterized mainly in vivo examinations, separated into MRI and MRS to describe 
the different sub-specialties. This nomenclature is convenient, however, it ignores to a 
certain extent the existence of electron spin resonance (ESR). So far, this did not 
cause major problems since there are only very few ESR applications in vivo–mainly 
due to the very high RF frequencies that are too strongly absorbed in human tissue
282. 
2.3.2.6  The delay in clinical MRS applications 
MRS needed field strengths and homogeneity that were not available before the end of 
the  1980s.  In  a  parallel  yet  much  less  noticed  development, smal l -bore magnets at 
higher field of 2.35 and 4.7T became available. These magnets were typically used for 
MRS studies in extremities and smaller animals
282.  
Another  element  used  in  MRI  was  adopted  for  the  development  of  “chemical  shift 
images”  (CSI)  or “ s p e c t r o s c o p i c  i m a g i n g ”  ( S I )
320-322.  The  almost  independent 
development of diagnostic MRI in whole-body magnets and biomedical MRS in small-
bore magnets led to a separation of the two fields. This separation in the development 
of  the  two  technologies  and  the  differing  demands  led  to  the  somewhat  delayed 
development of in vivo spectroscopy. Small-bore magnets had only surface coils to 
locate the signal in the body or had considerable problems with the gradient systems. 
Whole body systems, although advancing due to the development of MRI, had minor 
or no capabilities to do spectroscopy. It was to the unintended benefit of MRS that 
several MRI applications also required very homogeneous fields and stable gradient 
systems. The quality of current magnet technology has led to a late but noticeable 
reunion  of  parts  of  biomedical  MRS  and  diagnostic  MRI.  One  commercial  product 
(PROBE, proton brain examinations) even allows acquiring 
1HNMR spectra from the 
human brain in an automatic way, comparable to imaging sequences. MRS of other 
nuclei than 
1H, however remains possible in only very few commercial systems and 
only  as  a  research  tool.  This  fact  is  one  reason  that  delays  a  widespread  use  of  
51 
diagnostic MRS
282. 
2.3.2.7  Technical developments meet the request of new MRI sequences 
The  time  between  1985  and  1995  has  seen  an  enormous  effort  of  commercial 
companies  in  technological  development,  often  based  on  ideas  from  academic 
researchers.  Passive and active shielding of magnets enabled them to be housed in 
radiology departments where previously they had been isolated to avoid problems with 
stray fields. Earlier acquisition times of MR sequences were typically 10-30min. Much 
faster  sequences  were  suggested
323,324 a n d  a d a p t e d  b y  t h e  i n d u s t r y .  A l t h o u g h  
Mansfield’s “echo planar imaging” (EPI) promised to allow image acquisition almost in 
real  time,  it  was  particularly  demanding
325 a n d  a b o u t  a  d e c a d e  a h e a d  o f  t h e  
technological  possibilities.  In  1985,  the  same  author  proposed  a  solution  of  this 
problem in the form of actively shielded gradients
326. The technical improvement of 
gradients as a result of this idea and the desire to obtain images in real time is an 
illustrative example of the driving force of MRI. RF emitting and receiving parts of the 
MR  systems  experienced  a  steady  improvement  over  the  decade  with  better  coils 
being  constructed  and  transmitters  and  receivers  being  digitized.  The  enormous 
amount  of  data  acquired  during  EPI  acquisitions  demanded  increasingly  faster 
analogue-digital converters
282. 
2.3.2.8  Advances in NMR  
NMR in physics, chemistry, and biology is far more successful and widely used than 
recognized  by  the  medical  MR  community,  e.g.  rarely  a  new  drug  will  become 
available that has not been characterized extensively by NMR. In solid state physics 
the aims, the problems, and the methods are so different that there is rarely an overlap 
between the two fields. One of these uncommon yet theoretically exciting examples 
has  been  observed  in  human  muscle
327. 
1HNMR  spectra  showed  orientation-
dependent effects in vivo that required theories typically used in solid state NMR to be 
explained
282.   
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High resolution NMR in liquids is nowadays an indispensable method in chemistry and 
is used to characterize reactions, products, molecular conformations, etc.
309-311,328. An 
extension  of  classical  high  resolution  NMR  as  used  in  chemistry  can  be  found  in 
biological research
314,315,329-331. While chemistry uses NMR to analyze relatively small 
molecules extensively, biological NMR benefits from the fact that the molecules can be 
studied in solution. Other powerful methods such as X-ray diffraction have proven their 
value for decades, however, crystals are not a biological environment, and the study of 
(large) biological molecules in solution is desirable. Modern NMR uses a combination 
of chemical methods (labelling) and sophisticated pulse sequences (two-, three-, and 
four-dimensional  spectroscopy)  resulting  in  a  tremendous  wealth  of  information 
contained in such spectra. This helps in particular to study conformation changes and 
plasticity of molecules that can be hidden in crystals. Strong magnetic field strengths 
together  with  sophisticated  pulse  sequences  promoted  examinations  of  larger  and 
biologically important molecules such as proteins and nucleic acids. Wuthrich’s group 
investigated  conformation  of  biological  molecules  in  solution  and  has  pushed  the 
boundaries  of  the  field  in  the  last  decades  with  the  increasing  help  of  the  whole 
arsenal  of  NMR  methods  to  increase  the  size  of  the  investigated  molecules  from 
fragments of hormones
332 to much larger proteins
314 and DNA
282.  
2.3.2.9  Advances in diagnostic MRI 
Diagnostic  MRI  became  an  essential  tool  in  radiology  in  1980s  and  1990s.  This 
success of diagnostic MRI was supported by the excellent soft tissue contrast, the 
variable  orientation  of  the  scan  planes,  the  possibility  to  acquire  three-dimensional 
data sets, the high information content of contrast agent application, the combination 
of  morphological  imaging  with  flow  sensitive  methods,  MR  sequences  that  display 
functions of different organs, and others. More advanced types of MR examinations 
are known, successfully presented in scientific meetings, and used in some advanced 
departments.  However,  these  methods  still  need  methodological  or  technical  
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improvements and the majority of the radiologists do not use them frequently. A few 
examples of these techniques include interventional MRI, functional MRI of the brain 
for pre-surgical examinations, quantitative analysis of MR images, MR-angiography of 
the coronary arteries
282. 
The demonstration of the feasibility by academic institutions is often followed by an 
enormous effort of the commercial MRI suppliers to meet the required specifications. 
An  impressive  example  has  been  given  by  the  group  at  Harvard  who  initiated  the 
construction of a totally new type of an open magnet used for interventional MRI
333-335. 
The revolutionary design of the magnet allows surgeons to step into the magnet and to 
observe the imaged volume from outside as well as from inside on the MRI screen. 
Another method with an enormous potential is functional MRI (fMRI) of brain activity. It 
began  with  the  observation  of  blood  flow  in  the  brain  using  contrast  agents
336,337. 
Another breakthrough was achieved when blood deoxygenation was recognized as a 
natural contrast agent
338. fMRI is now able to follow brain activity at a spatial resolution 
that is far better than the closest rival, PET. Diffusion weighted MRI is based on the 
Brownian motion of the water molecules
339,340. The mobility of the water molecules is 
limited in one or more spatial directions in intact tissue. Diffusion weighted MRI is used 
for  the  detection  of  stroke  in  an  early  phase  and  the  differentiation  of  stroke  ad 
penumbra.  Magnetization  transfer M R I  m e a s u r e s  a n  e x c h a n g e  o f  m a g n e t i z a t i o n  
between bound pools of tissue (e.g., tissue water bound to membranes etc) and free 
pools
341,342. The amount of interaction can either be used to increase contrast (as it is 
done in low field MR systems), or it can be used to evaluate spatial neighbourhood on 
the nanometer scale
282. 
MRI methods are still developing and surprising applications are being developed in 
scientific laboratories. Some are taken up by commercial research and development 
departments and get a chance to be used by the larger MR community–others do not. 
It is a characteristic of scientific MR meetings that totally new ideas are presented, not  
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only  improvements  of  already  known  applications.  This  is  a  consequence  of  the 
tremendous versatility of MR, which is also the reason for the parallel development of 
different  applications  in  chemistry,  physics,  and  biology.  An  example  of  an  MRI 
method  that  has  not  been  considered  by  a  larger  group  before  was  the  use  of 
hyperpolarized  gases  to  image  the  lung  cavity
343,344.  Another  very  sophisticated 
application uses multiquantum filters that have been developed in high-resolution NMR 
and which allow the observation of order in biological tissue, e.g., in tendons
345 or to 
measure shearing stress on vessel walls
282,346.  
2.3.2.10 Advances in biomedical and clinical MRS 
Most of the current in vivo applications of MRS are research studies in animals or 
cohorts  of  volunteers  and  patients.  The  motivations  for  such  studies  are  often 
pathophysiological or biochemical questions. The majority of these studies aim at a 
better  understanding  of  biomedical  mechanisms  and  may  not  have  an  immediate 
therapeutic  bearing  on  patients.  The  topics  of  these  studies  cover  a  wide  range, 
including  sophisticated  experiments  with  enriched  isotopes  for  the  observation  of 
biochemical fluxes, studies of blood-brain barrier, liver metabolism, glucose uptake in 
muscle of diabetes patients, muscle force production, tumour viability, and many other 
basic medical problems
282,347-357. 
With the appearance of whole body MR systems and the success of MRI in clinical 
routine, MRS has also been forced into individual diagnosis–with little success until 
recently.  The  reasons f o r  t h e  d e l a y e d  i n t r o d u c t i o n  o f  M R S  i n t o  c l i n i c a l  r o u t i n e  are 
multiple:  the  complexity  of  MRS,  the  biochemical  background  that  is  needed  to 
perform  adequate  MRS  examinations,  lack  of  standardized  protocols  and  normal 
values,  variability  of  the  experimental  circumstances,  different  philosophy  of 
spectroscopists and clinicians, large volumes that are required for signal generation, 
etc.  With  the  advent  of 
1H-MRS  in  standard  1.5T  MR  systems,  clinical  MRS 
examinations became much more feasible. An automated and partially standardized  
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procedure and sequence for the acquisition of brain spectra became available for one 
commercial MR system (PROBE from General Electric), integrating to a certain extent 
the push-button philosophy of MRI into MRS applications. Another recent development 
since 2005 that has resulted in more widespread use of clinical MRS, particularly brain 
MRS, is that it became reimbursable by some health management organizations in 
some countries, particularly the USA in the states of California and Ohio. More MRS 
users may help to acquire a sufficient number of pathologies such that a set of brain 
pathologies will be well documented
282. Brain MRS is one of the few fields where MRS 
has entered the realm of a diagnostic modality, particularly in seizure lateralization
358, 
differentiation of neoplasms
359-361,  ischaemia
362,363 and others
348. 
1H-MRS of the prostate 
seems to be another application that is able to generate clinically relevant data
282,364,365.  
2.3.2.11 Future developments 
The  number  of  MR  systems,  the  technical  evolution,  and  the  number  of  relevant 
applications has always increased much faster than anyone could imagine. When the 
first  images  were  taken,  several  serious  authors  claimed  that  MRI  would  never 
surpass CT in image quality and would never replace CT in some applications. When 
images of reasonable quality were made in about 20min, everyone believed that time 
would  be  the  crucial  problem  of  MRI  forever.  When  diagnostic  imaging  was 
established, many radiologists concluded that the main development was over and 
were surprised when, e.g., fMRI became feasible. The only conclusion that is possible 
from looking back at the last decade is that the development of MR is far from over
282. 
It seems to be one characteristic of MR that often not specific inventions pushed the 
development but a series of “small” improvements. Major improvements in MR (and 
NMR) are often a consequence of a series of small steps that lead to better signal to 
noise  ratio  (SNR),  improved  image  quality,  etc.  Currently,  the  human  body  is  the 
inherent  limit  for  some  “brute-force”  developments  such  as  stronger  and  faster 
gradients. It can be expected that the future will not so much see faster and stronger  
56 
gradients but improved quality. Magnetic field strength on the other hand will increase 
dramatically for some applications. The typical 0.5 or 1.5T system will still be used for 
routine  clinical  imaging.  Research  systems,  however,  are  available  at  much higher 
field strength, i.e., up to 4.7T
366,367 or even 8T
368. These strong fields are particularly 
suited to MRS and fMRI. RF par t s such as coi l s,  t r ansmi t t er s,  and r ecei ver s have 
already a very high quality, however, it can be expected that new developments and 
techniques will lead to higher SNR and, consequently, to better spatial resolution
282. 
It may happen that MRI will reach a plateau. Some applications, however, are still in a 
development  phase  and  need  further  consolidation  and  verification.  This  includes 
popular fields like fMRI, interventional MRI, hyperpolarized gases, imaging of coronary 
arteries, etc. Among the most promising aspects for the future of MRI are molecular 
effects such as diffusion, magnetization transfer, multiquantum filters, etc. Observation 
of  processes  and  structures  on  the  molecular  level  can  be  assessed  by  MR  if 
appropriate methods are chosen
282. 
2.3.3  Application of MRS to the hepatobiliary and liver transplant field 
2.3.3.1  MRS studies of bile 
In  recent  years,  high  resolution 
1HNMR  spectroscopy  has  been  established  as  a 
powerful technique to explore the biochemical composition of biological fluids such as 
plasma,  bile,  seminal  and  synovial  fluids,  in  various  pathological  conditions
23.  This 
technique  is  rapid,  non-invasive  and  non-destructive  and  can  detect  metabolites 
present at the millimolar without preparation of the sample; another application of this 
technique is to detect unexpected compounds in biological fluids
369. It has been used 
to confirm the hydrophobic association in micelles of conjugated bile acids and biliary 
lipids
8. It has also been used to assess micelle formation
9, the effects of cholesterol on 
the fluidity of human gallbladder bile
10,370, the amount of conjugated bile acids in bile
371 
and  to  identify  the  lipid  content  of  plasma  membranes
13,372.  A  preliminary  study  of 
1HNMR analysis of bile after liver transplantation has been reported by Powell et al in  
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1990, suggesting that this technique might help to distinguish ischaemia from rejection 
post-transplant  by  detecting  large  resonance  peaks  for  lactate  and  acetate
17.  More 
recently, attempts to predict graft function by analysing bile production immediately 
after  transplantation  showed  that  bile  from  steatotic  grafts  collected  before 
transplantation  had  more  PC  than  bile  from  normal  grafts.  It  also  showed  slower 
clearance of University of Wisconsin solution in grafts with subsequent primary graft 
dysfunction, suggesting a slower recovery of bile secretion
18. 
2.3.3.2  MRS in liver failure 
In a recent study, Dabos et al used 
1HNMR of plasma to develop a prognostic model 
of outcome for patients with paracetamol induced acute liver injury
373. They identified 
plasma phenylalanine, pyruvate, alanine, acetate, calcium, haemoglobin and lactate 
as  independent  variables  of  poor  prognosis  (i.e.  death  or  the  need  for  a  liver 
transplant).  A  prognostic  model  was  then  constructed  by  stepwise  forward  logistic 
regression analysis: [(400 X pyruvate (mmols/L)+(50 X phenylalanine (mmols/L)]-[4 X 
hemoglobin (g/dL)]. They were able to identify patients who died from paracetamol 
overdose fulminant hepatic failure as accurately as King’s College criteria, but at a 
much earlier stage in their condition
373. This followed on from previous similar work on 
non-paracetamol  induced  fulminant  hepatic  failure,  where  Dabos  et  al  identified 
significantly lower levels of lactate, alanine, valine, and bilirubin and significantly higher 
levels of pyruvate and albumin in patients who survived spontaneously compared with 
those  that  died  or  needed  or  received  transplants
374.  By  use  of  multiple  logistic 
regression  analysis,  an  equation  was  devised  that  best  predicted  clinical  outcome: 
0.5x(albumin [g/L])-2x(lactate [mmol/L])-36x(valine [mmol/L])-38x(pyruvate [mmol/L]). 
This algorithm was applied on admission, thus expediting decision-making
374.  
Liver  failure  may  cause  low-grade  reversible  brain  oedema  through  an  increase  in 
brain glutamine. Cordoba et al used 
1HNMR to demonstrated cerebral oedema in non-
encephalopathic  non-alcoholic  cirrhosis,  which  was  not  evident  by  standard  
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neuroimaging techniques
375. They assessed magnetization transfer ratio and
 1HNMR  
before and after liver transplantation to determine changes in brain water content in 
cirrhosis. Cirrhotic patients showed a decrease in magnetization transfer ratio and an 
increase  in  glutamine/glutamate  signal,  which  correlated  to  the  decrease  in 
magnetization  transfer  ratio  and  to  neuropsychological  function.  Following  liver 
transplantation, there was a progressive normalization of magnetization transfer ratio, 
glutamine/glutamate signal and neuropsychological function. Accordingly, correlations 
between these variables were lost after liver transplantation
375.  
2.3.3.3  MRS in hepatic steatosis 
The presence of non-alcoholic fatty liver disease often precludes potential organs from 
being  used  for  transplantation.  Alwayn  et  al  investigated  the  effect  of  omega-3 
polyunsaturated fatty acid supplementation on the treatment of hepatic steatosis in 
mice fed a high-carbohydrate, fat-free diet and in obese mice
376. The percentage of fat 
content relative to water was determined by MRS using numeric integration of areas 
under lipid and water peaks. Omega-3 fatty acid supplementation reversed hepatic 
steatosis in mice fed a high-carbohydrate, fat-free diet and converted macrovesicular 
to  microvesicular  steatosis  in  obese  mice  as  determined  by  histology,  magnetic 
resonance spectroscopy, and liver biochemistry
376.   
2.3.3.4  MRS in ischemic preconditioning 
Livers  from  obese  donors  often  have  fatty  infiltrates  and  are  more  susceptible  to 
ischaemia-reperfusion  injury  and  subsequent  graft  dysfunction.  Niemann  et  al 
investigated IPC as a protective modality in obese Zucker rats during cold ischaemia. 
Liver samples were analyzed by 
1H- and 
31PNMR to assess whether IPC improves 
hepatic  cellular  metabolism.  IPC s i g n i f i c a n t l y  i m p r o v e d  h i g h  e n e r g y  p h o s p h a t e  
metabolism and graft survival in obese rat livers
377. 
2.3.3.5  MRS in hepatic energetics 
31PNMR was al r eady i n t he f ocus i n t he l at e 70s and ear l y 80s t o opt i mi ze or gan  
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preservation techniques. The energy status of solid organs had been recorded as a 
function of the duration of cold ischaemia for various buffer solutions
378. 
31PNMR has 
been applied to monitor the hepatic energetics of intact cold preserved pig liver using 
standard clinical harvesting and storage techniques
5,379.  
This  principle  has  been  applied  clinically  in  a  recent  study  from  Hong  Kong  in 
paediatric liver transplants where 
31PNMR was used to determine hepatic functional 
status. Chu et al compared 
31PNMR with blood biochemistry and liver biopsy results in 
paediatric  patients  after  liver  transplantation
380.  Patients  with  good  graft  function 
displayed  spectral  profiles  similar  to  those  of  the  healthy  subjects.  Patients  with 
abnormal  liver  function  and  biopsy-proven  hepatic  complications  showed  elevated 
phosphomonoesters to total phosphorus ratios when compared with those of both the 
control subjects and the group with good graft function
380.  
2.3.3.6  MRS in analysis of organ viability for transplant 
The  continuing  shortage  of  donor  organs  is  seriously  limiting  transplant  programs. 
Organs from marginal and non-heart-beating donors are increasingly being used, but 
their viability may be compromised. There is currently no rapid yet accurate method for 
assessing donor organ viability that can be applied within the window of opportunity 
between  harvesting  and  implantation.  MRS t e c h n i q u e s  might  be  useful  in  the 
noninvasive assessment of isolated donor organ viability. In particular 
31PNMR has 
been  extensively  applied  to  assess  organ  viability  probing  endogenous  tissue 
metabolites  such  as  energy  phosphates,  phospho- m o n o - a n d  d i -esters  (PME  and 
PDE) and inorganic phosphate levels
5. 
2.3.3.7  MRS in liver transplantation 
The use of MRS in liver transplantation has been reviewed by Davidson et al
381.  
A  recent  report  of
 1 HNMR o f  s e r u m  a n d  u r i n e  s a m p l e s  f r o m  o n e  p a e d i a t r i c  l i v i n g  
related  OLT  recipient  revealed  an  increase  in  serum  and  urinary  glutamine  post- 
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transplantation associated with reduced urea levels in urine were found to be evidence 
of impairment in urea cycle and compatible with persistently abnormal graft function
382. 
Toxic  ammonia  is  converted  into  urea  through  the  urea  cycle  in  the  liver.  A  small 
proportion  also  gets  metabolized  into  glutamine
383.  In  acute  and  chronic  liver  cell 
failure, there is impairment in the urea cycle, resulting in abnormally high levels of 
blood  ammonia  and  decreased u r e a  l e v e l s .  I n c r e a s e d  a m m o n i a  l e v e l  t r i g g e r s  
glutamine  synthesis
384,385.  Ischaemia-induced  acute  liver  failure  treated  with  a 
bioartificial liver has been studied by two-dimensional NMR of plasma from pigs
386. The 
concentrations of choline and trimethylamine-N-oxide were found to increase in pigs 
after treating with the bioartificial liver, from the beginning to the end
386. Metabolites 
such  as  glutamine,  N-acetylglucosamine  and  pyruvate  were  also  detected.  Usually 
blood  ammonia  levels  are  measured  biochemically,  but  the  accuracy  of  ammonia 
measurement  is  constrained  by  time,  temperature  and  haemolysis  of  the  sample 
drawn
383.  
One  interesting  aspect  of  the  report  by  Singh  et  al,  2003  is  that 
1HNMR a c t u a l l y  
demonstrated graft failure before the infarct could be detected by histology
382. On day 
3 post-transplantation, the patient developed both portal vein (PV) and hepatic artery 
(HA) thromboses. Abrupt increase of glutamine levels both in serum and urine and 
abrupt decrease of urea to undetectable level in urine on day 3 were observed. An 
immediate re-exploration thrombectomy with revision of both PV and HA anastomoses 
were carried out. The liver still looked viable, and biopsy did not reveal major infarct. 
Increased  levels  of  glutamine  in  serum  and  urine  as  observed  by 
1HNMR 
spectroscopy were compatible with persistent abnormal graft function in terms of INR, 
ALT, AST and serum lactate levels
382.  
Patients with liver cirrhosis are transplantation candidates. Adipose tissue fatty acid 
composition in malnourished cirrhotics and in healthy volunteers was investigate by in 
vivo 
13C MRS to assess it as a predictor for transplant survival
387. In vivo 
13CNMR  
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spectra from the subcutaneous adipose tissue before and 8 weeks after orthotopic 
liver transplantation revealed significant differences in levels of individual fatty acids, 
particularly  n-3  fatty  acids  which  were  lower  in  cirrhotics.  Eight  weeks  following 
transplantation,  recipients  showed  a  considerable  increase  in  body  mass. 
13CNMR 
revealed a significant increase in saturated fatty acids and a decrease in unsaturated 
fatty acids
387. This may be useful in optimizing the dietary management of severely 
malnourished cirrhotics before liver transplantation
387. 
2.3.3.8  MRS in primary graft non-function and dysfunction 
The  current  shortage  of  donor  organs  in  liver  transplantation  has  led  experienced 
transplant  centres  to  use  more  marginal  grafts.  Melendez  et  al  proposed  that  the 
development of a reliable technique of bile collection
388 could allow the characterization 
of hepatic grafts from both donors and recipients
18. He collected bile from eight liver 
donors (four with normal and four with steatotic grafts) during organ retrieval and four 
transplant  recipients  (two  with  good  early  graft  function  and  two  with  primary 
dysfunction) immediately after graft reperfusion. Bile analysed using 
1HNMR showed 
that the hepatic bile from steatotic grafts collected before transplantation had more 
intense phosphatidylcholine head group resonance than bile from normal grafts. It also 
showed  slower  clearance  of  University  of  Wisconsin  (UW)  solution  in  grafts  with 
subsequent primary graft dysfunction, suggesting a slower recovery of bile secretion. 
He  suggested  a  role  for  the  monitoring  of  the  resonance  signal  of  UW  solution 
washout, bile acid, and biliary lipid secretion may help to predict the development of 
primary graft dysfunction and avoid the need for retransplantation
18.  
Metabolic assessment of viability indicators in UW solution of isolated human donor 
liver of prognostic value for transplantation outcome using 
31PNMR revealed that the 
individual  PME,  inorganic  phosphate  (Pi),  PDE,  and  nicotine  adenine  dinucleotide 
peaks did not correlate with post-operative hepatocellular damage or liver metabolic 
capacity
389.  It d i d  n o t  r e s u l t  i n  a  r e l i a b le  noninvasive  test  to  predict  primary  graft  
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dysfunction
389. 
31PNMR h a s  b e e n  a p p l i e d  t o  c h a r a c t e r i s e  h u m a n  l i v e r  a l l o g r a f t s  p o s t o p e r a t i v e l y .  
Patients with chronic ductopenic rejection were shown to have significantly elevated 
PME/NTP and PDE/NTP ratios, whereas patients with good graft function displayed no 
spectral  abnormalities  in  vivo
390.  In  vitro  spectra  from  chronic  ductopenic  rejection 
patients displayed elevated phosphoethanolamine and phosphocholine, mirroring the 
in  vivo  changes  in  PME,  but  reduced g l y c e r o p h o s p h o r y l e t h a n o l a m i n e  a n d  
glycerophosphorylcholine concentrations, in contrast to the in vivo PDE findings. The 
increase in PME/NTP reflects altered phospholipid metabolism in patients with chronic 
ductopenic  rejection,  while  the  increase  in  PDE/NTP  may  represent  a  significant 
contribution from bile phospholipid
390.  
This review chapter had two aims: firstly, to describe the main pathways by which the 
different agents modulating IRI in the liver. Secondly, to highlight the history and new 
developments  that  are  ongoing  in 
1HNMR  spectroscopy a n d  t o  p r e s e n t  t h e  
experimental and clinical evidence about its role in the study of hepatic IRI to date.   
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3  Materials and Methods 
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3.1  Rabbit model of lobar ischaemia/reperfusion 
The  study  was  conducted  under  a  project  license  granted  by  the  Home  Office  in 
accordance  with  the  Animals  (Scientific  Procedures)  Act  1986.  New  Zealand  white 
rabbits were used for the experiments. All animals were kept in temperature controlled 
environment with 12 hour light-dark cycle. Animals were kept without food overnight 
prior  to  the  experiments.  Experimental  research  protocols  were  approved  by  the 
hospital ethics committee.  
New  Zealand  white  rabbits  (3.8±0.5kg)  were  used  in  a  validated  model  of  lobar 
ischaemia
391-400.  Anaesthesia  was  induced  by  an  intramuscular  injection o f  0 . 5 ml/kg 
fentanyl  citrate  and  fluanisone  (Hypnorm;  Janssen  Animal  Health  Ltd., 
Buckinghamshire, UK). Following tracheostomy anaesthesia was maintained with 1.5-
3%  isoflurane  (Forane;  Abbott  Laboratories,  Chicago,  IL, U S A ) ,  t h r o u g h  a n  
anaesthetic  circuit.  Body  temperature  was  maintained  at  37-38.5
oC  by  a  warming 
blanket  (Homoeothermic  blanket  control  unit;  Harvard  Apparatus,  Southmatick, 
Massachusetts,  USA).  Haemoglobin  saturation  and  heart  rate  were  continuously 
recorded  by  a  pulse  oxymeter  (Ohmeda  Biox  3740  pulse  oxymeter;  Ohmeda, 
Louisville, Colorado, USA). A radio-opaque catheter 20 gauge (G) was inserted into 
the right femoral artery, in the pilot study, but changed to the right ear marginal artery 
for all other studies, and connected to a pressure transducer for monitoring of mean 
arterial  blood  pressure
401.  Ear  marginal  veins  were  cannulated  with  radio-opaque 
catheters (22G) for the administration of anaesthetics, fluids and medication. 
After induction of anaesthesia a midline laparotomy was performed. The ligamentous 
attachments of the liver were divided and the liver was exposed. The bile duct was 
cannulated with a polyethylene catheter (PE-50, 0.58mm inner diameter, Portex, Kent, 
UK) for continuous measurement of BF and collection of samples for 
1HNMR. 
Laparotomy was performed through a midline or transverse subcostal incision. The 
ligamentous attachments from the liver to the diaphragm were divided and the liver  
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was exposed.   
3.1.1  Lobar Clamping 
Lobar ischaemia was induced by clamping the vascular pedicles of the median and left 
lobes of the liver, using an atraumatic microvascular clip. This method produces a 
severe  ischaemic  insult  without  mesenteric  venous  hypertension
400,402,  which  can 
confound observations, and hemodynamic instability
396,402.  
Moreover, lobar clamping avoids the cessation of biliary drainage, a characteristic of 
the total hepatic ischaemia model
403, permitting the effects of I/R on biliary composition 
to be evaluated. As common bile duct cannulation results in the collection of bile from 
both  the  ischemic  and  non-ischemic  lobes  we  compared  the  findings  from  the  I/R 
group with a sham control (non-ischemic) group to ensure that these changes in bile 
composition were the result of the I/R procedure (ischemic lobe) although previous 
studies  have  shown  no  difference  in  bile  salt  secretion  or  any  other  measured 
parameters, besides a decrease in BF, between ischemic and non-ischemic lobes in a 
similar lobar ischaemia rat model
404.  
3.1.2  Model stability 
Tracheostomy  and  ventilation  stabilized  the  model  hemodynamically  and  permitted 
bile  constituents  to  be  analyzed  into  the  late  phase  of  I/R.  An  inhaled  anaesthetic 
agent isoflurane, which is mainly metabolized in the lungs rather than in the liver, was 
also  used  for  maintenance  of  anaesthesia,  in  order  to  avoid  cumulative  effects  or 
hepatotoxicity. 
After 60 min of ischaemia, the vascular clip was removed and reperfusion was allowed 
for  up  to  7  hours.  At  the  end  of  the  experiment  the  animals  were  killed  by 
exsanguination. 
A rabbit model was used instead of a rat model since the size of rabbits is more 
convenient  for  the  placement  of  probes,  BF  measurement  and  blood  uptake  at  
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different time points. The period of hepatic inflow ischaemia (1 hr) is also similar to the 
warm ischaemia time during human liver resection and transplantation. 
There are certain limitations to the experimental model, a) partial lobar ischaemia and 
not total hepatic ischaemia b) biliary drainage from both lobes and not the ischaemic 
lobe and c) the availability of another body fluid suitable to MRS. 
3.1.3  Liver blood flow 
The  liver  gets  a  dual  blood  supply  from  the  portal  vein  and  hepatic  arteries.  The 
hepatic portal vein supplies 75% of the liver's blood supply. It drains venous blood 
from the splanchnic circulation. It divides into two branches, the right and the left portal 
veins,  which  divide  into  sectoral  and  segmental  branches  interhepatically
405.  The 
hepatic arteries supply the remaining 25% of the liverʼs blood supply, and is one of 
three terminal branches of the coeliac trunk of the aorta. It divides, into lobar, sectoral 
and segmental branches interhepatically
405. The liverʼs oxygen is supplied 50% through 
the hepatic artery, and 50% through the portal vein
406.  Blood flows through the liver 
sinusoids and empties into the central vein of each lobule. The central veins coalesce 
into hepatic veins, which leave the liver into the inferior vena cava. 
3.1.3.1  What happens on portal flow reduction or clamping 
There  is  a  reciprocal  relationship  between  arterial  and  portal  volume  flow;  it  is 
effectuated  by  the  state  of  constriction  or  dilation  of  the  mesenteric  and  hepatic 
arterioles, both under myogenic control. Portal blood delivers directly to the hepatocyte 
all water-soluble substances absorbed from the intestines or produced in the intestinal 
walls. The hepatic artery maintains an appropriate PO2 gradient between the acinar 
zones  and  flow  of  blood  against  increased  tissue  resistance;  it  assures  a  steady 
clearance of blood-borne substances, e.g., hormones and endogenous products
407.  
Hepatic parenchymal cell metabolic status does not control the hepatic arterial blood 
flow
408. Regulation of arterial flow is less neural than neurohumoral, through an arterial  
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adenosine-dependant  humoral  paracrine  pathway.  In  order  to  maintain  a  relatively 
stable overall hepatic inflow, arterial vasodilation occurs in cases of decreased portal 
flow and vasoconstriction in cases of increased portal flow
407,409. Portal blood flow is a 
major intrinsic regulator of hepatic arterial tone. Hepatic arterial blood flow changes so 
as  to  buffer  the  impact  of  portal  flow  alterations  on  total  hepatic  blood  flow,  thus 
tending to regulate total hepatic flow at a constant level. This response is called the 
“hepatic  arterial  buffer  response”  (HABR).
408 T h e  m e c h a n i s m  o f  t h e  a r t e r i a l  b u f f e r  
response seems to depend on portal blood flow washing away local concentrations of 
adenosine from the area of the arterial resistance site. If portal flow decreases, less 
adenosine i s  w a s h e d  a w a y  a n d  t h e  l o c a l  c o n c e n t r a t i o n  r i s e s  r e s u l t i n g  i n  a r t e r i a l  
dilation
408. 
3.1.3.2  Hepatic Compliance  
One mechanism is a simple physical consequence of the very high vascular blood 
volume  and  compliance  (change  in  hepatic  blood  volume  per  unit  change  in 
intrahepatic pressure). A decrease in portal blood flow leads to a passive decrease in 
intrahepatic pressure and a passive expulsion of blood from the large hepatic reservoir 
into  the  central  venous  system.  This  increase  in  venous  return  leads  to  increased 
cardiac output that, in turn, leads to elevated blood flow in the splanchnic arteries that 
feed the portal venous bed, thus at least partially correcting the initial flow deficit
410.  
3.1.3.3  Hepatic Arterial Buffer Response 
Reduced portal flow activates the HABR secondary to reduced washout of adenosine 
from the space of Mall, which surrounds the terminal branches of the portal vein and 
hepatic artery before they drain into the hepatic sinusoids. Adenosine appears to be 
secreted at a constant rate into the space of Mall, with the local concentration of the 
potent vasodilator being regulated by the rate of washout into the portal blood. By this 
mechanism,  reduced  portal  flow  leads  to  accumulation  of  adenosine  and  hepatic  
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arterial dilation, thereby serving to buffer the impact that changes in portal flow have 
on total hepatic blood flow
410.  
3.1.3.4  Hepatorenal Reflex 
The accumulated adenosine also activates sensory nerves in the liver, which results in 
activation of a hepatorenal reflex (HRR). This reflex leads to reduced renal output and 
fluid  retention,  thereby  elevating  blood  volume,  venous  return,  cardiac  output,  and 
splanchnic  blood  flow.  The  elevated  adenosine  level  that  occurs  in  response  to 
reduced  portal  flow  leads  to  rapid  responses.  The  hepatic  artery  is  dilated  within 
seconds  and  the  response  is  well  maintained.  Although  the  HRR  is  also  activated 
immediately,  but  the  renal  fluid  retention  only  has  cardiovascular  impact  after  fluid 
retention becomes significant, which is over a longer timescale
410. 
3.1.3.5  Hepatic Mass Regulation 
A third mechanism is modulated through high or low vascular shear stress regulates 
NO and prostaglandin release to trigger a cascade leading to hepatocyte proliferation 
or apoptosis. By this mechanism, hepatic cell mass is adjusted to maintain a constant 
ratio to the average hepatic blood supply over a long time period
410. 
3.1.4  Models of total hepatic ischaemia 
Ideally, experimental design should not include too many compromises, however, the 
principle of reduction in animal experimentation, an important principle in modern life-
sciences, necessitates thinking very carefully how best to use every experiment to 
benefit a maximum number of experiments. Model standardisation, also allows sharing 
of data across several sets of experiments, as the model is the same. So a sham 
group  can  be  shared,  or  a  control  I/R  group  can  be  shared,  across  several 
modulating/interventional agents, or different investigative approaches.  
Most experimental animal models for studying hepatic IRI involve partial or segmental 
ischaemia of the liver with the disadvantage of triggering the above mechanisms or a  
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portocaval  shunt  procedure  to  avoid  mesenteric  congestion,  which  is  technically 
difficult the smaller the animal model. From a technical aspect, vascular anastomosis 
required in portal shunting is very labour intensive, over several experimental groups, 
and if this were going to be attempted, then the investment in time and effort would 
best be directed at transplantation. Transplantation in the rat has a stable model, but 
one which needs months of technical training to achieve, and consequently defies the 
principle of reduction in animal experiments.  
In these experiments, there was a requirement for several samples, of both blood and 
liver, which would not have been achievable in a smaller rat model, due to liver size. 
Interestingly, a rat model of total hepatic ischaemia (arterial and portal clamping) is 
more tolerant, even without portal shunting, and can achieve an hour of total hepatic 
ischaemia. Although without portal shunting, gut I/R would have been a confounding 
variable.    Essentially,  this  model  does  not  reflect  the  global  ischemia  that  occurs 
during liver transplantation. Survival of a rabbit model of total hepatic ischemia without 
a portocaval shunt was questionable for the 60 mins of ischaemia required. As the 
group of experiments that formed this thesis were coming to an end, Towards the end 
of  the  period  when  these  experiments  were  conducted—they  spanned  a  period 
between 2001 and 2004—a total hepatic ischemia without a portocaval shunt model in 
the  rabbit  was  attempted  in  the  department
400.  Four  groups  were  prepared,  sham-
operated, 20-minute total hepatic ischemia, 25-minute total hepatic ischemia and 30-
minute total hepatic ischemia. Total hepatic ischemia was induced by occluding the 
portal inflow vessels—portal vein and artery—with an atraumatic vascular loop and 
were measurements taken for 2 hours during reperfusion. A total hepatic ischemia of 
30  minutes  caused  severe  liver  injury  resulting  in  cardiac  arrest  at  2  hours  of 
reperfusion  in  all  five  animals  due  to  metabolic  acidosis.  Twenty  minutes  of  total 
ischemia was tolerated and did not produce significant liver injury. Twenty-five minutes  
70 
of total ischemia was tolerated but at 2 hours of reperfusion. In addition, the model 
needed to be stable for a significant reperfusion period to assist in observing a timeline 
of reperfusion changes. 
These experiments aimed to simulate ischaemic operative challenges in liver surgery, 
and 60 min of ischaemia was selected as a time-frame that would be representative of 
the  amount  of  warm  ischaemia  experienced  during  liver  surgery,  and  one  where 
significant damage would be guaranteed. Sixty minutes of total hepatic ischaemia was 
initially thought to be unachievable in the rabbit model, and was later proven to be so, 
with only 25 mins being achievable, and shorter timeframes not resulting in liver injury 
at  all.  However,  if  this  model  had  been  available  at  the  time  of  conducting  these 
experiments, it may have offered a closer representation of liver ischaemia without the 
reliance on sham and control group comparison. There is an argument that such a 
model should have been developed for these studies, but as suspected, and since 
proven, the tendency to follow a 60 min ischaemia model prevented its consideration, 
this may appear in hindsight a limitation of these studies. 
3.1.5  Ischaemic or non-ischaemic bile 
The second issue is the bile retrieval from the common hepatic duct not originating 
from the ischaemic or partially ischaemic lobe. Direct cannulation of the ischaemic lobe 
is possible, but in doing so the cannula would have to pass through the common bile 
duct,  and  then  into  the  ischemic  lobe  bile  duct  to  ensure  tight  fixation.  Such  a 
technique would naturally block the non-ischaemic lobe, which would lead to increased 
bile flow
411, rise in plasma bilirubin
412 and changes in canalicular permeability
413 that 
may affect the interpretation of bile volumes and composition, an integral part of this 
thesis.  
These studies relied on the established technique of utilizing sham and control groups 
to prove a causal link. In experimental procedures, many factors are standardized,  
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while one of two are varied to study their effect, and the resulting observations are 
attributed to the varied factors. In these studies, the variable interventions were the 
lobar clamping, and drug modulation. If sham and controls are compared, the only 
variable is lobar clamping. There is an argument as to which lobe produces the bile 
compositional changes observed, and the comparison of sham and control suggests 
that the change in bile composition is due to lobar clamping and ischaemia, as in both 
cases the CBD is cannulated and mixed lobar bile is collected. Although this does not 
fully answer the question of which lobe, it does strongly suggest that the variation is 
due to ischaemia. It would be a very interesting subject of further study, the effect of 
ischaemia on a non-ischaemic lobe. 
3.1.6  Bile or Urine 
Clinical  MRS  more  recently  has  been  moving  over  to  urine  MRS  in  its  search  for 
biomarkers. The reason is that urine samples are more accessible in more quantity, 
with non- or minimally invasive techniques, and while bile can be reasonably resolved 
at  11  Tesla  strengths,  it  is  not  as  easily  resolved  at  lower  clinical  MRS  strengths. 
Clinical  MRS  is  increasing  in  strengths  with  3  Tesla  becoming  more  prevalent, 
however using urine to look for biomarkers resolves the need for high strength clinical 
MRI scanners, once a biomarker is identified, and due to its high accessibility, can 
even  be  extracted  and  measured  in  a  high  strength  magnet  without  much 
inconvenience to the subject being studied, so not only does it resolve more at lesser 
strengths,  but  can  be  moved  to  higher  strengths  if  required  easily.  The  initial 
hypothesis was that bile would directly reflect the changes taking place in the liver, 
however, urine is an excellent surrogate for changes in serum concentrations
414, In the 
true metabolomic sense, it can mirror the changes in patients with or without HIV and 
can identify if they are taking treatment with more resolution than that evident in the 
blood
414,415. Where blood constituents are masked with large protein peaks, and bile by  
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lipid peaks, urine does not contain these difficulties, with a much sharper resolution 
with twice as many metabolites identified as blood
415. It has been used to delineate 
pathology in chronic obstructive pulmonary disese
416, lung cancer
417, atherosclerosis 
development
418,  inflammatory  bowel  disease
419,  metabolic  syndrome
420, 
hyperlipidaemia
421, hepatoxicity
422, alcoholic liver injury
423, ischaemic heart failure
424 and 
hepatic encephalopathy
425. 
Hepatic microcirculation was continuously measured via a probe placed on a fixed site 
on the median lobe of the liver and held in place by a retort holder during ischaemia 
and reperfusion period. Hepatic tissue oxygenation was continuously measured via 
optodes placed on the surface of the left liver lobe during ischaemia and reperfusion 
period.  
Blood samples (1ml each) were collected from the arterial line at different time points 
during the experiment for serum transminases.  
Liver tissue at baseline and at the end of the experiment was taken from the ischaemic 
liver lobe fixed in 10% formalin for histological study. 
Steatosis was induced by feeding the animals with a high-cholesterol (2%) diet for 8 
weeks.  Unlike  the  commonly  used  low-choline  methionine  diet,  which  produces 
periportal  fatty  infiltration
240,426,  with  this  model  a  central  lobular  deposition  of  fat  is 
observed,  similar  to  that  found  in  the  majority  of  human  fatty  livers,  such  as  in 
diabetes, obesity and alcoholism
427. 
 
3.2  Hepatic microcirculation 
3.2.1  Basic principles   
Hepatic microcirculation (HM) was measured by a surface laser Doppler flowmeter 
(LDF) (DRT4, Moor Instruments Limited, Axminster, UK) in flux units. Measurement is  
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easy  to  perform  and  provides  a  continuous  signal  without  interference  with  tissue 
blood flow
428-430.  
Briefly, a monochromatic laser light from a 2mV-helium neon laser operating at 632nm 
is guided to the tissue via optical fibres. The back-scattered light from the tissue is 
transmitted  through  optical  fibres  to  photodetectors.  Only  the  photons  which  are 
scattered by moving red blood cells will have a Doppler frequency shift, whereas those 
from the static tissue matrix will not be Doppler shifted. Mixing of these components at 
the photo detector surface produces an electrical signal containing all of the Doppler 
frequency  shift  information.  Further  processing  of  the  signal  produces  an  output 
voltage that varies linearly with the product of total number of moving red blood cells in 
the measured volume of a few cubic millimetres multiplied by the mean velocity of 
these cells.  
Linearity  of  the  LDF  signal  from  the  liver  with  total  organ  perfusion  has  been 
demonstrated and the technique has been shown to be sensitive to rapid changes in 
organ blood flow
428,429,431. The LDF measurements are expressed in arbitrary perfusion 
units (flux). Due to the problems associated with variation in signal across the surface 
of the liver, it is not possible to apply a conversion factor so that the LDF signal can be 
expressed in absolute flow units
428,431. 
The  application  and  reproducibility  of  LDF  measurement  for  assessment  of  liver 
microcirculation has been validated in both experimental animals
431 and human liver 
transplantation
432.  
3.2.2  LDF application in the rabbit, data collection, analysis 
The  hepatic  microcirculation  in  this  study  was  assessed  using  a  commercially 
available dual channel surface LDF ( DRT4,  Moor  I nst r ument s Lt d. ,  Devon,  UK)  as 
shown  in  figure  2.  The  LDF  was  calibrated  before  each  study  against  a  standard 
reference (Brownian motion of polystyrene micro spheres in water) provided by the  
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manufacturer.  The LDF probe was placed on a fixed site on the median lobe of the 
liver in order to avoid any error due to anatomical variation in the microcirculation. It 
was held in place by a probe holder in order to minimise any disturbance to blood flow 
by the LDF probe pressure on the tissue.  Data were collected continuously. Data from 
the continuous measurement by LDF was collected via the near infrared spectroscopy 
(NIRS)  software t h a t  c a n  a c c e p t  t h e  i n p u t  o f  4  d i f f e r e n t  c l i n i c a l  m o n i t o r s .  A f t e r  
conversion of the NIRS data to excel sheets, the LDF data at the relevant points in 
each experiment was calculated as a mean of 2-min data.  
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Figure 2: Dual channel surface laser Doppler flowmeter and its probes 
 
 
 
Laser Doppler flowmeter (LDF) and its probes (DRT4, Moor Instruments Ltd., Devon, 
UK) 
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3.3  Intracellular oxygenation and mitochondrial activity 
Under  aerobic  conditions,  the  mitochondrial  membrane  functions  as  an  energy 
production  system  through  the  coupling  of  the  electron  transport  system  and  ATP 
synthase. The mitochondrial respiratory chain is a multi-enzyme complex forming an 
integral part of the mitochondrial inner membrane
433,434 (figure 3). The respiratory chain 
includes five complexes, each with several subunits.  
The  reducing  equivalents  nicotine  adenine  dinucleotide  (NADH)  and  flavin  adenine 
dinucleotide  (FADH2),  that  are  generated  by  the  tricarboxylic  acid  cycle,  are 
transferred  to  the  respiratory  chain  as  a  substrate,  where  electrons  are  then 
transferred from NADH or FADH2 to oxygen
433,434. The electrons that are donated by 
NADH and FADH2 enter the respiratory chain at complex I (NADH dehydrogenase) 
and complex II (succinate dehydrogenase). Electrons are then transferred to complex 
III (cytochrome c), complex IV (cytochrome oxidase: COX), and finally, to molecular 
oxygen, which then combines with protons to produce water. The passage of electrons 
through the respiratory chain is associated with the translocation of protons from the 
mitochondrial  matrix  into  the  intermembrane  compartment.  This  generates  an 
electrical  membrane  potential  and  proton  concentration  gradient
433,434.  The  energy 
which is released during re-entry of protons into the matrix is then utilised by ATP 
synthase  (complex  V)  to  generate  ATP  from  adenosine  diphosphate  (ADP)  and 
inorganic  phosphate  (Pi)
433,434 ( f i g u r e  3 ) .  About  95%  of  the  total  cellular  ATP  is 
produced via this mitochondrial oxidative phosphorylation
433,434. The rate of oxidative 
phosphorylation is governed by the interplay of four factors: the concentration of the 
respiratory chain enzyme; the concentration of oxygen; the relative concentrations of 
the substrates including glucose, ADP, adenosine monophosphate (AMP), and Pi; and 
the rate of ATP utilisation
433,434. 
COX a c t i v i t y  a s  a  r e f l e c t i o n  o f  h e p a t i c  i n t r a c e l l u l a r  o x y g e n a t i o n  w as  continuously 
measured  using  NIRS.  In  all  tissues  a  number  of  colour-bearing  compounds  
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(chromophores), namely oxyhaemoglobin (HbO2), deoxyhaemoglobin (Hb) and COX 
are present in variable concentrations. They have different absorption spectra (figure 
4c)  in  the  near  infrared  (NIR)  light  and  their  absorption  characteristics  are  oxygen 
dependent
435. 
COX is the terminal complex of the mitochondrial respiratory chain (figure 3). It takes 
electrons from cytochrome c and catalyses the reduction of oxygen to water with the 
concomitant synthesis of ATP through the oxidative phosphorylation process
436,437. In 
hepatocytes, approximately 90% of the oxygen is consumed by mitochondrial COX. 
COX contains four redox-active metal sites: two haem iron (haem a and haem a3) 
centres,  the  copper-copper  dimer  (CuA),  and  the  binuclear  haem-copper  coupled 
centre (haem a3/CuB). These four metal centres accept or donate electrons during the 
electron  transfer  through  the  respiratory  chain,  changing  their  redox  state.  The 
oxygen-binding site of the enzyme is the binuclear unit formed of the CuB and haem a3. 
The donation of electrons from this unit to oxygen accounts for the majority of oxygen 
consumption  in  the  tissues.  The  CuA  and  haem  a  centres  donate  electrons  to  the 
binuclear unit and therefore are not directly involved in oxygen reduction
436,438. In the 
absence  of  oxygen,  electron  transfer  to  oxygen  cannot  take  place.  Electrons 
accumulate on the haem and copper atoms and COX becomes reduced. With oxygen 
availability the electrons are transferred rapidly from the metal centres to oxygen and 
COX becomes oxidised. Many factors can affect the COX redox state in vivo, but the 
most  significant  factors  are  the  oxygen  concentration
436,439,  NO i n  p h y s i o l o g i c a l  
circumstances
440,441 and oxidants such as ROS and RNS during oxidative stress
442,443.   
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Figure 3: Cellular respiration 
(a) Components of mitochondrial electron transport chain  
 
The process of ATP production through the c, also known as the respiratory chain, is 
called  oxidative  phosphorylation:  NAD+=nicotinamide  adenine  dinucleotide; 
NADH=reduced  form  of  NAD+;  FAD+=flavin  adenine  dinucleotide;  FADH=reduced 
form  of  FAD+;  CoQ=coenzyme  Q;  Cyt  c=cytochrome  c;  O
•=oxygen r a d i c a l ; 
H2O=water;  ADP=adenosine  5'-diphosphate;  Pi=inorganic  phosphate;  IMM=inner 
mitochondrial membrane
444.  
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(b) Glycolysis, Krebs cycle and ketone body formation 
 
Glucose-6-phosphate  produced  from  glucose  can  be  converted  to  glycogen  or  is 
metabolized through the pentose-phosphate pathway. Acetyl-CoA is oxidized through 
the Krebs cycle or utilised to produce ketone bodies. 
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All 4 centres exhibit different absorption characteristics depending on their redox state. 
The copper centres are optically sensitive in the NIR region in contrast with the haem 
centres that absorb visible light
436,437,441,445. Absorption of the NIR light by COX occurs 
primarily at the CuA centre within COX. The oxidised CuA centre has a characteristic 
shape spectrum with a broad peak centred around 845nm
435,439. The signal intensity 
decreases  on  reduction  of  this  centre.    The  contribution  of  haem  iron  centres  to 
absorption  of  NIR  is  less  than  10%  of  the  total  signal  in  the  reduced–oxidised 
spectrum
439,446. 
The redox state of COX CuA is dependent on cellular oxygen availability
436,437,441,447. In 
the presence of oxygen electron transfer occurs and the enzyme becomes oxidised 
whereas lack of oxygen results in a decreased flow of electrons and COX becomes 
reduced. The increase in the reduction state of COX reflects severe cellular hypoxia.  
Another synthetic chromophore that can be measured by NIRS is indocyanine green 
(ICG). ICG is an anionic dye that has been used for many years to measure hepatic 
blood flow and as a test of liver function
448. It has a characteristic maximum absorption 
peak  at  805nm  in  the  NIR  light  region  allowing  its  absorption  coefficient  to  be 
incorporated in the NIRS algorithm to measure directly its concentration in the hepatic 
tissue
449.  
3.3.1  Basic principles of NIRS 
Light interactions with the tissue involve the combination of reflectance, scattering and 
absorption which depends upon many factors including the light wavelength and the 
illuminated tissue type
435. In the visible region of the spectrum (450-650nm) light is 
strongly attenuated due to the intense absorption by haemoglobin and light scattering 
in tissues, which increases with decreasing the wavelength. Therefore, light fails to 
penetrate  more  than  1cm  of  tissue
435,450,451.  However,  the  NIR  region  of  the 
electromagnetic  spectrum  (700-1000nm)  represents  an  optical  window  of  relative 
transparency  and  a  significant  amount  of  radiation  can  be  effectively  transmitted  
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through biological materials over distances of up to 8cm
435,452. 
The  technique  of  NIRS  relies  upon  two  main  physical  properties:  (1)  the  relative 
transparency of biological tissue to light in the NIR region of the spectrum and (2) the 
existence of different tissue chromophores with characteristic absorption spectra in the 
NIR light spectrum
453-456. In tissue with homogeneous scattering the calculation of light 
attenuation  and  the  relationship  between  the  optical  absorption  and  chromophore 
concentration  may  be d e s c r i b e d  b y  a  m o d i f i e d  B e e r -Lambert’s  law.  The  law 
modifications  include  (a)  an  additive  term,  G,  due  to  scattering  losses  and  (b)  a 
multiplier, to account for the increased optical pathlength due to scattering. This law 
can be used to convert the obtained optical densities to concentration changes of Hb, 
HbO2, and COX in µmole/L per optical pathlength
454:  
A = α. c. d. B + G 
A  is t h e  a t t e n u a t i o n  o f  l i g h t  ( o p t i c a l  d e n s i t y ) ,  α i s  t h e  a b s o r p t i o n  c o e f f i c i e n t  o f  t h e  
chromophore  (µmole
-1.cm
-1),  c  is  the  concentration  of  the  absorbing  compound 
(µmole/L) and d is the geometrical distance between the points where light enters and 
leaves the tissue (cm). B the differential pathlength factor (DPF) which accounts for 
the  increase  in  optical  pathlength  due  to  light  scattering  (which  causes  the  optical 
pathlength to be greater than d) and G is a constant geometrical factor which accounts 
for loss of photons by scattering. As G cannot be quantified in vivo and is dependent 
upon the scattering coefficient of the tissue interrogated, it is not possible to measure 
the absolute concentration of the chromophore in the tissue from measurement of the 
absolute attenuation. If α, B, and d are known and G assumed to remain constant 
during measurement, we can measure the change in the chromophore concentration 
(Δc) from measuring the change in attenuation (ΔA) from the following formula:  
Δc = ΔA / α. d. B.  
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Since the absolute concentration of tissue chromophores are unknown and cannot be 
calculated due to the effect of light scattering within the tissue, all NIRS measurements 
are expressed as absolute concentration changes (µmole/L) from an arbitrary zero at 
the start of the measurement. The absorption coefficient of COX was obtained in vivo 
from the brains of experimental animals whose blood had been replaced by a blood 
substitute (fluorocarbon) with exposure to 100% O2 or N2 to obtain the oxidised and 
reduced COX spectra
454-457.  
For  simultaneous  computation  of  the  changes  in  concentration  of  a  number  of 
chromophores from changes in attenuation at a number of wavelength, an algorithm 
can  be  used  which  incorporates  the  relevant  absorption  coefficient  for  each 
chromophore at each
454-456,458. 
3.3.2  Near infrared spectrophotometer 
The NIR spectrometer used in this study is the NIRO 500 (Hamamatsu Photonics K.K., 
Hamamatsu, Japan) (Figure 4). This spectrometer is the commercial version of an 
instrument  developed  by  colleagues  in  the  Department  of  Medical  Physics  and 
Bioengineering,  University  College  London
458.  In  the  NIRO  500,  the  light  source  is 
monochromatic light generated from semiconductor laser diodes. The light is produced 
at four wavelengths (774, 826, 849, and 906nm). The choice of the wavelengths is 
based on 765nm, the absorption maximum for Hb; 810nm, the isobestic wavelength at 
which  the  extinction  coefficients  of  HbO2  and  Hb  are  equal  which  can  be  used  to 
calculate haemoglobin concentration independent of oxygen saturation; 845nm, the 
absorption maximum for oxidised COX; and 900nm, a reference wavelength
435,454,455. 
The light is produced by laser diodes and carried to the liver via a bundle of optical 
fibres in sequential pulses. The optical fibres are covered by a light proof protective 
sheath and its distal end terminated in a very small glass prism which reflects the light 
through 90
o to direct it into the tissue
453. Photons emerging from the liver are collected 
by the second bundle of optical fibres and detected by a photomultiplier tube light  
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detector
453. The incident and transmitted light intensities are recorded and from these 
the changes in the concentration of tissue chromophores (µmol/L) are calculated using 
an algorithm incorporating the known chromophores absorption coefficients and an 
experimentally measured optical pathlength.   
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Figure 4: Near infrared spectrometer  
(a)  (b) 
 
 
 
(a)  The  NIRO  500  dual  channel  surface  laser  Doppler  flowmeter  (Hamamatsu 
Photonics KK, Hamamatsu, Japan). (b) The NIRS and LDF probe placement on the 
liver lobes. 
(c) 
 
 
(c) Absorption spectra of HbO2,Hb, & COX in the NIR light region
435 
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The standard NIRO 500 algorithm was developed using the wavelength dependant-
pathlength for the brain tissue
459. As a part of this study, modification of the NIRO 500 
algorithm  has  been  carried  out  in  the  Department  of  Medical  Physics  and 
Bioengineering, University College London for its hepatic application
458. The absorption 
coefficient of a freshly dissected and viable blood free pig liver was measured. The 
absorption coefficient was found to be 0.04mm
-1 at 800nm which is some four times 
larger  than  that  of  normally  perfused  brain  tissue  although  the  transport  scattering 
coefficient was similar near 1.0mm
–1. When the absorption coefficient of blood in a 
normally perfused liver was added to the blood free absorption coefficient the overall 
absorption  coefficient  was  near  0.1mm
–1 w i t h  t h e  s c a t t e r i n g  c o e f f i c i e n t  e s s e n t i a l l y  
unchanged. The optical pathlength as a function of wavelength for normally perfused 
liver was then calculated incorporating the measured absorption coefficient and the 
scattering  coefficient  mathematically  corrected  for  the  contribution  of  haemoglobin 
absorption.  The  average  blood  content  of  the  liver  was  assumed  to  be  12%  by 
volume
460 at an average haemoglobin saturation of 60%.  
3.3.3  NIRS application in the rabbit, data collection, analysis 
NIRS probes were mounted inside a probe holder and placed on the liver surface at a 
fixed site of the left lobe of the liver in all the animals in each experiment to avoid any 
anatomical variation, which could influence in tissue oxygenation and blood volume. 
As a part of the modification of this instrument for use on the liver, a flexible rubber 
holder was made to hold the NIRS probes at a fixed spacing over the liver surface 
(Figure  4).  This  probe  holder  ensured  that  the  sites  of  light  entry  and  exit  are 
maintained at a constant and known spacing distance which minimises the possibility 
of artefact due to changes in the distance between the probe ends. Also, it allows a 
satisfactory contact between the liver surface and the probe ends.  
The  NIRS  includes  the  facility  to  set  the  attenuation  and  therefore  chromophore  
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concentration  changes  to  zero  with  the  NIRS  initial  setting.  Since  all  the 
measurements are changes from an arbitrary initial zero, this function is important to 
ensure  that  artefacts  such  as  system  drift,  optode  movement,  and  excessive  light 
having a minimal effect on the data. The NIRS data were continuously collected in a 
laptop  computer  connected  to  the  NIRS.  These  data  are  the  changes  in  light 
attenuation (optical densities: OD) at four wavelengths due to absorption by the tissue 
chromophores.  A  software  program  called  ONMAIN
 ( H a m a m a t s u  P h o t o n i c s  K . K . ,  
Hamamatsu, Japan) was used to convert these data into changes in concentration 
changes of COX (µmol/L) using the previously defined algorithm in the NIRO 500. This 
was  then  transferred  to  excel
 d a t a  s h e e t s  ( M i c r o s o f t  C o m p a n y ,  S e a t t l e ,  U S A )  f o r  
analysis. The data at the relevant time points were collected as the mean of 2-minute 
data and calculated in regard to the baseline value at the start of the experiment.   
3.4  Ultrasonic transit time flowmetry 
In this study blood flow through the PV was measured using ultrasonic transit time 
flowmetry. 
3.4.1  Principle of ultrasonic transit time flowmetry 
Using wide-beam illumination, two transducers pass ultrasonic signals back and forth, 
alternately intersecting the flowing liquid in the upstream and downstream directions. 
The transit time of such beam is a function of the volume flow intersecting this beam, 
regardless  of  vessel  dimensions  or  cross-sectional  area.  In  the  same  way  that  a 
swimmer will move quicker in the downstream direction than in the upstream direction, 
the  speed  of  the  ultrasound  is  affected  by  the  flow  of  liquid  passing  the  ‘acoustic 
window’ of the flow probe. The flowmeter derives an accurate measure of the transit 
time it took the wave of ultrasound to travel from one transducer to the other. The 
difference  between  the  upstream  and  downstream-integrated  transit  times  is  a 
measure of volume flow rather than velocity
461. The ultrasonic transit time flowmetry 
has  been  demonstrated  to  provide  an  accurate  method  for  hepatic  blood  flow  
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measurement
462-464. 
3.4.2  Ultrasonic flowmetry in the rabbit model 
Portal vein blood flow was measured continuously using a dual ultrasonic transit time 
flowmeter  (HT207,  Transonic  Systems  Inc,  NY,  USA)  as  shown  in  figure  5.  The 
flowmeter  perivascular  probes  were  placed  around  the  portal  vein  (figure  5).  The 
accuracy of this technique is dependent on careful positioning and alignment of the 
probe with respect to the vessel. The vessel should be positioned within the central 
area  of  uniform  ultrasonic  intensity  of  the  probe  window  i.e.  away  from  the  probe 
window edges, which have lower ultrasonic beam intensity
461. Also, it requires accurate 
selection of the probe size, which was determined by the outer diameter of the blood 
vessel. 
3.4.3  Ultrasonic transit time flowmetry data collection and analysis 
Data from continuous measurement by the ultrasonic flowmeter was collected 
via the NIRS software. After conversion of the NIRS data to Microsoft Excel 
sheets, the ultrasonic flowmeter data at the relevant points in each experiment 
was calculated as a mean of 1-minute data.  
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Figure 5: Dual ultrasonic transit time flowmeter 
 
 
 
Dual  ultrasonic  transit  time  flowmeter  (HT207,  Transonic  Systems  Inc.,  NY, 
USA) and the perivascular probes.  
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3.5  Indocyanine green (ICG) clearance 
Measurement of ICG blood clearance 24hrs following liver transplantation proved to be 
more accurate than the conventional liver function tests as a predictor of liver-related 
graft outcome
465. Its clearance also showed significant correlation with the severity of 
preservation injury, the duration of intensive care unit and hospital stay, prolonged liver 
dysfunction, and septic complications
465. ICG clearance was also found to correlate 
significantly with free oxygen radicals and neutrophil elastase, as mediators for I/R 
injury, after liver transplantation
466. Also, ICG clearance correlated with parameters of 
liver  injury  such  as  AST  and  prothrombin  time  at  24hrs  post-transplantation
466. 
Measurement of blood ICG clearance requires frequent blood sampling and gives a 
global idea about both hepatic circulation and function.  
For measurement of hepatic ICG clearance, a bolus of ICG (Cardiogreen, 90% dye 
content, Sigma, Dorset, UK) 0.5 mg/kg was given. ICG was dissolved in sterile water 
(1mg/ml) and given via the ear vein over 20 seconds. ICG was prepared immediately 
before administration to avoid its degradation by light, which results in slower hepatic 
uptake and excretion that could cause inter-animal variation
467. An ICG of 0.5 mg/kg 
was used to ensure that ICG clearance is controlled by both the blood flow and hepatic 
function
468.  For  continuous  measurement  of  hepatic  tissue  ICG  concentration,  the 
NIRO 500 probes were placed, with a 10 mm separation, on the left lobe of the liver for 
30 minutes after ICG injection (figure 4b).  
Continuous measurement of hepatic ICG by NIRS produces a concentration-
time  curve.  This  curve  was  analysed  to  produce  two  exponential  rate 
constants, representing hepatic ICG uptake from the plasma to the hepatocytes 
(α) and hepatic ICG excretion from the liver by cytoplasmic transport and biliary 
excretion  (β).  These  rate  constants  were  calculated  by  fitting  the  ICG 
concentration-time curve to a two-compartment mathematical model as defined  
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by the sum of two exponential equations as previously reported by Shinohara 
and colleagues
449:  
ICG (t) = - A exp (-α t)
 + B exp (-β t) 
Where ICG (t) is the hepatic concentration of ICG at any time (t), α and β        
(min
-1)  are  the  rate  constants  for  the  hepatic  ICG  uptake  and  excretion, 
respectively. A and B are the zero time intercepts, both theoretically equal to 
the initial hepatic concentration. The assumption is that α > β and A ≈ B. 
The  fitting  to  this  model  was  done  using  a  commercial  computer  package 
based on the non-linear least square regression (Graph Pad Prism, Graph Pad 
Software  Inc.,  San  Diego,  USA).  The  iterative  procedure  of  the  program 
minimises the reduced sum of squares. The goodness of the fit was evaluated 
by the R
2 value. 
3.6  Liver transaminases 
Alanine  aminotransferase  (ALT),  aspartate  aminotransferase  (AST)  and  creatinine 
kinase  (CK)  activity  were  measured  in  serum.  Blood  samples  were  centrifuged  at 
2,000G for 10min at room temperature.  Serum was separated from the samples and 
stored at –20°C until assayed. Measurements were made using an automated clinical 
chemistry analyser (Hitachi 747, Roche Diagnostics, Lewes, UK).  
3.7  Histology 
Small wedge biopsies were taken in baseline and at the end of the procedure from the 
ischaemic liver lobes. The liver tissue was fixed in neutral buffered formalin (10%), 
embedded in paraffin and stained with haematoxylin and eosin (H&E). Sections were 
examined under microscope (digital light microscope CLF 60 optical system, Nikon UK 
Ltd, Surrey, UK). For assessment of the degree of injury a semi quantitative method 
was  used  in  which  a  blinded  liver  pathologist  estimated  the  number  of  neutrophils  
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(PMN)  in  sinusoids,  the  aggregation  of  PMN,  structural  changes  in  KC a n d  t h e  
presence of necrosis and apoptosis in 5 high power fields per slide.  
For steatotic livers formalin fixed but not paraffin embedded tissue was stained for fat 
using  the  Swank  &  Davenport  modification  of  the  Marchi  method
469.  The  grade  of 
steatosis was analysed in a semi-quantitative manner: mild (<30 %), moderate (30-60 
%) and severe (>60 %) using a clinically applied grading system
235.  
3.8  Proton Nuclear Magnetic Resonance (
1HNMR) Spectroscopy 
High resolution proton nuclear magnetic resonance (
1HNMR) spectroscopy has been 
established  as  a  powerful  technique  to  explore  the  biochemical  composition  of 
biological  fluids  such  as  plasma,  bile,  seminal  and  synovial  fluids,  in  various 
pathological conditions
8. This technique is rapid, non-invasive and non-destructive and 
can detect metabolites present at the millimolar concentrations and can be applied to 
detect  unexpected  compounds  in  biological  fluids
9.  It  has  been  used  to  study  bile 
composition
10-15. 
1HNMR analysis of bile after liver transplantation suggested that this 
technique  might  help  to  distinguish  ischaemia f r o m  r e j e c t i o n  p o s t -transplant
17 a n d  
there has been growing interest in attempting to predict graft function by analysing bile 
production immediately after transplantation
18.  
3.8.1  Nuclear moment, excitation, and induction decay 
Many nuclides possess permanent magnetic moments (spin) and, when placed into an 
external  magnetic  field,  align  (the  axis  of  their  spin)  along  the  magnetic  field.  The 
orientation is never complete due to thermal fluctuations, and some nuclides orient 
parallel to the field while others prefer the anti-parallel arrangement. At equilibrium, the 
magnetic moments of all nuclides present in a sample produce a net macroscopic 
magnetization c a l l e d  nuclear  magnetization,  which  can  be  represented  by  a 
magnetization vector (Figure 6a)
470,471.  
In equilibrium, nuclear magnetization is aligned along the magnetic field and is almost  
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impossible  to  detect  against  the  main  field  background.  By  applying  a  suitable 
radiofrequency pulse, nuclear magnetization can be rotated by any desired angle and 
thus brought into a non-equilibrium state in which it is no longer aligned with the field. 
This is called excitation (Figure 6b)
471. The excitation pulse is typically very powerful 
(0.1-10 kW) but short (of the order of 1-100 microseconds)
470,471.  
Once excited, the nuclear magnetization vector is not longer aligned with the magnetic 
field.  Those  vectors  that  are  transversal  to  the  magnetic  field  precesses  (rotates) 
around the field direction with a frequency f proportional to the field strength B, f = γB, 
where  the  proportionality  constant  γ i s  c h a r a c t e r i s t i c  o f  the  particular  nuclide.  This 
“Larmor frequency” is usually in the radiofrequency range
470,471.  
The excitation pulse, in order to be effective, must have a carrier frequency very close 
to the Larmor frequency (the resonance condition). Consequently, it can only excite, 
for example, 
1H nuclides or 
13C nuclides, but not both at the same time. 
The precessing component of nuclear magnetization, though tiny, is easy to detect 
because it rotates and thus can induce RF signals in a nearby receiver coil (hence the 
term nuclear induction) as shown in figure 6c
470,471. 
After  excitation,  nuclear  magnetization  returns  back  to  its  equilibrium  state.  This 
process  is  called  relaxation a n d  t h e  r e t u r n  p a t h s  ( r e l a x a t i o n  c u r v e s )  c a n  b e  q u i t e  
complex.  In  the  simplest  and  somewhat  idealized  case,  it  is  characterized  by  two 
times: 
•  T1,  the  exponential  rate  with  which  the  longitudinal  component o f  t h e  
magnetization returns to its equilibrium value, and 
•  T2,  the  exponential  rate  with  which  the  transversal  component,  while 
precessing around the field direction, decreases in magnitude towards zero.   
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The two relaxation times are subject to the condition T2 ≤ T1. Their numeric values are 
characteristics of the measured substance and of its thermodynamic state and can 
assume values ranging from a few microseconds to several days. This means that, 
after excitation, there is often a relatively long period during which the receiver coil 
picks up a decaying (transient) response signal, called “free induction decay”
470,471. 
3.8.2  Magnetic field variations 
What makes magnetic resonance interesting, is that there are differences between the 
magnetic fields perceived by individual nuclides due to local variations induced by the 
electronic shells of molecules (chemical shifts), variations at a nuclide's location due to 
interactions w i t h  c l o s e -by  nuclides,  field  variations  between  different  areas  of  a 
heterogeneous  sample,  variations  produced  on  purpose  by  precisely  controlled 
magnetic field gradients which vary the field perceived in each voxel of the sample 
according to its location in space
470,471. This is the technical basis of MRI. 
Chemical  shifts  are  the  basis  of  NMR  spectroscopy a n d  i t s  m a n y  a p p l i c a t i o n s  t o  
chemistry. Being very small, they are measured in parts per million (ppm) with respect 
to the external field
470,471.  
All local field variations translate into corresponding variations of the Larmor frequency 
of the nuclides. The observed signal is therefore a sum of superposed signals with 
many  different  frequencies.  Fortunately,  there  are  various  ways  of  mathematically 
decomposing  such  a  composite  signal  (interferogram)  into  its  harmonic 
components
470,471.  The  best  known  and  most  widely  used  of  these  methods  is  the 
Fourier transform (figure 6d)
471. Frequency measurements can be made with incredible 
precision.  
MRS equipment can be tuned, like a radio receiver, to pick up signals from different 
chemical nuclei within the sample or body
470,471. The most common nuclei to be studied 
are protons (hydrogen), phosphorus, carbon, sodium and fluorine.  
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Figure 6: The physics of NMR 
 
(a) Alignment of nuclear moment at equilibrium in a magnetic field to produce a 
“magnetization vector.” 
 
 
 
(b) Excitation and precession following a radio frequency pulse 
 
If the magnetization vector is tilted away from the z axis it executes a precessional 
motion in which the vector sweeps out a cone of constant angle to the magnetic field 
direction. 
 
 
(c) Nuclear precession following excitation produces a radio frequency signal in 
receiver coil 
 
The precessing magnetization will cut a coil wound round the x axis, thereby inducing 
a current in the coil. This current can be amplified and detected; it is this that forms the 
free induction signal. For clarity, the coil has only been shown on one side of the x 
axis.  
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(d) Fourier transforming the free induction decay signal 
 
 
 
3.8.3  Experimental 
1HNMR protocol 
In chapter four and five,
 1HNMR spectra of hepatic bile samples was obtained using 
spectrometer (Eclipse+ 500; JEOL Ltd., Tokyo, Japan) operating at 11.7 Tesla (500 
MHz for 
1H) as shown in figure 7. All Spectra were recorded at 25°C. 600µL of bile 
was placed in a 5mm tube with a 2mm coaxial insert containing 100µL of 1mg/ml of 
sodium  trimethylsilyl-[
2H4]propionate  (TSP)  dissolved  in  deuterium  oxide  (
2H2O, 
Fluorochem Ltd., Old Glossop, Derbyshire, UK) and set at 0.0 parts per million (ppm). 
To reduce the large water resonance signal a gated secondary irradiation at the water 
frequency was applied. Published peak assignments
10,18,370,472 were used. Integration of 
the 
1HNMR spectra areas was measured relative to the TSP area and obtained using 
MestRe-C software (version 2.3a, Departmento de Química Orgánica, Universidade 
de Santiago de Compostela). 
In chapter six, seven and eight, 
1HNMR analysis was performed on an 11.7T (500 
MHz for protons) spectrometer (Varian Unity +; Varian, Palo Alto, CA, USA) at 25
oC. 
Bile  was  thawed  at  room  temperature  and  placed  in  5mm  NMR  tube.  For  a 
field/frequency lock a coaxial capillary insert was used (Wilmad, Buena, NJ, USA). 
This  capillary  insert  was  filled  with  a  deuterium  oxide  solution  of  sodium  TSP t h a t  
acted both as a chemical shift reference and quantification standard. This capillary  
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was calibrated by using a series of known concentration solutions of deoxycholate and 
a  calibration  curve  was  obtained ( a p p e n d i x  s e c t i o n  1 0 . 1 ) .  This  was  then  used  for 
quantification of bile components, which enabled an accurate comparison bile levels 
between the groups. One dimensional NMR spectra were obtained at 500MHz with a 
sweep width of 6kHz and 32k data points in 64 scans were collected in both normal 
and spin echo mode. Presaturation of bile was carried out to attenuate the intensity of 
water signal. The spectra were analysed using software from MestRe-C version 3.1.1 
(Universidade de Santiage de Compostela, Spain). 
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Figure 7: 
1HNMR spectrometer 
 
 
 
 
 
The 
1HNMR spectrometer: Eclipse+ 500 (11.7 Tesla) with automatic sample-loader 
(JEOL Ltd., Tokyo, Japan)   
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Table 2: 
1HNMR Peak Assignments 
 
Peak Assignments  ppm  Range of Integration 
TSP  0.0  -0.02-0.02 
C-18 bile acids  0.7  0.61-0.73 
ß-hydroxybutyrate  1.2  1.18-1.22 
Lactate methyl group (CH3)  1.3  1.25-1.38 
Acetate methyl group (CH3)  1.9  1.89-1.95 
Acetoacetate  2.2  2.29-2.25 
Pyruvate methyl group (CH3)  2.3  2.34-2.38 
PC head group –N+(CH3)3   3.2  3.20-3.27 
Acetoacetate  3.4  3.42-3.45 
Water  4.7  4.61-4.66 
C-25 Glycine (CH2)  3.8  3.76-3.92 
β-glucose anameric proton peak  5.2  5.20-5.25 
 
3.9  Bile sampling for MRS  
The bile duct was cannulated with a polyethylene catheter (PE-50; Portex, Kent, UK) 
for measurement of BF and collection of samples for 
1HNMR spectroscopy. Bile was 
stored in liquid nitrogen for days at -80°C in clear polypropylene Eppendorf safe lock 
microcentrifuge tube 1.5mL. It has been known for several years that chemicals (e.g., 
BPA and phlalates) can leach out of the plastic, such as toys and baby bottles
473,474. 
The  impact  of  these  chemicals  on  human  health  is  well  known.  Recent  scientific 
reports have now noted that chemicals used in the manufacturing of disposable plastic 
labware, such as slip agents or plasticizers, can leach out of the plastic and affect 
laboratory experiments leading to erroneous results
475-477. If these experiments wwere  
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to  be  repeated  today,  the  use  of  reagent  free t u b e s ,  o r  g l a s s w a r e  w o u l d  b e  
encouraged. 
 
3.10 Blood sampling for liver function  
Arterial blood samples (1ml each) were taken before the induction of liver ischaemia 
(baseline), at the end of ischaemia (60 min) and 2, 5 and 7 hours after reperfusion for 
measurement of ALT activity. An equal volume of normal saline was used to replace 
the volume of the blood taken. Serum was separated from the samples and stored at -
20
oC  until  assayed.  The  measurements  were  done  using  an  automated  clinical 
chemistry analyzer (Hitachi 747, Roche Diagnostics Ltd., Sussex, UK).     
3.11 Data collection and statistical analysis 
Data  from  the  pulse  oximeter,  blood  pressure,  LDF  and  NIRS  were  collected 
continuously on a laptop computer. The data were averaged for two minutes before 
the induction of ischaemia (baseline), at the end of ischaemia and at the end of each 
hour of the reperfusion period. Changes in hepatic tissue oxygenation at the end of 
each  period  were  calculated  relative  to  baseline.  Values  are  expressed  as  mean, 
standard deviation (SD). ANOVA with Bonferroni adjustment for multiple comparisons, 
unless otherwise stated. P<0.050 was considered statistically significant. 
The “Student” t test was developed by W. S. Gossett [1876-1937] to solve problems 
stemming from his employment in a brewery. Student's t-test deals with the problems 
associated with inference based on “small” samples: the calculated mean (Xavg) and 
standard  deviation  (σ)  may  by  chance  deviate  from  the  “real”  mean  and  standard 
deviation  (i.e.,  what  you'd  measure  if y o u  h a d  m a n y  m o r e  d a t a  i t e m s :  a  “ l a r g e ”  
sample).  
For example, it is likely that the true mean size of maple leaves is “close” to the mean 
calculated from a sample of N randomly collected leaves.  
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If N=5, 95% of the time the actual mean would be in the range: Xavg± 2.776 /N
1/2 ;  
if N=10: Xavg± 2.262 /N
1/2 ;  
if N=20: Xavg± 2.093 /N
1/2 ;  
if N=40; Xavg± 2.023 /N
1/2 ;  
and for “large” N: Xavg± 1.960 /N
1/2 .  
While  the  t-test  is  limited  to  comparing  means  of  two  groups,  one-way  ANOVA 
(Analysis of Variance) can compare more than two groups. Therefore, the t-test is 
considered  a  special  case  of  one-way  ANOVA.  These  analyses  do  not,  however, 
necessarily imply any causality (i.e., a causal relationship between the left-hand and 
right-hand side variables). The t-test assumes that samples are randomly drawn from 
normally  distributed  populations  with  unknown  population  means.  Otherwise,  their 
means are no longer the best measures of central tendency and the t-test will not be 
valid. In a t-test you are able to test one sample mean vs. a single value or two sample 
means against each other. ANOVA allows you to test if multiple means are equal to 
each other.  
In other words, the null hypothesis of the t-test is: µ1 = µ2 
the null hypothesis for ANOVA is: µ1 = µ2 = µ3 = .... = µn 
 
The reason we have the different tests is because of the errors in multiple testing. 
For example you have four means to look at, µ1, µ2, µ3, µ4.  
If  you  use  t-tests  to  test  if  each  mean  is  equal  to  each  other  at  say  the  0.05 
significance level then you have a 4C2=6 tests to conduct and a probability of not 
committing a Type I error decreasing from 0.95 to 0.95
6=0.7350919.  
This means that using 6 independent t-tests for the four equality of four means you 
have a probability of committing a Type I error—reject the null hypothesis when it is 
true—from 0.05 to over 26%.  
This is not desirable, you can correct this by using the Bonferroni correct or Fisher's  
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LSD or any other multiple testing correction method. In ANOVA, the test is designed to 
test for multiple mean equalities and the significance of the test is preserved. 
3.12 Metabolomics in MRS analysis 
A  more  contemporary  technique  of  analysis  of  MRS  spectra  would  include 
metabolomic analysis FIDs themselves, not the outcome of integrations, taking into 
account every variation in the area under the curve. 
The main strengths of NMR spectroscopy are reproducibility
478, with little variance
479, 
the a b i l i t y  t o  quantify c o m p o u n d s  i n  m i x t u r e s  a n d  t h e  a b i l i t y  t o  i d e n t i f y  u n k n o w n  
metabolites.  Given  that  peak  area  in  the  NMR  spectrum  relates  directly  to  the 
concentration of specific nuclei, quantification of compounds in a complex mixture is 
very precise
480. 
Over  the  last  decade  there  has  been  an  advance  in  ‘big  data’  and  data-mining 
techniques, focusing no extracting information and patterns from large data sets. The 
emerging “-omics” subspecialties are its application in biomedical sciences, such as 
proteomics,  transcriptomics,  and—as  the  probably  closest  to  the  “bedside” 
metabolomics. Metabolomics can learn from the issues that have plagued “-omics” 
researchers over the last years, namely standardization
480, data processing
481 and data 
interpretation
482. 
3.12.1  The “–omics” sciences 
Proteomics i s  t h e  l a r g e -scale  study  of  proteins,  particularly  their  structures  and 
functions
483,484. The word proteome is a blend of protein and genome. The proteome is 
the entire complement of proteins
485, including the modifications made to a particular 
set of proteins, produced by an organism or system 
The study of transcriptomics, also referred to as expression profiling, examines the 
expression  level  of  mRNAs  in  a  given  cell  population,  often  using  high-throughput 
techniques  based  on  DNA  microarray  technology o r  n e x t  g e n e r a t i o n  s e q u e n c i n g   
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technology called RNA-Seq. 
Metabolomics i s  t h e  s t u d y  o f  t h e  u n i q u e  c h e m i c a l  f i n g e r p r i n t s  t h a t  s p e c i f i c  c e l l u l a r  
processes  leave  behind,  i.e.  the  study  of  their  metabolite p r o f i l e s .  “Clinical 
metabolomics” a i m s  a t  e v a l u a t i n g  a n d  p r e d i c t i n g  h e a l t h  a n d  d i s e a s e  r i s k  i n  a n  
individual by investigating metabolic signatures in body fluids or tissues, which are 
influenced by genetics, epigenetics, environmental exposures, diet, and behavior
486.  
3.12.2  Metabolomics 
The idea, that biological fluids mirror the health of the whole entity, has existed for a 
long  time.  Ancient  Chinese  doctors  used  ants  to  detect  glucose  in  the  urine  of 
diabetics
487. In the Middle Ages, “urine charts” were used to link the colours, tastes and 
smells of urine to various medical conditions, which are metabolic in origin
488. 
Seeley  et  al.  demonstrated  the  usefulness  of  using  MRS  to  detect  metabolites  in 
unmodified  biological  samples
489.  As  sensitivity  of  MRS  has  improved  with  the 
evolution of higher magnetic field strengths and magic angle spinning, it continues to 
be  a  leading  analytical  tool  to  investigate  metabolism
487,488. P r o f e s s o r  J e r e m y  
Nicholson has pioneered efforts to use MRS for metabolomics at Birkbeck College, 
and later at Imperial College London, University of London. In 1984, Nicholson showed 
1HNMR  spectroscopy  could  potentially  be  useful  in  the  diagnosis  and  treatment  of 
diabetes mellitus. He later pioneered the application of pattern recognition methods to 
NMR  spectroscopic  data
490,491 a n d  t h e  q u a n t i t a t i v e  m e a s u r e m e n t  o f  t h e  d y n a m i c  
multiparametric metabolic response of biological systems to pathophysiological stimuli. 
Jeremy Nicholson pioneered this approach at Imperial College London and has been 
used in toxicology, disease diagnosis and a number of other fields. Historically, the 
metabonomics approach was one of the first methods to apply the scope of systems 
biology to studies of metabolism
492-494.  
The data generated in metabolomics usually consist of measurements performed on 
subjects under various conditions. These measurements may be digitized spectra, or a  
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list  of  metabolite  levels.  In  its  simplest  form  this  generates  a  matrix  with  rows 
corresponding to subjects and columns corresponding to metabolite levels
487. Several 
statistical  programs  are  currently  available  for  analysis  of  both  NMR  and  mass 
spectrometry data. Metabolomics data may also be analyzed by statistical projection 
(chemometrics)  methods  such  as  principal  components  analysis  and  partial  least 
squares  regression
495.  The  large  spectral  datasets  generated  by  MRS a r e  o f t e n  
analyzed using data reduction techniques like Principal Component Analysis (PCA). 
Although rapid, these methods are susceptible to solvent and matrix effects, high rates 
of  false  positives,  lack  of  reproducibility  and  limited  data  transferability  from  one 
platform to the next
496. 
3.12.2.1 Principal component analysis 
NMR spectra of biological samples are extremely complex and an optimized method to 
explore the information from the NMR spectral data is needed: this is made possible 
using  multivariate  data  analysis  which,  in  this  context,  is  called  chemometrics
497. 
Principal  component  analysis  (PCA)  is  a  commonly  used  chemometric  tool  as  it 
simplifies the multivariate data into a few dimensions that can be readily understood 
and  evaluated.  In  this  manner,  each  sample  (spectrum)  can  be  represented  by 
relatively few numbers (PC scores) instead of thousands of variables (spectral data 
points).  PC  scores  can  then  be  plotted,  making  it  possible  to  visually  assess 
similarities and differences between samples and to determine whether samples can 
be  grouped  into  meaningful  patterns.  As  an  exploratory  method,  PCA  is  most 
commonly  used  to  identify  how  one  sample  is  different  from  another,  and  which 
variables contribute the most to this difference. 
3.12.2.2 Multivariate Data Analysis 
Multivariate Data Analysis (MVA) extracts the information from large data sets and 
presents  the  results  as  interpretable  plots  based  on  the  mathematical  principle  of 
projection. Even data characterized by thousands of variables can be reduced to just a  
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few information rich plots.  
3.12.2.3 Partial least squares discriminant analysis 
Partial  least  squares  discriminant  analysis  (PLS-DA)  determines  the  relationship 
between the response vector Y (i.e. sham control group versus ichaemia/reperfusion) 
and the matrix X (concentration of particular metabolites) by simultaneous projections 
of both Y and X spaces to a plane. PLS-DA generates a prediction score (0–1) for 
each  animal  based  on  the  value  of  the  metabolites  (i.e.,  scores  <0.5  would  be 
predicted to be sham control animals versus I/R animal >0.5). This process identifies 
the metabolites whose concentrations differed significantly between groups of animals. 
As  might  be  expected,  most  metabolites  measured  do  not  differ  greatly  between 
groups. In contrast, the greater the consistent difference in metabolite concentration 
between groups, the more important a metabolite becomes.  
 
Due to the large discrepancy between when these experiments were conducted, and 
when the thesis was examined, these new techniques which have emerged in the 
interim should have been utilized in the analysis but have not been. 
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4  Pilot study to determine the effect of 
hepatic warm ischaemia reperfusion on 
bile composition  
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4.1  Introduction 
Bile  formation  is  an  active  secretory  process  involving  bile  salt  dependent  and 
independent mechanisms
25. Bile excretion is used as an indicator of liver function and 
recovery following ischaemia in experimental studies
25,34,39-41,43,44,498-500 and clinical liver 
transplantation
501. However, little is known about changes in bile composition during 
liver ischaemia and following reperfusion.  
In recent years, high resolution 
1HNMR has been established as a powerful technique 
to  explore  the  biochemical  composition  of b i o l o g i c a l  f l u i d s  s u c h  a s  p l a s m a ,  b i l e ,  
seminal  and  synovial  fluids,  in  various  pathological  conditions
371.  This  technique  is 
rapid,  non-invasive  and  non-destructive  and  can  detect  metabolites  present  at  the 
millimolar concentration. In bile, it has been used  to  investigate  biliary  lipids
14 a n d  
conjugated bile acids
15. In the liver, NMR has also been used to assess glutamine 
metabolism
16, energy status after warm ischaemia
17, and to study effects of I/R on liver 
cell  membranes
18,502.  A  preliminary  study  of 
1HNMR  analysis  of  bile  after  liver 
transplantation suggested that this technique might help to distinguish ischaemia from 
rejection  post-transplant  by  detecting  large  resonance  peaks  for  the  ischemic 
metabolites lactate and acetate
18. More recently there has been growing interest in 
attempting  to  predict  graft  function  by  analyzing  bile  production  immediately  after 
transplantation
503. 
Melendez  et  al  in  2001  published  a  small  pilot  study  consisting  of  only  four  liver 
transplants in which they analyzed donor organ bile before and after transplant. One 
recipient had primary graft non-function, another had early graft dysfunction and two 
had good early graft function. 
1HNMR analysis of bile demonstrated that good graft 
function was associated with rapid clearance of sugar peaks derived from University of 
Wisconsin solution, lower lactate and an increase in PC head group and bile acid 
levels
19.   
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With advances in MRI technology, spectroscopy is an increasingly available option 
utilising voxel analysis
19,504-510. In vivo MRS assay of the gall bladder has recently been 
reported
19 with direct MRS assay of the degree of liver steatosis
506-510. The obvious 
implication is for the use of in vivo bile spectroscopy to assess liver function in a non-
invasive manner. The aim of this study is to examine bile composition during liver 
ischaemia a n d  r e p e r f u s i o n  i n  a n  e s t a b l i s h e d  m o d e l  o f  w a r m  l o b a r  l i v e r  I R I
396 t o  
determine any compositional changes during I/R. 
4.2  Objectives 
1.  To determine if there is any change in bile composition with I/R 
2.  To identify the differences in chemical composition between sham and I/R 
3.  To  ascertain  if  these  changes  fit  with  established  understanding  of  the 
mechanisms involved in liver IRI 
4.  To compare these changes with some established markers of IRI 
4.3  Materials and methods  
4.3.1  Model of lobar ischaemia/reperfusion 
The study was conducted under a license granted by the Home Office in accordance 
with the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits (3.8 ± 
0.5  kg)  were  used  in  a  validated  model  of l o b a r  i schaemia
391-400.  Anaesthesia  was 
induced  by  an i n t r a m u s c u l a r  i n j e c t i o n  o f  0 . 5 ml/kg  fentanyl  citrate  and  fluanisone 
(Hypnorm;  Janssen  Animal  Health  Ltd.,  Buckinghamshire,  UK).  Following 
tracheostomy  anaesthesia  was  maintained  with  isoflurane  (Forane;  Abbott 
Laboratories,  Chicago,  IL,  USA),  (0.5-3%)  through  an  anaesthetic  circuit.  Body 
temperature  was  maintained  at  37-38.5
oC  by  a  warming  blanket  (Homoeothermic 
blanket  control  unit;  Harvard  Apparatus,  Southmatick,  Massachusetts,  USA). 
Haemoglobin  saturation  and  heart  rate  were  continuously  recorded  by  a  pulse 
oxymeter (Ohmeda Biox 3740 pulse oxymeter; Ohmeda, Louisville, Colorado, USA). 
One  catheter  (20G)  was  inserted  into  the  right  femoral  artery  for  arterial  blood  
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pressure monitoring and collection of blood samples. The femoral vein was cannulated 
with another catheter (22G) for the administration of anaesthetics and fluids. 
Laparotomy was performed through a midline incision. The ligamentous attachments 
from the liver to the diaphragm were divided and the liver was exposed. The bile duct 
was  cannulated  with  a  polyethylene  catheter  (PE-50;  Portex,  Kent,  UK)  for 
measurement of BF and collection of samples for 
1HNMR spectroscopy.  
4.3.2  Experimental groups and protocol  
Two  groups  of  animals  were  used;  the  I/R  group  (n=6)  had  lobar  liver  ischaemia 
induced by clamping the vascular pedicles of the median and left lobes of the liver, 
using an atraumatic microvascular clip. This method produces a severe ischemic insult 
without inducing mesenteric venous hypertension
398,400. After 60 min of ischaemia the 
vascular  clip  was  removed  and  reperfusion  was  allowed  for  7  hours.  During  the 
ischaemia and reperfusion period, the abdomen was covered with a plastic wrap to 
prevent fluid evaporation. At the end of the experiment the animals were killed by 
exsanguination.  The  sham  group  (n=6)  underwent  laparotomy  for  8  hours,  without 
hepatic inflow occlusion. In both groups 10ml/kg/h of 0.9% NaCl was administered IV 
to compensate for intraoperative fluid loss.  
4.3.3  Blood sampling for liver function  
Arterial blood samples (1ml each) were taken before the induction of liver ischaemia 
(baseline), at the end of ischaemia (60min) and 2, 5 and 7 hours after reperfusion for 
measurement of ALT activity. An equal volume of normal saline was used to replace 
the volume of the blood taken. Serum was separated from the samples and stored at -
20
oC  until  assayed.  The  measurements  were  done  using  an  automated  clinical 
chemistry analyzer (Hitachi 747, Roche Diagnostics Ltd., Sussex, UK).     
4.3.4  Liver Histopathology 
Small wedge biopsies were taken at the end of the procedure from the ischemic and 
non-ischemic  lobes.  Formalin-fixed  liver  tissue  samples  were  embedded  in  paraffin  
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and  stained  with  hematoxylin  and  eosin  for  subsequent  microscopy  (digital  light 
microscope CLF60 optical system, Nikon UK Ltd, Surrey, UK). For assessment of the 
degree  of  injury  a  semi  quantitative  method  was  used  in  which  a  blinded  liver 
pathologist estimated the number of PMN in sinusoids, the aggregation of PMN, the 
hypertrophy of KC and the presence of necrosis and apoptosis in 5 high power fields 
per slide.  
4.3.5  Measurement of cytochrome oxidase activity 
The effect of I/R on intracellular liver tissue oxygenation was measured by NIRS. Light 
at  visible  wavelength  (450-700nm)  is  strongly  attenuated  and  as  a  result  can  only 
penetrate a maximum distance of a few millimetres. However, the absorption of light 
by  tissue  chromophores  is  significantly  lower  at  near i n f r a r e d  w a v e l e n g t h s  ( 7 0 0 -
1000nm),  which  allows  photons  at  this  wavelength  to  penetrate  deeply  into  the 
tissue
511.  There  are  three  main  components  in  liver  tissue  whose  NIR a b s o r p t i o n  
characteristics vary with their oxygenation status, namely HbO2, Hb and redox state of 
COX
268,396. The change in the concentration of these chromophores can be quantified 
by using a modified Beer-Lambert Law
18. NIRS instrument (NIRO-5000; Hamamatsu 
Photonics  K.K.,  Hamamatsu,  Japan)  has  been  used  to  measure  liver  tissue 
oxygenation changes following warm liver IRI
512.  The optical-fibre bundles (probes) 
were positioned on the left lobe of the liver, with a 10mm separation. A flexible probe 
holder  was  used  to  ensure  that  probes  have  a  satisfactory  contact  with  the  liver 
surface and a fixed inter-probe spacing. A NIRS algorithm was developed to measure 
continuously changes in redox state of CuA centre of COX  in µmol/L. The pre-ischemic 
baseline was taken as baseline against which changes recorded. 
4.3.6  Measurement of bile flow and 
1HNMR bile spectroscopy  
The common bile duct was cannulated with a polyethylene catheter (PE-50, Portex, 
Kent, UK) for continuous collection of bile. Bile samples were collected continuously 
and aliquoted in separate containers at the end of baseline (before the I/R procedure),  
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following  60  min  ischaemia a n d  h o u r l y  d u r i n g  r e p e r f u s i o n .  T h e  t otal  bile  volume 
collected was expressed as µL/min/100g of liver wet weight and then each aliquot was 
analyzed  by 
1HNMR  spectroscopy.  Spectra  of  hepatic  bile  samples  were  obtained 
using a 
1HNMR spectrometer (Eclipse+ 500; JEOL Ltd., Tokyo, Japan) operating at 
11.7T (500 MHz for 
1H). All Spectra were recorded at 25°C. 600µL of bile was placed 
in a 5mm tube with a 2mm coaxial insert containing a reference standard of 100µL of 
1mg/ml  of  sodium  trimethylsilyl-[
2H4]propionate  (TSP)  dissolved  in  deuterium  oxide 
(
2H2O, Fluorochem Ltd., Old Glossop, Derbyshire, UK) and set at 0.0 parts per million 
(ppm). To reduce the large water resonance signal a gated secondary irradiation at the 
water frequency was applied. Published peak assignments
10,18,370,472 were used. In brief, 
these were lactate methyl group peaks (1.33 ppm), acetate peaks (1.91 ppm), PC 
head  group  –N+(CH3)3  (3.20  ppm)  and  C-25  glycine  methylene  proton  peak  (3.80 
ppm), as shown in figure 13. Integration of the 
1HNMR spectra areas was measured 
relative to the reference standard TSP area and obtained using MestRe-C software 
(Departmento  de  Química  Orgánica,  Universidade  de  Santiago  de  Compostela, 
Santiago de Compostela, Spain). 
4.3.7  Data collection and statistical analysis  
Values are expressed as mean ± standard deviation. Spectroscopy values are shown 
as  a  percentage  change  of  baseline  values.    For  statistical  analysis  ANOVA  with 
Bonferroni/Dunn post hoc analysis was performed as well as simple and polynomial 
regression  analysis  with  P<0.05  considered  statistically  significant.  Statistics  were 
calculated using commercially available software (SatView 5.0.1; SAS Institute Inc., 
Cary, NC, USA).  
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4.4  Results  
4.4.1  Liver biochemistry 
In the sham group, levels of ALT rose throughout the experiment from 54.0±5.65 IU/L 
at baseline to 91.5±36.06 IU/L after 7hrs reperfusion. A similar effect was seen in AST 
levels. In the I/R group there was a marked significant increase in ALT and AST at 2, 5 
and 7hrs reperfusion as shown in figure 8 and 9 respectively. 
4.4.2  Liver Histopathology 
Examination  of  liver  histology  revealed  PMN  accumulation  in  sinusoids,  PMN 
aggregation, KC hypertrophy, necrosis and apoptosis in the I/R group compared to the 
sham group as shown figure 10. 
4.4.3  Bile Flow 
BF gradually decreased in the sham group over the period of the experiment from 
208.5±5.65  µL/min/100g  at  baseline  to  155.0±8.49  µL/min/100g  liver  wet  weight  at 
7hrs  reperfusion  (P=0.0051).  BF  in  the  I/R  group  was  similar  to  sham  group  at 
baseline,  227.5±29.01  µL/min/100g  liver  wet  weight,  but  reduced  significantly  to 
60.5±19.16, (26.6% of baseline) during ischaemia (P=0.0008 compared to sham). BF 
increased on reperfusion to but remained significantly less than sham as shown in 
figure 11. 
4.4.4  Cytochrome oxidase activity 
In the I/R group COX reduced significantly during ischaemia (-24.23±5.52 µmol/L vs. 
12.75±11.66 µmol/L, P=0.0007) and 7hr (-26.00±10.49 µmol/L vs. 7.00±7.07 µmol/L, 
P=0.0054) reperfusion as compared to sham as shown in figure 12. 
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Figure 8: Changes in alanine transaminase during I/R 
 
 
 
Figure 9: Changes in aspartate transaminase during I/R 
 
 
 
P=0.0041 
P=0.0376 
P=0.0069 
P=0.0417 
P=0.0132 
P=0.0486  
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Figure 10: Light microscopy of liver changes during I/R 
 
 
 
Light  microscopy  (x100)  stained  with  hematoxylin  and  eosin  showing  more  I/R 
associated liver damage in the I/R group (b) than in the sham group (a). 
 
b 
a  
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Figure 11: Bile flow following warm liver I/R  
 
 
 
 
Figure 12: Cytochrome activity during warm liver I/R 
 
  P=0.0054 
P=0.0007 
P=0.0056 
 
P=0.0148 
P=0.0008  
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4.4.5 
1HNMR spectroscopy of bile 
A baseline spectrum of bile is shown in figure 13. There was no difference in biliary 
lactate concentration between the sham and I/R groups at baseline.  Biliary lactate 
levels  were  significantly e l e v a t e d  i n  t h e  I / R  g r o u p  a t  5 hrs  post-reperfusion  to 
165.44±22.97% of initial baseline values (P=0.0036 vs. sham), followed by a decline at 
7hrs to 89.13±29.91% of baseline values (figure 14).  
Analysis  and  integration  of  peaks  corresponding  to  phosphatidylcholine  (PC)  head 
group (figure 15) revealed that I/R produced a significant two-fold increase during the 
ischemic phase (213.04±64.06% of baseline vs. 82.13±31.91% of baseline in sham, 
P=0.0106). Mean values for PC over all time points tended to be higher in the I/R 
group than sham group (P<0.0001 as assessed by ANOVA).  
Acetate  levels  were  reduced  compared  to  baseline  throughout  the  period  of  the 
experiment  in  both  the  I/R  and  sham  groups  (figure  16). T h e  r e d u c t i o n  w a s  
significantly  greater  in  the  I/R  group  by  5hrs  post-reperfusion  (50.75±13.24%  vs. 
70.35±6.86%, P=0.0490) and 7hrs post-reperfusion (37.47±7.49% vs. 69.36±13.29%, 
P=0.0058) than in the sham group. 
Correlation  of 
1HNMR  bile  spectroscopy  data  with  other  parameters  revealed  that 
acetate  decreased  with  increases  in  ALT  (R=0.762,  P<0.0001) ( f i g u r e  1 7),  AST 
(R=0.679,  P=0.0006)  (figure  18)  and  increased  with  increases  in  BF  (R=0.458, 
P=0.0109)  and  ΔCOX ( R = 0 . 6 5 0 ,  P = 0 . 0 0 0 1 )  a s  s h o w n  i n  f i g u r e  1 9. 
Phosphatidylcholine  increased  with  increases  in  ALT  (R=0.428,  P=0.0295)  and 
decreased  with  increases  in  BF  (R=0.699,  P<0.0001)  and  ΔCOX ( R = 0 . 6 4 4 ,  
P<0.0001). Lactate increased with increases in AST (R=0.445, P=0.0200) and tended 
to decrease with increases in ΔCOX (R=0.319, P=0.0857), however these results did 
not reach statistical significance.   
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Figure 13: 
1HNMR spectrum of baseline bile 
 
 
 
L=lactate,  G=glycine,  T=taurine,  PC=phosphatidylcholine,  BA=bile  acid, 
Ch=cholesterol, TSP=sodium trimethylsilyl-[
2H4]propionate standard, Ac=acetate   
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Figure 14: Biliary lactate levels following warm liver I/R 
(a) 
 
 
 
(a)  Lactate levels were calculated by integration of peaks at 1.3 ppm and expressed as 
a percentage of baseline values 
 
 
 
    (b)        (c) 
       
 
Bile lactate spectra (1.25-1.38 ppm) scaled to TSP from (b) baseline and (c) five hours 
of reperfusion in the I/R group (scale in ppm).  
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Figure 15: Biliary phosphatidylcholine levels following warm liver I/R 
(a) 
 
 
 
(a) PC levels were calculated by Integration of peaks at 3.2 ppm and expressed as a 
percentage of baseline values. 
 
   (b)      (c) 
       
Bile PC spectra (3.20-3.27 ppm) scaled to TSP from (b) baseline and (c) ischaemia in 
the I/R group (scale in ppm). 
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Figure 16: Bile Acetate levels following warm liver I/R 
(a) 
 
 
(a) Acetate levels were calculated by integration of acetate peaks at 1.91 ppm and 
expressed as a percentage of baseline values. 
(b)            (c) 
 
      
 
1HNMR bile spectra of acetate peaks (2.0-1.84 ppm) scaled to TSP at (b) baseline and 
(c) after 7 hours of reperfusion showing significant reduction (scale in ppm). 
 
P=0.0490 
P=0.0058  
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Figure 17: Correlation of ALT and biliary acetate 
 
 
 
 
 
Figure 18: Correlation of AST with biliary acetate 
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Figure 19: Correlation between change in liver cytochrome oxidase and biliary acetate 
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4.5  Discussion 
This is the first time that 
1HNMR analysis of bile has been applied to a controlled 
experimental model of warm liver I/R. Liver warm IRI can be divided into an early 
phase which is associated with KC activation and a cytokine surge
513 and a late phase 
(>4hrs) which is mainly due to the accumulation of PMN and is associated with more 
extensive injury
514.  
A r a b b i t  l o b a r  I / R  m o d e l  w a s  u s e d  w i t h  reperfusion  period  of  seven  hours
396,  The 
benefits of employing this model have been discussed above (section 3.1), briefly it 
permitted the analysis of bile constituents in both the early phase and the beginning of 
the  late  phase  of  IRI,  avoiding t h e  p r o d uction  of  acute  portal  hypertension  and 
intestinal ischaemia, maintained hemodynamic stability throughout the duration of the 
experiment, and avoiding the complete occlusion of biliary drainage in the total hepatic 
ischaemia model permitting the effects of I/R on biliary composition to be evaluated. 
BF in the sham-operated group decreased due some to bile acid depletion from bile 
duct cannulation. ALT activity increased mildly over the duration of the experiment in 
the  sham-operated  group  suggesting  minimal o p e r a t i v e  a n d  a n a e s t h e t i c  t r a u m a  t o  
liver  function  over  this  lengthy  surgical  procedure
436,437.  However,  the  6-10 fold rise 
following reperfusion in the study group suggests significant IRI
436,437,441,447.  
COX is the terminal complex of the mitochondrial respiratory chain. It takes electrons 
from  cytochrome  c  and  catalyses  the  reduction  of  oxygen  to  water  with  the 
concomitant synthesis of ATP through the oxidative phosphorylation process
396,515. In 
hepatocytes, approximately 90% of the oxygen is consumed by mitochondrial COX. 
Absorption of the NIR light by COX occurs primarily at the Cu A centre within COX. 
There is a decrease in signal intensity on reduction of this centre. The redox state of 
COX CuA is dependent on cellular oxygen availability
25,34. In the presence of oxygen, 
electron transfer occurs and the enzyme becomes oxidised, whereas lack of oxygen,  
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results in a decreased flow of electrons and COX becomes reduced. The increase in 
the reduction state of COX reflects severe cellular hypoxia. NIRS has been used to 
measure liver tissue oxygenation changes following warm liver IRI
25,39,498,499. There was 
a significant chemical reduction in COX following ischaemia that was still persistent at 
5 and 7hrs following reperfusion in the I/R group. 
The drop in BF during ischaemia corresponds to the exclusion of liver mass in the I/R 
group  during  this  phase.  A  post-reperfusion  reduction  in  BF  has  been  reported 
previously
41,43,44 and bile excretion has been used as an indicator of liver function and 
recovery  following  ischaemia i n  e x p e r i m e n t a l  s t u d i e s
512  and  clinical  liver 
transplantation
512,516. 
1HNMR  spectroscopy  of  bile  revealed  changes  in  the 
concentration  of  some  bile  constituents.  Bile  lactate  were  elevated  towards  the 
beginning of the late phase of I/R, at a period when it is known there is significant 
neutrophil  activation
517.  It  has  been  observed  that  the  injury  produced  during  the 
beginning of the late phase is a more severe hepatocellular injury in comparison to the 
early  phase
517-519.  PMN s e q u e s t r a t i o n ,  s inusoidal  narrowing  and  vasoconstriction 
combine to form a “no-reflow paradox” whereby hepatocytes are subjected to a further 
perfusion deficit and persistent ischaemia
404,520. This may explain the observed peak in 
lactate at this late time point
521,522 especially since lactate levels have been shown to 
become elevated in bile even when they are not elevated in serum
523. This may explain 
the observed peak in lactate at this late time-point. Lactate levels have been shown to 
become elevated in bile even when they are not elevated in serum
524. ATP degradation 
after ischaemia leads to the activation of glycolysis, resulting in the net formation of 
lactate.  Serum  lactate  concentration  has  been  shown  to  increase  progressively 
following liver ischaemia, primarily from glycolytic/gluconeogenic pathway. This was 
verified  by  measuring  glucose-6-phosphate  and  fructose-6-phosphate  which  were 
shown to increase with IRI
525. 
PC was raised following ischaemia and reperfusion at 2hrs and 5hrs. The main source  
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of PC in cells is in the plasma membrane, which suggests that the increase during 
ischaemia and again at 5hr post-reperfusion may be associated with an increase in 
cellular breakdown and membrane lipid peroxidation
18. Increased PC has also been 
observed  in  other  experimental  studies
526 a n d  i n  a s s o c i a t i o n  w i t h  p o o r  g r a f t  
function
18,524. 
Acetate  was  observed  to  decrease c o n t i n u o u s l y  f r o m  b a s e l i n e  t h r o u g h o u t  t h e  
experiment in the I/R group. Hepatocytes are one of the few cells that can utilize fatty 
acids  in  the  production  of  energy  through  the  β-oxidation  helix
527,528.  This  reaction 
requires ATP at its initiation. Post-reperfusion ATP is consumed to clear excess lactate 
and  pyruvate  and  may  not  be  readily  available  for  fatty  acid  oxidation.  The  ATP 
reduction as a result of I/R may result in decreased β-oxidation and acetate production 
is  reduced.  Biliary  acetate  decreased  with  increases  in  ALT  and  AST,  established 
markers of hepatocyte damage, and increased with increases in BF and changes in 
COX, accepted indicators of liver function and viability. 
In  conclusion,  bile  spectroscopy  has  demonstrated  significant  changes  in  bile 
composition during I/R. These changes are evident despite a constant, albeit reduced, 
post-reperfusion rate of BF.  
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5  Modulation of warm hepatic ischaemia 
reperfusion using NAC and its effect on 
bile composition  
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5.1  Introduction 
As liver transplantation becomes the treatment of choice in an ever-widening spectrum 
of indications, greater strain is put on a static donor pool, with the result of increasing 
numbers of patients spending longer on waiting lists and dying on these lists
179. This 
has  put  increasing  pressure  on  surgeons  and  physicians  to  accept  more  marginal 
grafts including those from non-heart-beating (cardiac death) donors, which have been 
subjected  to  periods  of  warm  ischaemia.  It  increases  the  need  for  a  greater 
understanding of warm IRI, its effects and its therapeutic modulation. 
Liver IRI occurs during major liver surgery, transplantation and following hypotensive 
shock/resuscitation
529.  Liver  I/R i s  a  complex  triggering  of  a  cascade  of  metabolic 
pathways and multiple mediators capable of inducing liver injury
102,103. One of the main 
contributors to liver damage is the release of ROS and RNS. A complex intracellular 
antioxidant system protects against oxidative stress, of which glutathione an important 
component. Glutathione is a powerful active radical scavenger that is depleted during 
liver  IRI
102. N A C  i s  a  t h i o l -containing  compound  that i s  h y d r o l y s e d  t o  c y s t e i n e —a 
glutathione precursor, capable of rapidly replenishing depleted concentrations
89, that 
has been used to reduce liver injury
89.  
Bile formation is an active secretory process
25  that  is  used  as  an  indicator  of  liver 
function and recovery following ischaemia
25,34,44. IRI has been shown to result in poor 
BF, that recovers in reversibly damaged organs, while persistent low bile output is a 
sign of PNF
530. Although BF has been considered a marker of liver function
8 and has 
been used to assess therapeutic and preservation strategies in liver transplantation
9, 
little is known, about changes in bile composition during liver I/R. In addition, little is 
also k n o w n  a b o u t  t h e  e f f e c t  o f  t h e r a p e u t i c  s t r a t e g i e s  t o  a m e l i o r a t e  I R I  o n  b i l e  
composition.  
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5.2  Objectives 
1.  To determine if the changes in bile composition during I/R can be reversed 
using NAC, an agent known to ameliorate IRI in liver 
2.  To  identify  the  differences  in  chemical  composition  between  sham,  I/R  and 
NAC+I/R, including further differences not previously identified in the pilot study 
e.g. conjugated bile acids 
3.  To  ascertain  if  these  changes  fit  with  established  understanding  of  the 
mechanisms involved in liver IRI and the actions of NAC 
4.  To compare these changes with some established markers of IRI 
5.3  Materials and methods  
The study was conducted under a license granted by the Home Office in accordance 
with  the  Animals  (Scientific  Procedures)  Act  1986.  New  Zealand  white  rabbits 
(3.7±0.6kg, n=18) were used. Anaesthesia was induced by an intramuscular injection 
of  0.5ml/kg  fentanyl  citrate  and  fluanisone  (Hypnorm;  Janssen  Animal  Health  Ltd., 
Buckinghamshire,  UK).  Following  tracheostomy  anaesthesia  was  maintained  with 
Isoflurane (0.5-3%) through an anaesthetic circuit. Body temperature was maintained 
at  37-38.5
oC  by  a  warming  blanket  (Homoeothermic  blanket  control  unit;  Harvard 
Apparatus,  Southmatick,  Massachusetts,  USA).  Haemoglobin  saturation  and  heart 
rate  were  continuously  recorded  by  a  pulse  oxymeter  (Ohmeda  Biox  3740  pulse 
oxymeter; Ohmeda, Louisville, Colorado, USA). A catheter (20G) was inserted into the 
median  ear  artery  for  arterial  blood  pressure  monitoring  and  collection  of  blood 
samples.  Ear marginal veins were cannulated with radio-opaque catheters (22G) for 
the administration of anaesthetics, fluids and medications
400.  
5.3.1  Ischaemia reperfusion procedure 
Laparotomy was performed through a midline incision. The ligamentous attachments 
from the liver to the diaphragm were divided and the liver was exposed. The bile duct 
was cannulated with a polyethylene catheter (PE-50, 0.58mm inner diameter, Portex, 
Kent,  UK)  for  measurement  of  BF.  The  portal  vein  was  dissected  and  a  transonic  
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Doppler flow probe was placed around the vein for measurement of the portal flow.  
5.3.2  Experimental groups and protocol 
Three groups of animals were used; the control group in which lobar ischaemia was 
induced by clamping the vascular pedicles of the median and left lobes of the liver, 
using an atraumatic microvascular clip. This method produces a severe ischemic insult 
without  inducing  mesenteric  venous  hypertension
432.  After  60  min  of  ischaemia t h e  
vascular  clip  was  removed  and  reperfusion  was  allowed  for  7  hours.  During  the 
ischaemia and reperfusion period, the abdomen was covered with a plastic wrap to 
prevent fluid evaporation. At the end of the experiment the animals were killed by 
exsanguination. 20 ml of 5% dextrose was infused through the ear vein, over the 15 
min before reperfusion and maintained at a dose of 10ml/kg/h during the reperfusion 
period.  In  group  the  ‘NAC’  group  animals  underwent  a  similar  procedure  and  150 
mg/kg of N-acetylcysteine (Parvolex, Medeva Pharma Limited, Lancashire, UK) in 20 
ml  of  5%  dextrose  was  infused  I.V.  through  the  ear  vein,  over  the  15  min  before 
reperfusion  and  maintained  at  10  mg/kg/h  in  5%  dextrose  during  the  7  hours 
reperfusion period. In the ‘sham operation’ group, animals underwent laparotomy for 8 
hours, without hepatic inflow occlusion. In all groups 10 ml/kg/h of 0.9 % NaCl was 
administered I.V. to compensate for intraoperative fluid loss. 
5.3.3  Blood sampling for liver function 
Arterial blood samples (1 ml each) were taken before the induction of liver ischaemia 
(baseline), at the end of ischaemia (60 min) and 2, 5 and 7 hours after reperfusion for 
measurement of alanine aminotransferase (ALT) activity. An equal volume of normal 
saline was used to replace the volume of the blood taken. Serum was separated from 
the samples and stored at -20
oC until assayed. The measurements were done using 
an  automated  clinical  chemistry  analyzer  (Hitachi  747,  Roche  Diagnostics  Ltd., 
Sussex, UK).      
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5.3.4  Measurement of portal flow 
 Portal flow was monitored continuously, using a perivascular transonic flow probe of 3 
mm  in  diameter  (Transonic  Medical  Flowmeter  system,  HT207;  Transonic  Medical 
System, Ithaca, New York, USA).  
5.3.5  Measurement of bile flow and 
1HNMR bile spectroscopy  
The common bile duct was cannulated with a polyethylene catheter (PE-50, 0.58 mm 
inner diameter, Portex, Kent, UK) for continuous collection of bile. Bile samples were 
taken  at  baseline,  following  60  min  ischaemia a n d  h o u r l y  d u r i n g  r e p e rfusion.  Bile 
volume was expressed as µL/min/100g of liver wet weight. 
1HNMR spectra of hepatic 
bile  samples  was  obtained  using  spectrometer  (Eclipse+  500;  JEOL  Ltd.,  Tokyo, 
Japan) operating at 11.7T (500 MHz for 
1H). All Spectra were recorded at 25°C. 600µL 
of bile was placed in a 5mm tube with a 2mm coaxial insert containing 100 µL of 
1mg/ml  of  sodium  TSP d i s s o l v e d  i n  d e u t e r i u m  o x i d e  (
2H2O,  Fluorochem  Ltd.,  Old 
Glossop, Derbyshire, UK) and set at 0.0 parts per million (ppm). A basic single pulse 
sequence was used to acquire the one-dimensional spectra using a 45° pulse (8.25µs) 
with an acquisition duration of 4.36s and a relaxation delay of 5s. To reduce the large 
water  resonance  signal  a  gated  secondary  irradiation  at  the  water  frequency  was 
applied. Published peak assignments
10,18,370,472 used are shown in table 2. Integration of 
the 
1HNMR spectra areas was measured relative to the TSP area and obtained using 
MestRe-C software (version 2.3a, Departmento de Química Orgánica, Universidade 
de Santiago de Compostela). 
5.3.6  Assessment of the hepatic microcirculation  
Hepatic microcirculation was measured by a surface LDF, (DTR4, Moor Instruments 
Limited, Axminster, UK) in flux units
396. The LDF probe was placed on a fixed site on 
the median lobe of the liver. LDF measurements were calculated as a mean of 2-min 
recording data before clamping (baseline), at the end of ischaemia and at the end of 
each  hour  of  reperfusion  for  each  animal.  The  alterations  during  I/R  period  were 
calculated relative to the baseline values.  
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5.3.7  Measurement of hepatic tissue oxygenation  
Hepatic tissue oxygenation was measured by NIRS. NIRS can be used to measure 
concentration changes of HbO2, Hb and COX
512. NIRS has been used to measure liver 
tissue oxygenation changes following warm liver IRI
516. For continuous monitoring of 
hepatic tissue oxygenation NIRS probes were positioned flat on the surface of the left 
lobe of the liver, with a 10mm separation. NIRS measurements during ischaemia and 
reperfusion were expressed relative to baseline values before vascular occlusion. For 
comparison  between  the  different  groups,  NIRS  measurements  (at  baseline, 
ischaemia a n d  e a c h  h o u r  o f  r e p e r f u s i o n )  w ere  calculated  as  the  mean  of  2min 
measurements at the end of each period. 
5.3.8  Data collection and statistical analysis  
Data from the transonic flowmeter, LDF and NIRS were collected continuously on a 
laptop  computer.  The  data  were  averaged  for  two  minutes  before  the  induction  of 
ischaemia (Baseline), at the end of ischaemia, and each hour of a 7hrs reperfusion 
period. T h e  h e p a t i c  t i s s u e  o x y g e n a t i o n  c h a n g e s  a t  t h e  e n d  o f  e a c h  p e r i o d  w e r e  
calculated  relative  to  baseline. V a l u e s  a r e  e x p r e s s e d  a s  m e a n ± SD.  Spectroscopy 
values  are  expressed  as  a  percentage  of  baseline  values.  One-way  analysis  of 
variance (ANOVA) with Bonferroni adjustment for multiple comparisons were used. 
Statistics were calculated using commercially available software (SatView 5.0.1; SAS 
Institute Inc., Cary, NC, USA). P<0.05 was considered statistically significant.   
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5.4  Results  
5.4.1  Liver function 
In the sham group, levels of ALT rose throughout the experiment from 56.0±2.8 IU/L to 
91.5±36.0  IU/L  after  8hrs  of  laparotomy.  In  the  I/R  group  there  was  a  marked 
significant increase in ALT levels. The I/R+NAC group did not start to rise till the 2
nd 
hour of reperfusion and increased to 8 fold at 7hrs reperfusion (figure 20). 
5.4.2  Bile Flow 
BF gradually decreased in the sham group over the period of the experiment from 
202±32 to 155.0±8.4 µL/min/100g liver wet weight (baseline vs 8hrs, P=0.045). BF in 
the I/R group was similar to sham at baseline (227±29 µL/min/100g liver wet weight) 
but reduced significantly to 60.5±19.0 (26.0±5.6%) during ischaemia (P=0.0001). BF in 
the I/R group then increased on reperfusion (116.5±33.1 at 2 hrs) but did not return to 
baseline values and was significantly lower than sham group values (P=0.0003 as per 
group comparison in ANOVA). Similarly, BF in the I/R+NAC infused group dropped 
significantly  during  ischaemia ( P = 0 . 0 0 1 )  a n d  r e c o v e r e d  t o  123±0.4  (58.9±0.2%)  at 
7hrs reperfusion, which was less than sham (P=0.0158, group comparison in ANOVA) 
as shown in figure 21.  
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Figure 20: Alanine aminotransferase serum levels following warm liver I/R and 
I/R+NAC 
 
 
 
Shaded  area   d e n o t e s  6 0  m i n u t e s  o f  i schaemia i n  I / R  a n d  I/R+NAC, * = P<0.05 
compared to shams, **=P<0.05 compared to controls 
Sham 
I/R 
I/R+NAC 
 ** 
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Figure 21: Bile flow following warm liver I/R and I/R+NAC  
 
 
 
 
Shaded  area   d e n o t e s  6 0  m i n u t e s  o f  i schaemia i n  I/R  and  I/R+NAC,  bile  flow 
measured in µL/min/100g liver wet weight, *=P<0.05 
 
Sham 
I/R 
I/R+NAC 
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5.4.3 
1HNMR spectroscopy of bile 
A baseline spectrum of bile has been shown in figure 13. Bile lactate levels decreased 
in I/R group during the ischemic period. Post-reperfusion levels were initially below 
baseline  (88.7±22.4%  of  baseline  values),  but  were  significantly  elevated  at  5hrs 
(165.4±22.9%  of  baseline  values,  P=0.0061 v s .  I/R)  followed  by  a  decline  at  7hrs 
(89.1±29.1% of baseline values). In shams bile lactate decreased during the period of 
anaesthesia but these changes were not statistically significant. In the I/R+NAC group, 
biliary lactate decreased steadily after reperfusion to reach 63.2±25.1% of baseline 
values at 7hrs reperfusion (figure 22). Integration of peaks corresponding to PC head 
group (figure 23) revealed that I/R produced a significant 2 fold rise in controls during 
the ischemic phase (213±64% vs. 82.1±31.9% in shams, P=0.0023). Mean values for 
PC  over  all  time  points  were  higher  in  the  control  group  than  in  the  sham  group 
(156.0±60.4% vs. 89±23.57%, P<0.0001). Addition of NAC significantly depressed the 
rise of PC during ischaemia (120.3±26.9% vs. 213±64% in controls, P=0.0372) and in 
total PC was higher than shams (P=0.0280), and lower than controls (P=0.0246).  
Integration of the C-25 glycine methylene proton peak associated with conjugated bile 
acids showed a significant increase after 1hr ischaemia in I/R group (141.2±31.2% vs 
64.1±19.9% in shams, P=0.0029), but declined to become similar with shams by 7hrs 
reperfusion  (figure  24).  Conjugated  bile  acids  showed  a  significant  increase  in  the 
I/R+NAC  group  after  1hr  of  ischaemia ( 1 1 7 . 1 ± 2 3 . 1 %  v s .  6 4 . 1 ± 19.9%  in  shams, 
P=0.0283) to drop to a similar value as shams at 7hrs reperfusion.   
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Figure 22: Lactate levels following warm liver I/R 
(a) 
 
 
 
(a) Lactate levels were calculated by Integration of peaks at 1.33 ppm and expressed as 
a percentage of baseline values, shaded area  denotes 60 minutes of ischaemia in 
I/R and I/R+NAC, * P<0.05 
 
    (b)              (c)           (d) 
         
 
Bile lactate spectra (1.25-1.38 ppm) scaled to TSP from five hours of reperfusion in the 
(b) sham, (c) I/R group and (d) the I/R+NAC group (scale in ppm). 
 
Sham 
I/R 
I/R+NAC  
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Figure 23: Phosphatidylcholine levels following warm liver I/R 
(a) 
 
 
(a) PC levels were calculated by Integration of peaks at 3.2 ppm and expressed as a 
percentage of baseline values, shaded area  denotes 60 minutes of ischaemia in 
I/R and I/R+NAC, * P<0.05 compared to shams, ** P<0.05 compared to I/R+NAC  
 
   (b)      (c) 
         
Bile PC spectra (3.20-3.27 ppm) scaled to TSP from ischaemia in the (b) I/R group 
and (c) I/R+NAC group (scale in ppm). 
Sham 
I/R 
I/R+NAC  
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Figure 24: Conjugated bile acid levels following warm liver I/R 
(a) 
 
 
(a) Conjugated bile acid levels were calculated by Integration of peaks at 3.8 ppm and 
expressed as a percentage of baseline values, shaded area  denotes 60 minutes of 
ischaemia in I/R and I/R+NAC, * P<0.05 
(b)        (c) 
          
1HNMR bile spectra of C25 glycine peak associated with conjugated bile acids (3.76-
3.92 ppm) scaled to TSP from ischaemia in the (b) I/R group and (c) I/R+NAC group 
(scale in ppm). 
 
 
Sham 
I/R 
I/R+NAC 
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Acetate  levels  were  reduced  during  the  period  of  the  experiment  in  both  the  I/R, 
I/R+NAC and sham groups (figure 25 & 26). However they were significantly lower in 
the I/R group by 7hrs reperfusion (37.5±56.0% vs. 69.4±13.3% in shams, P=0.0065). 
Correlation  of 
1HNMR  bile  spectroscopy  data  with  other  parameters  revealed  that 
acetate  decreased  with  increases  in  ALT  (R=0.769,  P<0.0001)  (figure  27),  AST 
(R=0.550,  P=0.0003)  and  portal  flow  (R=0.412,  P=0.0139)  and  increased  with 
increases in BF (R=0.432, P=0.0054) and ΔCOX (R=0.512, P=0.0006) as shown in 
figure 28. PC increased with increases in ALT (R=0.401, P=0.0113) and decreased 
with  increases  in B F  ( R = 0 . 6 1 6 ,  P < 0 . 0 0 0 1 ) ,  ΔLDF  (R=0.567,  P<0.0001)  and  ΔCOX 
(R=0.570, P<0.0001). Bile acids decreased with increased ALT (R=0.435, P=0.0057) 
portal flow (R=0.482, P=0.0033) and ΔHbO2 (R=0.369, P=0.0175). Lactate tended to 
increase with increases in AST (R=0.294, P=0.0657) and decrease with increases in 
ΔCOX ( R = 0 . 2 9 0 ,  P = 0 . 0 6 5 7 ) ,  h o w e v e r  t h e s e  r e s u l t s  d i d  n o t  r e a c h  s t a t i s t i c a l  
significance.   
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Figure 25: Acetate levels following warm liver I/R 
 
 
 
 
Acetate  levels  were  calculated  by  Integration  of  acetate  peaks  at  1.91  ppm  and 
expressed as a percentage of baseline values, shaded area  denotes 60 minutes of 
ischaemia in I/R and I/R+NAC, * P<0.05 
 
 
 
Figure 26: 
1HNMR spectra of acetate levels following warm I/R 
 
(a)            (b)    (c) 
 
             
 
1HNMR bile spectra of acetate peaks (2.0-1.84 ppm) scaled to TSP at (a) baseline in 
the I/R group and after 7 hours of reperfusion in (b) the I/R and (c) I/R+NAC groups 
showing significant reduction (scale in ppm). 
 
Sham 
I/R 
I/R+NAC  
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Figure 27: Correlation of bile acetate and serum ALT 
 
 
Acetate  levels  were  calculated  by  Integration  of  acetate  peaks  at  1.91  ppm  and 
expressed as a percentage of baseline values while ALT is expressed as a percentage 
of baseline values  
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Figure 28: Correlation of bile acetate and liver tissue cytochrome oxidase 
 
Acetate  levels  were  calculated  by  Integration  of  acetate  peaks  at  1.91  ppm  and 
expressed as a percentage of baseline values while cytochrome oxidase is expressed 
as change in µmolar units 
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5.5  Discussion 
Liver  warm  IRI  can  be  divided  into t w o  p h a s e s ,  a n  e a r l y  p h a s e  ( < 2 hrs)  which  is 
associated with KC activation and a subsequent cytokine surge
513 and a late phase 
(>4hrs), which is mainly due to the accumulation of PMN and is associated with more 
extensive injury
514.  
In this experiment, a rabbit lobar I/R model was used with reperfusion period of seven 
hours
396. The benefits of employing this model have been discussed above (section 
3.1), briefly it permitted the analysis of bile constituents in both the early phase and the 
beginning of the late phase of IRI, avoiding the production of acute portal hypertension 
and intestinal ischaemia, maintained hemodynamic stability throughout the duration of 
the experiment, and avoiding the complete occlusion of biliary drainage in the total 
hepatic  ischaemia m o d e l  p e r m i t t i n g  t h e  e f f e c t s  o f  I / R  o n  b i l i a r y  c o m p o s i t i o n  t o  b e  
evaluated.  
BF in the sham operated I/R group decreased, ALT activity increased and hepatic 
intracellular  oxygenation  significantly  decreased  during  the  period  of  anaesthesia 
compared  to  baseline.  These  findings  suggest  that  the  operative  trauma  and  the 
anaesthetic  agent  could  have  an  effect  on  liver  function  during  lengthy  surgical 
procedures (>8hrs)
512. The prolonged anaesthesia did not affect the flow in the hepatic 
microcirculation. The changes in flow in the hepatic microcirculation and intracellular 
tissue oxygenation during the early phase of reperfusion were similar with the results 
of previous studies
512,516,531. 
BF  fell  sharply  in  response  to  ischaemia,  and  recovered  after  reperfusion,  and 
although it did not regain pre-ischemic baseline values, it was fairly consistent at 31.1–
50.1%.  Despite  this  consistent  pattern  of  BF  in  I/R  and  I/R+NAC  groups, 
1HNMR 
spectroscopy  of  bile  revealed  fluctuations  in  the  concentration  of  some  bile 
constituents.   
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Lactate in particular shows a large peak at 5hr postreperfusion, this corresponds to a 
large burst of PMN activity that constitutes the beginning of the late phase of IRI
532. It 
has been observed that the injury produced during the beginning of the late phase is a 
more  severe h e p a t o c e l l u l a r  i n j u r y  i n  c o m p a r i s o n  t o  t h e  e a r l y  p h a s e
517-519.  PMN 
sequestration, sinusoidal narrowing and vasoconstriction combine to form a “no-reflow 
paradox” w h e r e b y  h e p a t o c y t e s  a r e  s u b j e c t e d  t o  a  f u r t h e r  p e r f u s i o n  d e f i c i t  a n d  
persistent ischaemia
404,520. This may explain the observed peak in lactate at this late 
time point
521,522 especially since lactate levels have been shown to become elevated in 
bile even when they are not elevated in serum
523. ATP degradation after ischaemia 
leads to the activation of glycolysis, resulting in the net formation of lactate
524. Serum 
lactate  concentration  has  been  shown  to  increase  progressively i n  i s c h e m i c  l i v e r s ,  
achieving a maximum level at 30min and remaining stable for 90mins. It has also been 
shown  that  glycogen  concentration  decreased  as  a  function  of  the  length  of  the 
ischemic  period.  This  suggests  that  serum  lactate  may  be  a  product  of  the 
glycolytic/gluconeogenic pathway, this was verified by measuring glucose-6-phosphate 
and fructose-6-phosphate which were shown to increase with ischaemia-reperfusion 
injury
18. Interestingly, NAC administration abolished this peak in lactate, as it lowered 
the levels of ALT.  
PC exhibited a biphasic pattern where ischaemia precipitated a 2 fold rise in the I/R 
group which subsided on reperfusion to be followed by a smaller peak at 5hrs. The 
main source of PC in cells is in the plasma membrane, this suggests that the increase 
during  ischaemia a n d  a g a i n  a t  5 h r  p o s t -reperfusion  may  be  associated  with  an 
increase  in  cellular  breakdown  and  membrane  lipid  peroxidation
533.  This  would 
coincide  with  a  period  of  hepatocellular  injury  during  ischaemia a n d  t h e  “no-reflow 
period”
534. Increased PC has also been observed by other authors in association with 
poor graft function but not hepatocellular injury
535. 
Interestingly,  a  similar  biphasic  pattern  was  apparent  in  bile  acids,  which  might  
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suggest that more bile acids are released during periods of hepatocellular damage. 
This is in concordance with observations by other authors who found total serum bile 
acids  found  to  be  early  markers  of  liver  function  in  porcine
526 a n d  c a n i n e
536 l i v e r  
transplants. Moreover the depression of bile acid synthesis is in accordance with both 
early and late reperfusion injury when hepatocyte injury is in process. The significant 
rise in conjugated bile acid during the ischaemia may be a result of the drop in BF. Bile 
acids fall with increased BF on reperfusion. Furthermore, the depressed rate of BF on 
reperfusion may contribute to the higher levels of bile acids seen post-reperfusion in 
the I/R and I/R+NAC groups but not in the sham group. The I/R group is interestingly 
associated with the lowest BF and the highest bile acid levels while shams have the 
highest BF and the lowest bile acid levels with the I/R+NAC group residing in between. 
Acetate was observed to drop continuously from baseline throughout the experiment, 
however, it correlated strongly to COX activity. Hepatocytes are one of the few cells 
that can utilize fatty acids in the production of energy through the β-oxidation helix
537. 
However, this reaction requires ATP at its initiation. Post-reperfusion ATP is consumed 
to clear excess lactate and pyruvate and may not be readily available for fatty acid 
oxidation.  The  I/R-induced  reduction  in  ATP  may  result  in  decreased  β-oxidation 
causing acetate production to falter; this might also explain its strong association with 
the change in COX.   
In  conclusion,  bile  spectroscopy  has  demonstrated  significant  changes  in  bile 
composition during I/R and NAC administrations. These changes are evident despite a 
constant,  albeit  reduced,  post-reperfusion  rate  of  BF.  Having  identified  significant 
changes in lactate, PC and acetate with I/R and NAC, further studies are required to 
evaluate the changes with other modifiers of IRI and continue to look for other MRS 
markers of IRI, to further strengthen the validity of these findings.  
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6  Modulation of warm hepatic ischaemia 
reperfusion using glycine and its effect 
on bile composition 
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6.1  Introduction 
Liver ischaemia-reperfusion (I/R) injury is a common sequel following liver resection
538 
and liver transplantation
185. One of the principle initiating steps of the I/R inflammatory 
cascade is KC activation
194,539. KC blockade has been shown to protect against warm 
IRI
540,541. Glycine, a nonessential amino acid and an inhibitory neurotransmitter, has 
recently been shown to be protective against hypoxia and ischaemia
542. It has been 
shown to modulate KC activity in animal models
195. Several mechanisms have been 
suggested to explain glycine-induced KC inhibition. Increasing chloride conductance 
which hyperpolarizes the cell membrane, thereby decreasing the rise in intracellular 
calcium by making voltage dependant calcium channels more difficult to open, is one 
theory
543.  The  inhibition  of  proteolysis,  a  pH  dependant  hydrolytic  activity,  which  is 
activated  following  the  recovery  of  intracellular  pH  post-reperfusion,  is  another 
theory
544.  Glycine  has  also  been  shown  to  have  a  membrane  stabilizing  action,  by 
suppressing the rearrangement of plasma membrane proteins which form water filled 
pores large enough to leak macromolecules
25, and it has even been suggested that 
glycine may inhibit an organic anion channel conducting low molecular weight species 
which opens prior to cell death
25,34.  
Bile  formation  is  an  active  secretory  process  mechanisms
44,530 t h a t  is  used  as  an 
indicator of liver function and recovery following ischaemia in experimental studies
25,34 
and clinical liver transplantation
35. IRI has been shown to manifest by poor BF in vivo
530 
and  in  vitro
30 a n d  r e d u c e d  b i l e  a c i d  s e c r e t i o n ,  h o we v e r  g r a d u a l  r e c o v e r y  o c c u r s  i n  
reversibly damaged organs while persistent low bile output is considered a sign of 
primary  graft  non  function
32.  Little  is  known,  however,  about  changes  in  bile 
composition during liver ischaemia and following reperfusion and less is known about 
the effect of therapeutic strategies to ameliorate IRI on bile composition. 
Bile salts are a major component of bile and have a significant influence on BF and the 
secretion  of  biliary  lipids  such  as  PC a n d  c h o l e s t e r o l
545.  Bile  salts  are  transported  
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across the canalicular membrane in a primary active ATP-dependent fashion
24,25 which 
is  mediated  by  the  BSEP
26.  BSEP  is  a  genuine  ATP-binding  cassette  other 
transporters expressed in many tissues and involved in active outward transport of 
molecules across the plasma membrane
23. 
In  recent  years,  high  resolution 
1HNMR s pectroscopy  has  been  established  as  a 
powerful technique to explore the biochemical composition of biological fluids such as 
plasma,  bile,  seminal  and  synovial  fluids,  in  various  pathological  conditions
8.  This 
technique  is  rapid,  non-invasive  and  non-destructive  and  can  detect  metabolites 
present  at  the  millimolar  concentrations  and  can  be  applied  to  detect  unexpected 
compounds in biological fluids
9. NMR has also been used to assess hepatic glutamine 
metabolism
16, hepatic energetic status after warm ischaemia
17, and to study effects of 
I/R on liver cell membranes
18. A preliminary study of 
1HNMR analysis of bile after liver 
transplantation suggested that this technique might help to distinguish ischaemia from 
rejection post-transplant by detecting large resonance peaks for lactate and acetate
18. 
More recently there has been growing interest in attempting to predict graft function by 
analysing bile production immediately after transplantation
396. 
6.2  Objectives 
1.  To determine if the changes in bile composition during I/R can be reversed 
using glycine, an agent known to ameliorate IRI in liver 
2.  To  identify  the  differences  in  chemical  composition  between  sham,  I/R  and 
glycine+I/R,  particularly  further  differences  not  explored  in  the  previous 
experiments, e.g. β-glucose and acetoacetate 
3.  To  ascertain  if  these  changes  fit  with  established  understanding  of  the 
mechanisms involved in liver IRI and the actions of glycine 
4.  To  utilise 
1HNMR  to  quantify  the  qualitative  changes  in  bile  composition 
previously  observed  in  micromolar  concentrations  after  running  a  calibration 
exercise (appendix section 10.1)  
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6.3  Materials and Methods 
This study was conducted under a license granted by the home office in accordance 
with the Animals (Scientific Procedures) Act 1986. New Zealand white rabbits (3.2±0.4 
Kg,  n=18)  were  used.  Anaesthesia  was  induced  by  an  intramuscular  injection  of 
0.5ml/kg  of  fentanyl  citrate  and  fluanisone  (Hypnorm;  Janssen  Animal  Health, 
Buckinghamshire,  UK).  Following  tracheostomy,  anaesthesia  was  maintained  with 
isoflurane (1.5-3%) through an anaesthetic circuit. Body temperature was maintained 
at  37-38
oC  by  a  warming  blanket  (Homeothermic  blanket  control  unit;  Harvard 
Apparatus,  Southmatick,  Massachussets,  USA).  Arterial  haemoglobin  oxygen 
saturation  and  heart  rate  were  continuously  monitored  and  recorded  by  a  pulse 
oximeter (Ohmeda Biox 3740 pulse oximeter; Ohmeda Louisville, Colorado, USA). Ear 
marginal vein and artery were cannulated for administration of fluids, anaesthetics, 
and blood sampling.  
After induction of anaesthesia a midline laparotomy was performed. The ligamentous 
attachments of the liver were divided and the liver was exposed. The bile duct was 
cannulated with a polyethylene catheter (PE-50, 0.58mm inner diameter, Portex, Kent 
, UK) for continuous measurement of BF.  
6.3.1  Experimental Groups  
Three  groups  of  animals  were  used  (n=6)  in  each  group.  Sham  group  of  animals 
underwent anaesthesia and laparotomy but no ischaemia or reperfusion was induced. 
The I/R group had 1 hour of ischaemia and 6 hours of reperfusion. The I/R+glycine 
group  received  300mosm  of  glycine  given  intravenously  at  a  dose  of  5ml/kg  body 
weight prior to induction of ischaemia by slow intravenous infusion over 15min, then 
treated as I/R group. 
6.3.2  Ischaemia-Reperfusion Injury protocol 
Lobar ischaemia was induced in the I/R and I/R+glycine group by clamping the left  
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portal vein, hepatic arteries and biliary radicals using an atraumatic vascular clip. This 
produces severe ischaemia to the left and median lobes of the liver without significant 
portal venous congestion. At the end of one hour of ischaemia the vascular clip was 
removed and reperfusion allowed for 6hrs in the I/R and I/R+glycine groups. At the end 
of the experiment the animal was killed by exsanguination. 
6.3.3  Bile flow and Proton nuclear magnetic resonance 
1HNMR spectroscopy 
Bile samples were taken at baseline and each hour thereafter and stored at -80°C. Bile 
volume  was  expressed  as  µL/min/100g  of  liver  weight. 
1HNMR  analysis  was 
performed on an 11.7T (500 MHz for protons) spectrometer (Varian Unity +; Varian, 
Palo Alto, CA, USA) at 25
oC. Bile was thawed at room temperature and placed in 5mm 
NMR  tube.  For  a  field/frequency  lock  a  coaxial  capillary  insert  was  used  (Wilmad, 
Buena, NJ, USA). This capillary insert was filled with a deuterium oxide solution of 
sodium TSP that acted both as a chemical shift reference and quantification standard. 
This capillary was calibrated by using a series of known concentration solutions of 
deoxycholate and a calibration curve was obtained (appendix section 10.1). This was 
then  used  for  quantification  of  bile  components,  which  enabled  an  accurate 
comparison  bile  levels  between  the  groups.  One  dimensional  NMR  spectra  were 
obtained at 500MHz with a sweep width of 6kHz and 32k data points in 64 scans were 
collected in both normal and spin echo mode. Presaturation of bile was carried out to 
attenuate the intensity of water signal. The spectra were analysed using software from 
MestRe-C version 3.1.1 (Universidade de Santiage de Compostela, Spain). All spectra 
were  integrated u s i n g  a  f i x e d  r a n g e  f o r  e a c h  p e a k  a n d  p u b l i s h e d  p e a k  
assignments
10,18,370,472 shown in table 2. 
6.3.4  Statistical analysis 
Results are presented as mean±SD. Statistical analysis was performed using a one-
way ANOVA with multiple comparisons adjusted for by the Bonferroni test. Statistics 
were calculated using commercially available software (SPSS release 11.0.0; SPSS  
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Inc., Chicago, IL, USA). P<0.05 was considered statistically significant. 
6.4  Results 
6.4.1  Bile flow 
There was not significant difference in BF in the sham group throughout the whole 
experiment (154.02±7.73 µL/min/100 gm wet liver wt) as shown in figure 29. However, 
in the I/R group, there was 79.71±7.10% drop in BF during the ischemic phase, which 
was significant (P<0.001) which recovered by the second hour of reperfusion and was 
maintained at 108.44±25.9 µL/min/100 gm wet liver wt till the end of the experiment. In 
the I/R+glycine group, there was a similar significant fall during ischaemia but BF was 
significantly greater than I/R alone during the reperfusion period (figure 29) and the 
second hour of reperfusion was similar to shams. 
6.4.2 
1HNMR spectroscopy of bile 
The  results  of  the  integration  of  the  area  under  curve  for  the  peaks  assigned  to 
conjugated bile acids in the sham group bile were relatively unchanged throughout the 
experiment at 4.91±0.95 µmol/L (figure 30). I/R group bile acid levels tended to be 
higher than shams throughout the experiment (P=0.002 when total group means were 
compared),  however,  they  did  not  reach  statistical  significance  when  compared  at 
individual  time  points.  I/R+glycine  group  bile  acid  levels  rose  significantly  following 
ischaemia to peak during the 1
st hr of reperfusion, where they were significantly higher 
than both sham (P<0.001) and I/R group (P=0.001).   
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Figure 29: Bile flow following warm liver I/R and I/R+glycine 
 
 
 
 
Bile flow measured in µL/min/100g liver wet weight, * P<0.05 compared to sham 
group, while ** P<0.05 between I/R+glycine and I/R group.  
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Figure 30: Bile Acid levels following warm liver I/R and I/R+glycine 
(a) 
 
 
(a)  Bile  acid  levels  were  calculated  by  integration  of  peaks  at  0.61-0.73  ppm  and 
expressed as µmol/L, *=P<0.05 compared to sham group, while **=P<0.05 between 
I/R+glycine and I/R group. 
 
        (b)       (c) 
         
 
Bile acid spectra (0.61-0.73 ppm) scaled to TSP from one hour of reperfusion in the (b) 
I/R group and (c) the I/R+glycine group (scale in ppm). 
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They remained significantly elevated, compared to both sham and I/R groups, during 
the 2
nd and 4
th hr of reperfusion (P<0.05). 
Integration of peaks corresponding to PC in the I/R group rose gradually till the 2
nd and 
4
th hr of reperfusion where they were significantly higher than I/R+glycine and sham 
groups (P<0.05). There was no significant difference between I/R+glycine and sham 
groups throughout the experiment (figure 31). Bile lactate levels in the I/R group rose 
following  reperfusion,  to  peak  significantly  at  4  hrs  (P<0.001  vs.  sham  and 
I/R+glycine).  There  was  no  statistical  difference  in  bile  lactate  levels  between 
I/R+glycine and sham groups during the procedure (figure 32). 
There was a wide range of bile acetate levels in each group (figure 33). Levels fell 
dramatically at 1 hr of reperfusion. Levels then rose during reperfusion and were not 
statistically different. The I/R group had lower acetate levels than shams (P<0.01) 
I/R  did  not  affect  pyruvate levels (sham vs I/R, NS) as shown in figure 34.  In  the 
I/R+glycine group, however, pyruvate levels were significantly elevated during the 2
nd 
and 4
th hr of reperfusion compared to both shams and I/R alone (P<0.05). I/R did not 
influence bile β-glucose levels (sham vs I/R, NS) as shown in figure 35. However, 
there was a significant rise in β-glucose levels in the I/R+glycine group from the 1
st hr 
of reperfusion till the 4
th hr of reperfusion (P<0.05).  
Acetoacetate levels were not statistically different for sham and I/R groups during the 
experiment (figure 36). The glycine+I/R group, however, showed significantly elevated 
acetoacetate levels during the ischemic phase, 1
st, 4
th and 6
th hr of reperfusion when 
compared to both shams and I/R (P<0.05). 
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Figure 31: Phosphatidylcholine levels following warm liver I/R and I/R+glycine 
 
 
Phosphatidylcholine levels were calculated by integration of peaks at 3.2 ppm and 
expressed as µmol/L, *=P<0.05 compared to sham group, while **=P<0.05 
between I/R+glycine and I/R group.   
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Figure 32: Lactate levels following warm liver I/R and I/R+glycine 
 
Lactate  levels  were  calculated  by  integration  of  peaks  at  1.33  ppm  and 
expressed as µmol/L, *=P<0.05 compared to sham group, while **=P<0.05 
between I/R+glycine and I/R group.   
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Figure 33: Acetate levels following warm liver I/R and I/R+glycine 
 
 
Acetate levels were calculated by integration of peaks at 1.9 ppm and expressed as 
µmol/L, *=P<0.05 compared to sham group. 
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Figure 34: Pyruvate levels following warm liver I/R and I/R+glycine 
(a) 
 
 
(a) Pyruvate levels were calculated by integration of peaks at 2.3 ppm and 
expressed as µmol/L, *=P<0.05 compared to sham group, while **=P<0.05 
between I/R+glycine and I/R group. 
 
 
(b)               (c) 
         
 
Bile pyruvate spectra (2.34-2.38 ppm) scaled to TSP from two hours of reperfusion in 
the (b) I/R group and (c) the I/R+glycine group (scale in ppm). 
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Figure 35: Glucose levels following warm liver I/R and I/R+glycine 
 
 
 
Glucose  levels  were  calculated  by  integration  of  peaks  at  5.2  ppm  and 
expressed as µmol/L, *=P<0.05 compared to sham group, while **=P<0.05 
between I/R+glycine and I/R group.  
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Figure 36: Acetoacetate levels following warm liver I/R and I/R+glycine 
(a) 
 
 
(a) Acetoacetate levels were calculated by integration of peaks at 2.2 ppm and 
expressed  as  µmol/L,  *=P<0.05  compared  to  sham  group,  while  **=P<0.05 
between I/R+glycine and I/R group. 
 
 
(b)                (c) 
       
 
Bile acetoacetate spectra (2.29-2.25 ppm) scaled to TSP from the ischaemia phase in 
the (b) I/R group and (c) the I/R+glycine group (scale in ppm). 
  
160 
6.5  Discussion 
The use of spin echo spectra, in this experiment, allowed us to reduce the interference 
from  broad  lipid  signals  and  improved  the  quantification  of  biliary  constituents. 
Calibration  using  known  concentrations  of  deoxycholate,  enabled  us  display  the 
results  in  micromolar  concentrations  instead  of  as  a  percentage  of  baseline 
concentrations.  
In this experiment, a rabbit lobar I/R model was used with reperfusion period of six 
hours
396. The benefits of employing this model have been discussed above (section 
3.1), briefly it permitted the analysis of bile constituents in both the early phase and the 
beginning of the late phase of IRI, avoiding the production of acute portal hypertension 
and intestinal ischaemia, maintained hemodynamic stability throughout the duration of 
the experiment, and avoiding the complete occlusion of biliary drainage in the total 
hepatic  ischaemia m o d e l  p e r m i t t i n g  t h e  e f f e c t s  o f  I / R  o n  b i l i a r y  c o m p o s i t i o n  t o  b e  
evaluated. 
BF was maintained throughout the procedure in the sham group, while it fell following 
I/R and in the I/R+glycine group. This response to acute liver ischaemia has been 
noted in previous studies
535. In the I/R+glycine group, BF on reperfusion recovered to 
become similar to sham within 2hrs of reperfusion, while in the I/R group remained 
depressed until the end of the experiment. Moreover, a rise in bile acid secretion was 
also noted on reperfusion, in the I/R+glycine group, compared to the I/R group. This 
suggests an early recovery of metabolic activity in the glycine-treated livers, which is 
supported by observations that total serum bile acids were found to be early markers 
of liver function in porcine
521,522 and canine
523 liver transplants.  The rise in bile acid 
observed during ischaemia may be a result of the drop in BF.  
In  this  experiment,  lactate  levels  were  elevated  with  I/R  and  were  higher  than  the 
sham  and  I/R+glycine  groups.  ATP  degradation  during  ischaemia l e a d s  t o  t h e   
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activation of glycolysis, resulting in the net formation of lactate
523. It has also been 
shown  that  glycogen  concentration  decreased  as  a  function  of  the  length  of  the 
ischemic  period
526.  This  suggests  that  serum  lactate  may  be  a  product  of  the 
glycolytic/gluconeogenic pathway, which was supported by the finding of glucose-6-
phosphate and fructose-6-phosphate increasing with IRI
512. However, the end product 
of  this  pathway  is  normally  pyruvate,  and  lactate  is  not  produced  except  during 
anaerobic situations
512,516.  It is interesting that this rise in lactate is observed at 4hrs 
reperfusion, t h i s  c o r r e s p o n d s  t o  a  l a r ge  burst  of  PMN a c t i v i t y  t h a t  c o n s t i t u t e s  t h e  
beginning of the late phase of IRI
512,516. It has been observed that the injury produced 
during the initial part of the late phase involves a more extensive hepatocellular injury 
in comparison to the early phase
546,547. Moreover, elements of neutrophil sequestration, 
sinusoidal  narrowing  and  vasoconstriction  combine  to  form  a  “no-reflow  paradox” 
whereby  hepatocytes  are  subjected  to  a  further  perfusion  deficit  and  persistent 
ischaemia
178,520. This may explain the observed peak in lactate at this late time point, 
especially since lactate levels have been shown to become elevated in bile even when 
they are not elevated in serum
18.  
PC was observed to be similar in sham and I/R+glycine groups, while it was raised in 
the I/R group during the 2
nd and 4
th hr of reperfusion. The main source of PC in cells is 
the  plasma  membrane,  which  suggests  that  the  post-reperfusion  increase  may  be 
associated with an increase in cellular breakdown and membrane lipid peroxidation
526. 
Increased bile PC levels has also been observed in association with poor graft function 
in liver transplants
369.  
An increase in post-reperfusion levels of biliary glucose and pyruvate were found on 
reperfusion in the I/R+glycine group compared to I/R, this suggesting an increased 
metabolic  activity  in  the  glycolytic/gluconeogenic  pathway  which  may  be  due  to 
conserved cellular energetics. Hepatocytes are one of the few cells that can utilize 
fatty  acids  in  the  production  of  energy  through  the  β-oxidation  helix,  a  reaction  
162 
requiring ATP at its initiation
548. Ischaemia–induced reduction of ATP may result in a 
decreased  ability  to  utilize  β-oxidation  inhibiting  acetate  production  and  increasing 
pyruvate. Glycine-treated livers possessed a greater ability to produce acetate than I/R 
group, suggesting less injury to their metabolic energetics.  
After  reduction  of  hepatic  blood  flow,  the  mitochondrial  redox  potential  is  reduced. 
Consequently,  there  is  accelerated  production  of  ketone  bodies  to  compensate  for 
inhibited  glucose  utilization.  Ketone  body  production  is  an  alternative  pathway  to 
supply  ATP  when  there  is  inhibition  of  glucose  oxidation  and  the  Krebs  cycle. 
Recently, higher acetoacetate perfusate levels have been demonstrated in isolated-
perfused rat livers preserved in University of Wisconsin versus Euro-Collins solution
549 
which  has  been  shown t o  c o r r e l a t e  w i t h  N A D
+/NADH  ratio  in  the  hepatocyte 
mitochondria
550.  The  elevated  levels  of  acetoacetate  observed  in  this  study,  during 
ischaemia a n d  r e p e r f u s i o n ,  s u g g est  that  glycine-treated  livers  can  utilize  this 
alternative  source  of  ATP,  again  suggesting  conserved  cellular  energetics  in  this 
group. 
In  this  study  bile  spectroscopy  has  demonstrated  significant  changes  in  bile 
composition following I/R and alterations with glycine administration. These changes 
are evident despite a constant post-reperfusion rate of BF. Glycine was associated 
with increased synthetic functional markers (BF and bile acid synthesis), decreased 
injury markers (lactate and PC levels) and enhanced metabolic indicators (acetate, 
pyruvate, glucose and acetoacetate).   
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7  Modulation of warm hepatic ischaemia 
reperfusion in steatotic liver using NAC 
and its effect on bile composition  
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7.1  Introduction 
Hepatic IRI always occurs following liver resection, trauma and transplantation, due to 
temporary complete or partial cessation of hepatic blood flow
549. It is widely accepted 
that the key feature of IRI is the formation of ROS and RNS
551. 
There are two distinct phases of liver IRI, the early phase (up to 2hrs post-reperfusion) 
and  the  late  phase  (4-24  hrs)
516,552.  The  early  phase  is  characterized  mainly  by 
activation of complement and KC and the production of ROS. The main event during 
the late phase is the accumulation of activated PMN and the production of ROS and 
proteases. Most liver injury occurs during the late phase
553 and can lead to increased 
morbidity and mortality and remote organ injury leading to multiorgan failure
554. 
Hepatic steatosis occurs with obesity, alcohol abuse and metabolic disorders
427, and 
an incidence up to 11% has been reported in autopsy studies on accidental deaths
224. 
It is now well recognised that steatotic livers are more susceptible to IRI than normal 
livers
229. The mechanisms involved are still poorly understood but, as fat accumulates 
within  the  hepatocytes,  cell  volume  increases  resulting  in  a  decreased  sinusoidal 
space
239,244 and impaired microcirculatory blood flow
229,238.  Sinusoidal blood flow can be 
reduced by 50% in fatty livers
244,555. Steatosis represents a risk factor in liver surgery, 
with  a  mortality  rate  up  to  14%  in  patients  undergoing  major  hepatic  resection
238. 
Similarly,  the  use  of  steatotic  grafts  for  transplantation  is  associated  with  a  much 
higher risk of primary graft non-function or dysfunction
231. As a period of ischaemia is 
often necessary in liver surgery, and is inevitable in organ retrieval and transplantation, 
pharmacological modulation could potentially protect steatotic livers, minimizing the 
detrimental effects of IRI.  
NAC is a thiol-containing compound that interacts and detoxifies free radicals by non-
enzymatic reactions, and is deacetylated to form cysteine, which supports biosynthesis 
of glutathione, one of the most important components of the intracellular antioxidant  
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system
556. Nakano et al. demonstrated that perfusion with NAC prior to organ retrieval 
reduced the extent of IRI after 24 hours of cold storage in an isolated perfused rat 
steatotic liver
37. A previous experiment demonstrated that NAC reduced IRI in normal 
livers
499 and modified biliary composition.  
7.2  Objectives 
1.  To determine if the changes in bile composition during I/R can be recorded in 
steatotic livers.  
2.  To  determine  if  these  changes  (if  they  occur)  can  be  reversed  using  NAC, 
similar to its action on normal livers.  
3.  To identify the differences in chemical composition between I/R and I/R+NAC 
4.  To  ascertain  if  these  changes  fit  with  established  understanding  of  the 
mechanisms involved in liver IRI and the actions of NAC 
7.3  Materials and methods 
7.3.1  Animal model 
The study was conducted under a license granted by the Home Office in accordance 
with the Animals (Scientific Procedures) Act 1986. A rabbit liver lobar I/R model was 
used where both the early and late phases of reperfusion injury could be studied.  12 
New  Zealand  white  rabbits  with  a  mean  body  weight  of  3.8±0.5kg  were  used. 
Steatosis was induced by feeding the animals with a high cholesterol (2%) diet for 8 
weeks.  Anaesthesia  was  induced  by  intramuscular  injection  of  fentanyl-fluanisone 
0.5ml/kg (Janssen Animal Health Ltd., Buckinghamshire, UK). 
Tracheostomy was performed and anaesthesia was maintained with Isoflurane (0.5-
2%) via an anaesthetic circuit. Temperature was measured by a rectal thermometer 
and maintained at 37-38.5°C with a warming blanket (Homeothermic blanket control 
unit;  Harvard  Apparatus,  Southmatick,  Massachusetts,  USA).  Arterial  oxygen 
saturation and heart rate were continuously recorded by a pulse oximeter (Ohmeda 
Biox 3740 pulse oxymeter; Ohmeda, Louisville, Colorado, USA), applied to the tail.  
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One  radiopaque  catheter  (20G)  was  inserted  into  the  ear  artery  to  collect  blood 
samples  and  connected  to  a  pressure  transducer  to  monitor  mean  arterial  blood 
pressure  and  heart  rate.  Ear  marginal  veins  were  cannulated  in  both  ears  with 
radiopaque catheters (22G) for the administration of fluids and drugs. Normal saline 
was infused at a rate of 15 ml/kg/h to replace the intraoperative fluid losses. 
Laparotomy  was  performed  through  a  bilateral  subcostal  (roof-top)  incision.  The 
ligaments from the diaphragm to the liver were divided and the liver was fully exposed. 
The bile duct was cannulated with a polyethylene catheter (PE-50,  0.58  mm  inner 
diameter, Portex, Kent, UK). BF was measured and calculated as µL/min/100g of liver 
wet  weight.  Following  dissection  of  the  portal  vein,  a  perivascular  Doppler  probe 
(HT207;  Transonic  Medical  System  Inc,  Ithaca,  NY)  was  positioned  around  it  to 
monitor the portal blood flow. Lobar ischaemia was induced by clamping the vascular 
pedicles of the median and left lobes of the liver, using an atraumatic microvascular 
clip.  The  microvascular  clip  was  removed  after  60  minutes  of  ischaemia a n d  
reperfusion was allowed for 6 hours. At the end of this period the animals were killed 
by exsanguination. 
7.3.2  Experimental groups and protocol 
Two animals groups (n=6 each) were used. In the I/R+NAC group 150 mg/kg of N-
acetylcysteine  (Parvolex,  Medeva  Pharma L i m i t e d ,  L a n c a s h i r e ,  U K )  i n  2 0 ml o f  5 %  
Dextrose was infused intravenously through the ear vein over the 15min immediately 
before  reperfusion  and  maintained  at  10mg/kg/h i n  5 %  D e x t r o s e  d u r i n g  t h e  6 h rs 
reperfusion period. In the I/R group 20ml of 5% Dextrose was infused intravenously 
15min before reperfusion and continued at a rate of 10ml/kg/h during the reperfusion 
period. 
In  both  groups, after laparotomy and a 10min peri od of  st abi l i zat i on,  syst emi c and 
hepatic haemodynamics, oxygen saturation, body temperature and BF were recorded 
continuously. Arterial blood samples were taken before the induction of liver ischaemia  
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(baseline) and at 2, 5 and 6hrs after reperfusion for measurement of ALT activity. An 
equal volume of normal saline was used to replace the volume of the blood taken. 
Serum  was  separated  from  the  samples  and  stored  at  -20°C  until  assayed.  The 
measurements  were  done  using  an  automated  clinical  chemistry  analyser  (Hitachi 
747, Roche Diagnostics Ltd, Sussex, UK). A biopsy was taken from the ischemic left 
liver  at  baseline  and  6  hours  after  reperfusion.  Formalin-fixed  liver  tissue  samples 
were embedded in paraffin and stained with haematoxylin and eosin for subsequent 
microscopy (digital light microscope CLF60 optical system, Nikon UK Ltd, Surrey, UK). 
Formalin fixed and not paraffin embedded tissue was stained for fat using the Swank & 
Davenport modification of the Marchi method
469. 
7.3.3  Bile flow and composition  
To  determine  the  effect  of  NAC  therapy  on  bile  production  and  excretion,  BF  was 
measured  and  bile  composition  analysed  with p r o t o n  n u c l e a r  m a g n e t i c  r e s o n a n c e  
spectroscopy (
1HNMR).  
Bile samples were taken at baseline and each hour thereafter and stored at -80°C. Bile 
volume was expressed as µL/min/100g of liver weight. 
1HNMR  analysis  was  performed  on  an  11.7T  (500MHz  for  protons)  spectrometer 
(Varian  Unity+;  Varian,  Palo  Alto,  CA,  USA)  at  25°C.  Bile  was  thawed  at  room 
temperature  and  placed  in  5mm  NMR  tube.  For  a  field/frequency  lock  a  coaxial 
capillary insert was used (Wilmad, Buena, NJ, USA). This capillary insert was filled 
with a deuterium oxide solution of sodium TSP that acted both as a chemical shift 
reference and quantification standard. This capillary was calibrated by using a series 
of  known  concentration  solutions  of  deoxycholate  and  a  calibration  curve  was 
obtained. This was then used for quantification of bile components (lactate, acetate,  
pyruvate  and  phosphatidylcholine)  which  enabled  an  accurate  comparison  of  bile 
levels between the groups. One dimensional NMR spectra were obtained at 500 MHz 
with a sweep width of 6kHz. Presaturation of bile was carried out to attenuate the  
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intensity of water signal. The spectra were analysed using software from MestRe-C 
version  3.1.1  (Universidade  de  Santiage  de  Compostela,  Spain).  All  spectra  were 
integrated using a fixed range for each peak and published peak assignments
10,18,370,472 
shown in table 2. 
7.3.4  Data collection and statistical analysis 
Data from the pulse oxymeter, blood pressure monitor, transonic flowmeter, LDF and 
NIRS were continuously recorded on a laptop computer. The data were averaged for 
two minutes before the induction of ischaemia (baseline), at the end of ischaemia, and 
each hour of a 6hrs reperfusion period. The hepatic tissue oxygenation changes at the 
end of each period were calculated relative to the baseline. 
Values are expressed as mean±SD. For statistical analysis, ANOVA with Bonferroni 
post  hoc  analysis  was  performed.  Statistical  analysis  was  performed  using 
commercially available software (Staview 5.0.1, SAS Institute Inc., Cary, NC, USA). 
P<0.05 was considered statistically significant.   
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7.4  Results 
All  animals  fed  with  a  high-cholesterol  (2%)  diet  for  8  weeks  developed  moderate 
hepatic  steatosis.  Histology  revealed  centrilobular  steatosis  (figure  37).  Mild  to 
moderate PMN infiltrate was evident in the liver tissue at the end of reperfusion.  
7.4.1  Systemic haemodynamics  
In both groups MAP and heart rate fell in the reperfusion period compared to baseline. 
There was no significant difference in MAP, heart rate and oxygen saturation values 
between the two groups through out the experiment. 
7.4.2  Hepatic haemodynamics  
Portal flow values are demonstrated in figure 38. There was no significant difference in 
baseline values between the two groups.  
Portal flow was higher in I/R+NAC group after the third hour of reperfusion and this 
difference  reached  significance  at  the  6
thhr  (67.2±8.3ml/min  vs  52.5±11.2ml/min, 
I/R+NAC vs I/R, P=0.031). 
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Figure 37: Histology demonstrating centrilobular steatosis 
 
 
 
Section  of  liver  stained  with  the  Marchi  method  showing  a  moderate  amount  of 
centrilobular fat (stained black), as seen generally in the study population. The arrows 
indicate two portal tracts (magnification 100x).  
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Figure 38: Portal flow in the I/R+NAC and I/R group 
 
 
 * A significant difference was recorded at 6
th hour (P=0.031). 
 
 
I/R+NAC 
I/R 
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7.4.3  Hepatic microcirculation  
During ischaemia LDF values were significantly reduced in both groups and became 
almost  nil  (figure  39).  In  the  I/R g r o u p ,  f l o w  in  the  hepatic  microcirculation w a s  
significantly reduced from baseline by 5
th hr (86±9.5 vs 60±10 flux/min, P=0.032) and 
6
thhr (86±9.5 vs 64±10 flux/min, P=0.048) post-reperfusion. In the I/R+NAC group no 
significant difference was recorded in LDF values between baseline and reperfusion.  
Flow in hepatic microcirculation was better in the I/R+NAC group in comparison to I/R 
group after the 3
rdhr of reperfusion and this difference became significant at the 5
thhr 
(86.4±21.1  vs. 6 0 ± 10  flux/min r e s p e c t i v e l y ,  P=0.034)  and  at  6
thhr  (89.6±23  vs. 
64.7±10.9 flux/min respectively, P=0.049). 
7.4.4  Liver function tests  
No significant difference between baseline ALT values in the two groups was recorded 
(40±12.7 in the I/R group vs. 44.7±11.8 IU/mL in the I/R+NAC group). ALT values 
were  significantly  greater  in  the  I/R  group  at  5
thhr  (249±8.7  vs.  195±15  IU/mL, 
P=0.019) and 6
th hr of reperfusion (288±24 vs. 216±13.7 IU/mL, P=0.019) as shown in 
figure 40. 
7.4.5  Bile flow and Proton nuclear magnetic resonance (
1HNMR) spectroscopy  
Baseline BF was similar in the two groups (175 µL/min/100gm in the I/R+NAC group 
vs. 189 µL/min/100g in the I/R group). BF was significantly greater in the NAC treated 
animals at 5
thhr (123±35 vs. 85±10 µL/min/100g, P=0.016) and 6
thhr of reperfusion 
(122±32 vs. 80±15 µL/min/100g, P=0.008) as shown in figure 41. 
Baseline I/R group bile spectra are shown in figure 42. The results of the integration of 
the area under curve for the assigned peaks are shown in table 3. Bile lactate levels 
rose  slightly  in  both  groups  during  ischaemia a n d  g r a d u a l l y  f e l l  a t  5
thhr  of  
173 
Figure 39: LDF in the I/R+NAC and I/R group.  
 
  
A  significant  difference  was  recorded  at  5
th a n d  6
thhr  (P=0.032 a n d  P=0.048 
respectively) 
I/R+NAC 
I/R 
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Figure 40: ALT levels in the I/R+NAC and I/R group 
 
 
Changes in ALT values were statistically different at 5
th and 6
th hr in the two groups 
(P=0.019 at 5
th and 6
th hr respectively) 
I/R+NAC 
I/R 
  
175 
Figure 41: Bile flow measurements in the I/R+NAC and I/R group 
 
 
Bile flow was significantly greater in the I/R+NAC group at 5
th and 6
th hr (P=0.016 at 5
th 
hr and P=0.008 at 6
th hr respectively) 
 
I/R+NAC 
I/R 
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Figure 42: Baseline bile spectra of steatotic bile 
 
 
1HNMR s p e c t r u m  o f  b a s e l i n e  I / R  b i l e .  T S P = s o d i u m  t r i m e t h y l s i l y l -[
2H4]propionate 
standard,  BA=bile  acid,  Lact=lactate,  Ac=acetate,  Py=pyruvate, 
PC=phosphatidylcholine head group, H2O=water, Gl=glucose 
ppm (t1)
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Table 3: Results of peak integration of 
1HNMR bile spectra 
 
  Group  Baseline  Ischaemia  2hr 
Reperfusion 
5hrs 
Reperfusion 
6hrs 
Reperfusion 
Lactate 1.3 ppm  I/R   11.73±6.14  12.98±9.01  11.29±6.24  11.32±7.21  12.88±9.73 
  I/R+NAC  13.84±3.93  17.22±0.75  17.46±3.02  14.34±4.88  15.16±3.55 
  P  0.5365  0.5733  0.0822  0.5137  0.6749 
Acetate 1.9 ppm  I/R   1.20±0.40  1.24±0.34  0.77±0.25  0.51±0.21  0.74±0.32 
  I/R+NAC  1.07±0.19  0.70±0.01  1.04±0.26  1.24±0.37  1.99±0.36 
  P  0.5249  0.1211  0.1326  0.0137  0.0022 
Pyruvate  I/R   0.98±0.39  0.86±0.38  0.84±0.32  0.56±0.40  0.89±0.43 
  I/R+NAC  1.37±0.19  1.75±0.08  1.86±0.31  1.39±0.36  1.57±0.82 
  P  0.0749  0.0538  0.0009  0.0224  0.1911 
PC head group  I/R   3.75±1.62  8.37±1.9  5.68±2.22  6.26±5.24  4.11±2.88 
  I/R+NAC  2.42±0.95  2.58±0.29  4.66±2.62  2.75±0.71  2.62±0.63 
  P  0.1510  0.0339  0.5237  0.2330  0.3499 
 
Peak integration of area under the curve of 
1HNMR bile spectra as per table 2 peak 
assignments,  shown  as  mean±SD  in  µmol/L c o n c e n t r a t i o n s  ( q u a n t i f i c a t i o n  a s  p e r  
appendix section 10.1). Numbers in bold are P<0.5 (I/R compared to I/R+NAC group).   
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reperfusion. They were higher in the I/R+NAC than in I/R group but this difference was 
not significant. During reperfusion bile acetate levels rose in the I/R+NAC group to 
almost two fold the baseline level at 5hrs post-reperfusion while in the I/R group they 
dropped to almost half their baseline levels. Acetate levels were significantly higher in 
the  I/R+NAC  group  compared  to  I/R  at  5hrs  (P=0.0137) a n d  6 hrs  reperfusion 
(P=0.0022) as shown in figure 43.  
Bile  pyruvate  levels  fell  during  ischaemia i n  t h e  I / R  g r o u p  w h i l e  t h e y  r o s e  i n  t h e  
I/R+NAC group (p=0.0538). Following reperfusion bile pyruvate levels continued to fall 
in the I/R group while they continued to rise in the I/R+NAC group. I/R+NAC group 
pyruvate levels were significantly higher compared to I/R group at 2 and 5hrs post-
reperfusion (p=0.0009 and p=0.0224 respectively). 
During ischaemia there was a two-fold rise in PC levels in the I/R group (P=0.0339) 
while in the I/R+NAC group, there was only a slight rise. On reperfusion PC levels fell 
in  I/R  group a f t e r  2 hrs  reperfusion  to  rise  again  at  5hrs p o s t -reperfusion.  In t h e  
I/R+NAC  group P C  l e v e l s  r o s e  t o  p e a k  a f t e r  1 hr  reperfusion  then  fell  to  close  to 
baseline values at 6hrs reperfusion. PC levels were consistently lower in the I/R+NAC 
group than in I/R group.   
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Figure 43: 
1HNMR spectra of acetate levels following warm I/R 
 
    
1HNMR spectra of acetate peaks (at 1.9 ppm) in representative samples from (a) the 
I/R and (b) I/R+NAC group at 6hrs post-reperfusion showing significant increase 
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7.5  Discussion 
This  study  has  shown  that  NAC  administration  reduces  IRI  in  the  steatotic  liver 
following a 1 hr period of partial inflow occlusion, and the benefit is mainly apparent in 
the late phase IRI.  
Rabbits were fed with high-cholesterol diet (2%) for 8 consecutive weeks in order to 
induce moderate steatosis
398. Unlike the commonly used low-choline methionine diet, 
which  produces  periportal  fatty  infiltration
240,426,  with  this  model  a  central  lobular 
deposition of fat is observed, similar to that found in the majority of human fatty livers, 
such  as  in  diabetes,  obesity  and  alcoholism
427.  Liver  steatosis  reduces  flow  in  the 
hepatic microcirculation and mitochondrial ATP generation
229. Fat accumulation in the 
cytoplasm of the hepatocytes causes compression or even complete occlusion of the 
sinusoidal spaces with shunting of a proportion of total hepatic blood flow (THBF)
240. 
Our  group  previously  demonstrated  in  an  experimental  model,  that  in  moderate 
steatosis, the THBF was reduced by 30% and flow in hepatic microcirculation was 
50% of normal I/R group
244.  
The benefits of employing this model have been discussed above (section 3.1), briefly 
it permitted the analysis of bile constituents in both the early phase and the beginning 
of  the  late  phase  of  IRI,  avoiding t h e  p r o d u c t i o n  o f  a c u t e  p o r t a l  h y p e r t e n s i o n  a n d  
intestinal ischaemia, maintained hemodynamic stability throughout the duration of the 
experiment, and avoiding the complete occlusion of biliary drainage in the total hepatic 
ischaemia model permitting the effects of I/R on biliary composition to be evaluated. 
Several studies on liver IRI have focused on the initial reperfusion phase
159,266,399, which 
is characterised by oxidative stress induced by KC and occurs in the first two hours
185. 
In the present study the observation time was extended to 6 hrs as a distinct late 
phase  of  warm  IRI  develops  4  hrs  after  reperfusion,  and  is  primarily  caused  by 
activated PMN with release of ROS and proteases
516,531.  
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NAC  was  chosen  as  an  antioxidant  to  modulate  hepatic  IRI  as  it  is  routinely 
administered  to  patients  with  acute  liver  failure  secondary  to  acetaminophen 
(paracetamol)  overdose
557,  and  has  been  used  in  other  clinical  conditions  where 
oxidant  damage  was  the  putative  or  known  mechanism  of  injury,  such  as  acute 
respiratory distress syndrome
558 and IRI following cardiac surgery
559. Recent work has 
also  shown  beneficial  effects  of  NAC  in  normal  liver  following  one  hour  of  lobar 
ischaemia
499. The dose of NAC administered is that used in clinical practice to treat 
patients with acute liver failure
557. The beneficial effect of NAC was demonstrated by 
improvement  in  liver  microcirculation,  bile  production,  associated  with  reduced 
hepatocellular injury.  
Several  studies  have  validated  the  use  of  LDF  to  measure  changes  in  hepatic 
microcirculation
396,560,561.  During  partial  inflow  occlusion,  parenchymal  perfusion  was 
greatly reduced but was still recordable. This low level of perfusion has also been 
reported in other studies and can be caused by a random wandering motion of red 
cells and breathing movements
532. In the NAC group hepatic microcirculation returned 
to baseline values at the end of reperfusion suggesting that NAC has reversed the 
perfusion failure of the late phase of IRI.  This correlates well with the return of portal 
blood flow rates towards baseline at the end of the reperfusion period in the NAC 
group.   
In order to adequately investigate hepatic injury and function, changes in serum ALT 
activity, BF and composition were studied. ALT is relatively liver specific and reflects 
the  loss  of  membrane  integrity  and  release  of  cytoplasmic  content  into  the 
circulation
221. Bile production is a reliable marker of liver function
25. The NAC group 
had  reduced  hepatocellular  injury  as  indicated  by  lower  ALT  values  following 
reperfusion, and improved biliary excretion, an energy dependent process, resulting in 
increased bile drainage volumes. A comparable rise in ALT values has been observed 
during reperfusion in steatotic animals subject to a similar ischaemic insult
37.  
182 
The use of spin echo spectra allowed the interference from broad lipid signals to be 
reduced  and  more  clearly  identify  and  comparatively  quantify  bile  constituents. 
Continuous  BF  was  recorded  in  both  the  I/R  and  I/R+NAC  groups,  and 
1HNMR 
spectroscopy revealed fluctuations in the concentration of several bile constituents. 
More specifically NAC administration enhanced the biliary excretion of acetate and 
pyruvate and reduced the excretion of PC. 
Acetate is produced as a result of fatty acid β-oxidation in the liver
526. This reaction 
requires ATP at its initiation. Following IRI ATP is consumed to clear excess lactate 
and pyruvate and may not be readily available for fatty acid oxidation. The I/R–induced 
reduction or depletion of ATP may result in a decreased ability to utilize β-oxidation 
causing acetate production to falter. The higher bile acetate levels in the NAC treated 
livers  would  suggest  improved  ATP  production  and  energetics.  The  increased 
excretion of pyruvate in the bile of NAC treated livers is difficult to interpret.  Steatotic 
livers have lower ATP levels after stress compared to normal livers and mitochondrial 
injury has been proposed as one of the causes of reduced hepatocellular ATP stores 
in steatosis
427. The main source of PC in the hepatocytes is the cell membrane. The 
increase following ischaemia and again at 5hr post-reperfusion correlates well with the 
theory of cellular breakdown and membrane lipid peroxidation
524. Increased PC has 
also been observed by other authors in association with poor graft function
394. 
In conclusion, the administration of NAC, prior to and during reperfusion, reduced the 
extent  of  IRI  in  the  steatotic  liver.  This  was  apparent  during  the  late  phase  of 
reperfusion  and  was  demonstrated  by  increased  portal  blood  flow  and  liver 
parenchymal  perfusion.  Bile  excretion,  biliary  acetate  and  pyruvate  were i n c r e a s e d  
and acute liver injury was reduced.   
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8  Modulation of warm hepatic ischaemia 
reperfusion in steatotic livers using 
ischaemic preconditioning and its effect 
on bile composition 
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8.1  Introduction 
Fatty liver or hepatic steatosis is a common histological finding in human liver biopsies, 
which is the result of the abnormal accumulation of triacylglycerol within the cytoplasm 
of  hepatocytes,  attributed  to  the  effects  of  alcohol  excess,  obesity,  diabetes,  or 
drugs
245. Estimates based on imaging and autopsy studies suggest that about 20% to 
30%  of  adults  in  the  United  State  and  other  western  countries  have  excess  fat 
accumulation  in  the  liver
562.  Hepatic  steatosis  can  be  graded  as  mild,  moderate  or 
severe, depending on the percentage of fat present
563.  
With the increasing numbers of orthotopic liver transplantations and the concomitant 
lack of suitable donors, many liver transplant programs increasingly use donor livers of 
“marginal”  quality  such  as  fatty  livers
229,564,565.  Fatty  livers  pose  an  increased  risk  of 
initial poor function and primary non-function of the graft after transplantation as they 
are particularly susceptible to IRI
229,566. There is therefore, an urgent need for strategies 
that improve the outcome after transplantation of fatty livers.  
Murry et al. first described IPC on observing that brief periods of ischaemia improves 
the tolerance to subsequent, prolonged ischaemia in various organ systems
258.  IPC 
has been shown to decrease liver injury after warm IR
34,259-261  as well as after cold 
ischemic storage
262-264. Recent studies show that IPC increases the tolerance of fatty 
livers to IRI in an animal model of steatosis
265,266. 
In a recent study, IPC significantly improved blood flow in the microcirculation during 
the reperfusion phase
267 in a rat IRI model and near infrared spectroscopy showed that 
preconditioned livers exposed to hypoxia maintained their COX redox state
268. There is 
growing evidence that mitochondria are a major target of IRI
269. For a metabolically 
active,  mitochondria  rich,  organ  such  as  liver  an  investigation  into  the  changes  in 
mitochondria  function  is  of  particular  importance  in  the  understanding  of  the  sub-
cellular mechanisms underlying hepatic I/R injury. Consequently, the aim of this study  
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was to investigate whether IPC protects fatty livers form IRI through a mechanism of 
improved intracellular tissue oxygenation and maintaining mitochondrial stability and 
function. 
It  is  not  known  whether  COX  activity  is  a  target  for  IRI  in  fatty  liver  and  whether 
maintaining COX activity reduces IRI. This chapter investigated the effects of I/R and 
IPC  on  hepatic  intracellular  tissue  oxygenation  and  COX a c t i v i t y  a s s o c i a t e d  w i t h  
mitochondrial function to establish whether mitochondrial damage is a key mechanism 
of IRI in fatty liver.  
8.2  Objectives 
1.  To  determine  if  IPC,  a  process  known  to  ameliorate  IRI  in  normal  livers, 
produces the changes in bile composition during I/R in steatotic livers.  
2.  To  identify  and  possibly  quantify  the  differences  in  chemical  composition 
between sham, I/R and IPC+I/R, particularly further differences not explored in 
the previous experiments, e.g. βHb and acetoacetate 
3.  To determine if the use of lactate/pyruvate and  βHb/AcAc ratios provides a 
better indicator for IRI 
4.  To  ascertain  if  these  changes  fit  with  established  understanding  of  the 
mechanisms involved in liver IRI and the actions of IPC 
8.3  Material and Methods 
8.3.1  Animal Model, Anaesthesia and Surgical Procedure 
This  study  was  conducted  under  a  project  license  in  accordance  with  the  Animals 
(Scientific Procedures) Act 1986. New Zealand white rabbits weighing between 3.0-
3.5kg were fed with a cholesterol rich (2%) diet for a period of 8 weeks to induce 
moderate steatosis.  
A rabbit lobar ischaemia model developed for the study of the later phase of IRI was 
used
499. Anaesthesia was induced by intramuscular injection of 0.5ml/kg fetanyl citrate  
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and  fluanisone  (Hypnorm;  Janssen  Animal  Health  Ltd.,  Buckinghamshire,  UK).  
Following tracheostomy, anaesthesia was maintained by 1.5-2% isoflurane through an 
anaesthetic circuit. A Homoeothermic blanket control unit was used to maintain body 
temperature  between  37-38.5°C  (Harvard  Apparatus,  Southmatick,  Massachusetts, 
USA). A radiopaque catheter (20G) was inserted into ear artery to monitor arterial 
blood  pressure  and  collect  blood  samples.  To  administer  anaesthetics,  fluids  and 
medication ear marginal veins were cannulated with radiopaque catheters (22G)
401. 
Laparotomy  was  performed t h r o u g h  a  m i d l i n e  i n c i s i o n .  E x p o s u r e  o f  t h e  l i v e r  w a s  
accomplished  by  severing  the  ligaments  that  attach  it  to  the  diaphragm.  Lobar 
ischaemia is induced by clamping the vascular pedicles of the median and left lobes of 
the liver, using an atraumatic microvascular clip. Blood supply to the caudate and right 
lobes  were  unaffected  by  this  method.  Removing  the  vascular  clamp  allowed 
reperfusion at the end of ischaemia. This method induces severe ischaemia without 
inducing  mesenteric  venous  hypertension.  The  bile  duct  was  cannulated  with  a 
polyethylene catheter (PE-50, 0.58 mm inner diameter, Portex, Kent, UK). Bile was 
collected  and  frozen  at  -80°  for  proton  magnetic  resonance  spectroscopy.  Hepatic 
tissue  oxygenation  was  continuously  monitored  in  the  left  and  median  lobes 
throughout the experiment. Liver tissue biopsies were taken at baseline, 2, 5 and 7hrs 
of reperfusion.  
Haemoglobin  saturation  and  heart  rate  were  continuously  recorded  by  a  pulse 
oxymeter.  Laparotomy  was  performed  through  a  midline  incision.  Portal  flow  was 
monitored continuously, using a perivascular transonic flow probe (Medical Flowmeter 
system HT207; Transonic Medical System, Ithaca, New York, USA). IPC was induced 
by 5min of ischaemia followed by 10min of reperfusion. After 60min of ischaemia the 
vascular clip was removed and reperfusion was allowed for 7hrs. At the end of the 
experiment the animals were killed by exsanguination.                                                                                                                       
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8.3.2  Experimental Groups & Protocol  
Under anaesthesia of isoflurane (1-2%), animals were subjected to 60 min liver lobar 
ischaemia followed by 7 hours of reperfusion. MAP, SaO2 and HR were continuously 
monitored.  HM w a s  a s s e s s e d  b y  LDF.  At  the  end  of  the  reperfusion  period,  ICG 
(0.5mg/kg)  was  administered  intravenously  and  the  clearance  rate  in  the  liver  was 
measured directly by NIRS. 
The animals were divided into following three groups: 
Sham  Group: S h a m  l a p a r o t o m y  ( n = 6 ) :  T h e  a n i m a l s  w e r e  a n a e s t h e t i z e d  a n d 
laparotomy performed for 8hrs without induction of ischaemia 
I/R  Group: I s c h a e m i a -Reperfusion ( n = 6):  Animals  were  subjected  to  60min  of 
ischaemia and 7hrs of reperfusion.  
IPC+I/R  Group: I s c h e m i c  P r e c o n d i t i o n i n g  ( n = 8 ) :  I P C  w a s  i n d u c e d  w i t h  5 m i n  
ischaemia followed by 10min of reperfusion before prolonged ischaemia was induced 
for 60mins followed by 7hrs of reperfusion.  
8.3.3  Measurement of tissue oxygenation 
Hepatic  tissue  oxygenation  was  measured  in  vivo  by  NIRS.  NIRS  (NIRO-500; 
Hamamatsu Photonics K.K, Hamamatsu, Japan) measured the concentration changes 
of Hb and HbO2 and the reduction oxidation (redox) changes of the copper centre of 
COX.  NIRS  probes  were  positioned  flat  on  the  surface  of  the  left  lobe  of  the  liver 
10mm  apart  to  continuously  measure  hepatic  tissue  oxygenation.  A  flexible  probe 
holder is used to ensure probes are touching liver. This technique has been validated 
in previous studies
266,268,394,396,499,567. 
8.3.4  Measurement of the hepatic microcirculation  
HM was measured by a surface LDF, (DTR4, Moor Instruments Limited, Axminster, 
UK) in flux units
432. The LDF probe was placed on a fixed site on the median lobe of 
the  liver.  LDF  measurements  were  calculated  as  a  mean  of  2-min  recording  data  
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before clamping (baseline), at the end of ischaemia and at the end of each hour of 
reperfusion for each animal. The alterations during I/R period were calculated relative 
to the baseline values 
8.3.5  Measurement of indocyanine green clearance 
At  the  end  of  reperfusion,  a  bolus  of  ICG  clearance  (0.5mg/kg)  was  administered 
intravenously. The clearance of ICG in the liver was directly monitored by NIRS for 
60min. Bile excretion of ICG during was also measured by spectrophotometry during 
this period.  
Continuous  measurement  of  hepatic  ICG  by  NIRS  produces  a  concentration-time 
curve.  This  curve  was  analysed  to  produce  two  exponential  rate  constants, 
representing hepatic ICG uptake from the plasma to the hepatocytes (α) and hepatic 
ICG  excretion  from  the  liver  by  cytoplasmic  transport  and  biliary  excretion  (β)  as 
shown in figure 48.  
8.3.6  Measurement of bile flow and composition 
To determine the effect of IPC on bile production and excretion, BF was measured and 
bile composition analyzed with 
1HNMR.  
Bile samples were taken at baseline and 2, 5 and 7hrs after reperfusion and stored at  
-80°C. Bile volume was expressed as µL/min/100g of liver weight. 
1HNMR analysis was performed on an 11.7 Tesla (500MHz for protons) spectrometer 
(Varian  Unity+;  Varian,  Palo  Alto,  CA,  USA)  at  25
oC.  Bile  was  thawed  at  room 
temperature  and  placed  in  5mm  NMR  tube.  For  a  field/frequency  lock  a  coaxial 
capillary insert was used (Wilmad, Buena, NJ, USA). This capillary insert was filled 
with a deuterium oxide solution of sodium TSP that acted both as a chemical shift 
reference and quantification standard. This capillary was calibrated by using a series 
of  known  concentration  solutions  of  deoxycholate  and  a  calibration  curve  was 
obtained. This was then used for quantification of bile components (lactate, acetate,  
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pyruvate  and  phosphatidylcholine),  which  enabled  an  accurate  comparison  of  bile 
levels between the groups. One dimensional NMR spectra were obtained at 500MHz 
with a sweep width of 6kHz. Presaturation of bile was carried out to attenuate the 
intensity of water signal. The spectra were analysed using software from MestRe-C 
(Mestrelab Research, Santiage de Compostela, A Coruña, Spain). All spectra were 
integrated using a fixed range for each peak and published peak assignments
10,18,370,472 
shown in Table 2. 
8.3.7  Assessment of hepatocellular injury  
Hepatocellular injury was accessed by measuring serum levels of AST and ALT using 
an automatic biochemical analyser (Hitachi 747; Roche Diagnostics Ltd., Sussex, UK).   
8.3.8  Histological examination 
Liver tissue samples were taken at the end of reperfusion and fixed in buffered 10% 
formalin and embedded in paraffin. 4µm thick sections were cut using a microtome 
and mounted on slides for H&E staining. Fat infiltration in the liver was detected by 
staining using Marchi method modified by Swank and Davenport
469. 
8.3.9  Data collection and statistical analysis 
Data  from  the  pulse  oxymeter,  blood  pressure  and  portal  flow  monitor,  LDF  were 
collected continuously on a computer. The data were averaged for two minutes before 
the induction of ischaemia (baseline), at the end of ischaemia, and 2, 5, and 7hrs 
reperfusion  period.  Values  are  expressed  as  mean±SEM.  For  statistical  analysis 
ANOVA with Bonferroni adjustment for multiple comparisons were used. P<0.05 was 
considered  statistically  significant. S t a t i s t i c a l  a n a l y s i s  w a s  p e r f o r m e d  u s i n g  
commercially available software (Staview 5.0.1, SAS Institute Inc., Cary, NC, USA).   
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8.4  Results 
All animals developed moderate centrilobular steatosis (figure 44) after 8 weeks on a 
cholesterol rich diet. There was no mortality in our model to this stage of the induction 
of steatosis.  
8.4.1  Effect of IPC on aminotransferase levels 
AST levels are shown in figure 45A where IPC+I/R levels were significantly less at 
2hrs (125±18 vs. 273±47; P=0.0049) and 7hrs (199±33 vs. 406±86; P=0.0287) after 
reperfusion than I/R and not significantly different from sham. ALT levels of IPC+I/R 
were significantly lower than I/R at 2hrs (40±8 vs. 111±16; P=0.0016), 5hrs (65±9 vs. 
159±28; P=0.005) and 7hrs (54±14 vs. 178±34; P=0.0149) after reperfusion (figure 
45B). 
8.4.2  Effect of IPC on systemic and hepatic haemodynamics 
Systemic and hepatic haemodynamics data are summarized in table 4. Heart rate, 
oxygen  saturation  and  mean  arterial  pressure  remained  stable  during  7hrs  of 
reperfusion in all three groups. Portal flow was generally low in all three groups. At the 
end of reperfusion, the flow was better in IPC+I/R group as compared with I/R but the 
differences  were  not  statistically  significant.  HM  was  reduced  with  induction  of 
ischaemia.  However,  there  were  significant  differences  in  HM  between  I/R  and 
IPC+I/R  groups  at  end  of  reperfusion  (73.3±3.3  vs.  118.3±16.2  flux;  P=0.0482)  as 
shown in figure 46. 
8.4.3  Effect of IPC on tissue oxygenation 
IPC+I/R and I/R groups begin with similar baseline values of COX activity. After the 
initial 5mins ischaemia the IPC+I/R group displays a clear increase in COX activity 
which remains constant for the next 10mins. At the beginning of 60 minutes ischaemia 
the COX activity of both IPC+I/R and I/R drop to similar levels, however IPC+I/R is 
slightly  higher  than  I/R  and  remains  higher  during  the  course  of  ischaemia.  On 
reperfusion the I/R and IPC+I/R groups shows an almost identical increase in COX 
activity; however, this is lower than the baseline values for both groups. In the I/R  
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group there is a decrease from 120mins, which reaches its lowest point at 240mins, 
around 2.5hrs reperfusion. IPC+I/R gradually increases until 240mins then levels off 
with  a  dip  seen  at  360mins.  During  reperfusion  the  IPC+I/R  group  maintains  the 
highest level of COX as shown in figure 47. 
8.4.4  Effect of IPC on ICG clearance 
Hepatic ICG uptake following I/R is shown in figure 48, representing the uptake from 
plasma to the hepatocytes (α-curve) in figure 48A and the hepatic ICG excretion from 
the liver by cytoplasmic transport and biliary excretion (β-curve) in figure 48B. The 
rates of ICG clearance were 57.8±13.5% and 44.4±4.0% in the sham and IPC groups 
respectively. Comparison bile ICG excretion between the groups is shown in figure 49. 
8.4.5  Effect of IPC on bile composition 
The result of integration of area under the curve for the assigned peaks is shown in 
Table  5.  A  baseline  bile  I/R  bile  spectrum  is  shown  in  figure  50a  showing  β-
hydroxybutyrate (βHb) and acetoacetate (AcAc). Bile lactate levels were higher in the 
I/R group than the IPC+I/R group during 5 and 7hrs postreperfusion (P=0.0092 and 
P=0.0036  respectively).  Bile  pyruvate  levels  were  higher  in  the  IPC+I/R  group 
compared to the I/R during 2, 5 and 7hrs postreperfusion (P=0.0157, P=0.0018, and 
P=0.0059 respectively). The redox lactate/pyruvate ratio is shown in figure 51a. PC 
bile  levels  were  higher  in  the  I/R  group  than  the  IPC+I/R  group  at  2  and  5hrs 
postreperfusion  (P=0.0004  and  P=0.0143  respectively).  Bile  acetate  levels  were 
significantly higher in the IPC+I/R group than in the I/R alone group at 5 and 7hrs 
reperfusion (P=0.0044 and P=0.0027 respectively) as shown in figures 50 b & c. Bile 
acetoacetate  levels  were  significantly  reduced  in  the  I/R  group  compared  to  the 
IPC+I/R group at 2, 5 and 7hrs postreperfusion (P=0.0163, P=0.0002 and P=0.0007 
respectively). Bile βHb levels significantly increased at 2hrs reperfusion in both I/R and 
IPC+I/R groups compared to sham. βHb levels were higher in the I/R group than the 
IPC+I/R  group  at  2,  5  and  7hrs  reperfusion  but  they  did  not  reach  statistical 
significance. The redox ratio of βHb/acetoacetate is shown in figure 51b.  
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Figure 44: Moderate hepatic steatosis  
 
 
 
 
Moderate hepatic steatosis was induced in New Zealand white rabbits by feeding with 
a cholesterol rich (2%) diet for a period of 8 weeks shown (a) macroscopically and (b) 
microscopically with haematoxylin and eosin stain. The vaculated appearance of the 
hepatocytes  is  due  to  the  dissolution  of  fat  deposits  by  alcohol  during  the  fixation 
process. 
 
(a) 
(b)  
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Figure 45: Effect of I/R and IPC on aminotransferase levels  
 (a) 
 
** = P<0.01 and * = P<0.05 
 
(b) 
 
** = P<0.01 and * = P<0.05 
 
Hepatocellular  injury  shown  by  aminotransferase  levels  with  of  (a)  aspartate 
transaminase in IU/L and (b) alanine transaminase in IU/L.  
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Table 4: Effect of I/R and IPC on hepatic haemodynamics  
 
  Sham   IR  IPC+IR 
   BL  2hrs  7hrs  BL  2hrs  7hrs  BL  2hrs  7hrs 
MAP (mmHg)  73±5.7  62±4.6  66±6.8  75±3.0  63±2  65±5  72±4  68±3  67±6 
HR (beat/min)  252±6  246±8  234±5  243±5  207±8  217±7  252±3  253±4  249±4 
SaO2 (%)  97.4±1.0  96.6±0.7  97.8±7.3  96.9±0.3  97.1±0.8  97.6±0.6  97.9±0.4  97.2±0.6  97.0±0.7 
PVF (ml/min)  81.0±5.8  86.3±7.8  84.4±8.2  78.1±9.5  69.8±6.9  72.5±8.0  76.5±10.3  73.3±10.0  83.9±8.1 
 
BL, baseline; MAP, mean arterial pressure; HR, heart rate; SaO2, oxygen saturation; 
PVF, portal venous flow. Values are presented as mean±SEM of 6 animals from each 
group.   
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Figure 46: The effect of I/R and IPC on hepatic microcirculation  
 
 
 
Hepatic microcirculation as measured by Laser Doppler Flowmetry in flux units.  
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Figure 47: Effect of and I/R IPC on COX 
 
 
*=P<0.05 I/R vs. IPC+IR 
The Effect of and I/R IPC on on the copper centre of cytochrome oxidase c (COX) as 
measured by NIRS.  
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Figure 48: Hepatic ICG uptake following I/R  
(A) 
 
(B) 
 
Hepatic ICG uptake following I/R (a) from the plasma to the hepatocytes (α-curve) and 
(b) hepatic ICG excretion from the liver by cytoplasmic transport and biliary excretion 
(β-curve).  
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Figure 49: Effect of I/R and IPC+I/R on hepatic ICG clearance 
 
Effect of I/R and IPC+I/R on hepatic ICG clearance through excretion from the liver 
by cytoplasmic transport and biliary excretion (b). 
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Figure 50: Bile 
1HNMR spectra showing β-hydroxybutyrate and acetoacetate.  
(a) 
 
(a) Baseline spin echo spectra of bile. PC, phosphatidylcholine; AcAc, acetoacetate; 
ßHb,  ß-hydroxybutyrate;  ppm,  parts  per  million;  TSP,  sodium  [
2d4]- 
trimethysilylpropionate 
(b)               (c) 
         
Details  of  acetate  peak  at  1.9  ppm  (scaled  to  TSP)  in ( b )  t h e  I/R  group  at  7hrs 
reperfusion compared to the same peak in (c) the IPC+I/R group (scale in ppm).    
   
Table 5: 
1HNMR bile composition in I/R and IPC+I/R in steatotic livers 
 
  Sham  I/R  IPC+I/R 
  Baseline  2hr  5hr  7hr  Baseline  2hr  5hr  7hr  Baseline  2hr  5hr  7hr 
Lactate  10.68±0.58  11.14±0.95  11.18±1.27  11.25±1.38  11.19±0.97  12.17±1.11  16.50±1.06
§  17.23±1.88  11.13±0.81  9.05±1.76  8.74±1.43*  7.80±1.28* 
Pyruvate  0.86±0.12  1.09±0.08  1.13±0.06  1.02±0.09  0.95±0.14  0.50±0.05
§  0.49±0.09
§  0.68±0.09
§  0.73±0.14  1.51±0.28*  1.55±0.14*  1.72±0.23* 
Acetate  1.01±0.23  1.16±0.15  1.11±0.13  0.93±0.07  0.88±0.16  0.38±0.05
§  0.43±0.04
§  0.34±0.05
§  0.95±0.23  0.58±0.17  0.79±0.06
§*  0.85±0.90* 
PC  4.11±0.22  4.22±0.32  4.28±0.49  4.40±0.33  4.51±0.35  8.07±0.32
§  5.54±0.54  4.20±0.52  4.04±0.33  5.59±0.25
§*  3.55±0.32*  3.91±0.14 
Acetoacetate  2.15±0.12  2.13±0.05  2.08±0.12  1.92±0.23  2.07±0.28  1.04±0.13
§  0.41±0.05
§  0.35±0.10
§  2.26±0.18  1.73±0.17*  1.48±0.16
§*  1.36±0.16* 
βHb  0.46±0.06  0.46±0.05  0.57±0.06  0.61±0.05  0.51±0.03  1.36±0.29
§  0.99±0.11
§  0.82±0.17  0.56±0.06  0.83±0.05
§  0.72±0.04  0.62±0.04 
 
Values represent integration of area under the curve for peak assignments as per table 2, represented as mean±SD of concentrations µmol/L as 
per appendix section 10.1. Values in bold represent P<0.05; *=P<0.05 compared to I/R; §=P<0.05 compared to sham. PC=phosphatidylcholine; 
and βHb=β-hydroxybutyrate. 
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Figure 51: Bile redox ratios for I/R and IPC+I/R  
(A)
 
(B) 
 
** = P<0.01 and * = P<0.05 
Bile  redox  ratios  for  I/R  and  IPC+I/R  showing  (a)  Lactate/Pyruvate  and                         
(b) β-hydroxybutyrate/Acetoacetate ratios as measured by 
1HNMR spectroscopy.  
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8.5  Discussion 
IPC is protective against IRI in normal
261-264 and fatty liver
265. The benefit of IPC has 
also been proven in human liver resection surgery
260. 
NIRS in vivo measurements show extracellular tissue oxygenation was improved in 
the  IPC+I/R  group  compared  with  the  I/R  group  during  reperfusion,  supporting 
previous  studies  in  normal  liver  that  have  shown  that  IPC  protects  hepatic 
microcirculation
34,267,268. However, this experiment suggests that IPC also protects fatty 
liver against microcirculatory dysfunction. This is of importance to fatty liver as it has 
diminished sinusoidal spaces due to fatty infiltration
239.  
This experiment shows that there is a decrease in intracellular hepatic oxygenation 
and mitochondrial function as represented by COX/CS activity between baseline and 
2hrs reperfusion; noted in all three groups studied. The I/R group was worst affected 
followed by sham and the IPC+I/R group showed the least change in activity of COX 
enzyme  suggesting  that  IPC  plays  a  protective  role  in  maintaining  COX  activity. 
Previous studies have shown that ATP production is closely correlated with HbO2, Hb 
and  change  in  COX  redox  state
398,568,  suggesting  that  ATP  generation  and  overall 
mitochondrial function in fatty liver is maintained. The results also suggest that most of 
the mitochondrial damage occurs within the first two hours of reperfusion, because 
there is less change in activity between 2hrs and 7hrs reperfusion.  
The in vivo NIRS monitored the change in parameters continuously, indicating redox 
state of mitochondria and intracellular hepatic oxygenation. Thus showing how much 
the organ is perfused. The in vivo method focuses solely on isolated mitochondria 
function.  There  is  wide  variation  in  the  data.  Assays  were  done  using  liver  tissue 
stored  at  –80˚C,  mitochondrial  function  may  have  been  affected  according  to  the 
duration  of  storage.  Trends  seen  in  IPC+I/R  and  I/R  groups  are  not  statistically 
significant due to the small number of animals tested. A larger number of animals 
should be used in future work to prove these findings as statistically significant.   
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Selzner et al found the mechanism of cell death in fatty liver was significantly different 
to  cell  death  in  normal  liver
257.  In  fatty  liver  cell  death  occurs  predominantly  by 
necrosis, whilst apoptosis was dominant in normal liver after IRI. Necrosis is more 
damaging because it is accompanied by the breakdown of organelles, membranes 
and  the  release  of  cytotoxic  cell  contents,  which  induce  inflammation,  whereas, 
apoptosis  does  not.  This  may  contribute  to  making  fatty  liver  less  tolerant  to  IRI 
injury
256.  Fatty  liver  has  diminished  sinusoidal  spaces  due  to  fatty  infiltration
239 a n d  
inflammatory mediators such as TNF-α and leukocytes cause a further decrease in 
sinusoidal  space  and  impairs  microcirculation  which  reduces  blood  flow  to  certain 
areas resulting in prolonged periods of ischaemia to certain areas of the liver. This 
causing activation of KC and other mechanisms of IRI
569.  
Glanemann et al have shown that IPC protects normal liver from IRI by maintaining 
hepatic microcirculation and reducing inflammatory response by preventing activation 
of  KC  and  maintaining  mitochondrial  redox  state  which  is  dependent  upon  oxygen 
availability
34.  
The use of spin echo spectra allowed the interference from broad lipid signals to be 
reduced and more clearly identify and comparatively quantify bile constituents.  
The energetic balance and redox status of hepatic tissue are intimately connected by 
substrate oxidation/reduction reactions via oxidized nicotinamide adenine dinucleotide 
(phosphate) (NAD(P)) at several key points, such as pyruvate/lactate interconversion 
in  the  cytosol  or  βHb/AcAc i n t e r c o n v e r s i o n  i n  t h e  m i t o c h o n d r i a  a l s o  k n o w n  a s  t h e  
ketone body ratio. βHb and AcAc are a redox pair coupled by interconversion from 
AcAc  (with  oxidation  of  NADH)  to  βHb  and  the  βHb/AcAc  ratio  is  an  indicator  of 
mitochondrial  redox  status
570.  βHb/AcAc  equilibrates  with  hepatic  mitochondrial 
NADH/NAD
+ b e c a u s e  t h e  e n z y m e ,  β-hydroxybutyrate  dehydrogenase,  resides  in 
mitochondrial cristae
571. In the IPC+I/R group more of the “oxidized” half of the couplet  
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(AcAc) could be detected in bile, this suggests a shift toward more aerobic conditions 
in the mitochondria. This could lead to more aerobic conditions within the cytosol and, 
thus, the reconversion of lactate to pyruvate during reperfusion, lactate and pyruvate 
being a redox pair that is an indicator of the cytosolic redox state. This is supported by 
our  findings  of  decreased  lactate/pyruvate  ratio  in  the  IPC+I/R  group  during 
reperfusion. 
Acetate is produced as a result of fatty acid β-oxidation in the liver
572. This reaction 
requires ATP at its initiation
573. ATP is consumed immediately following IRI to clear 
excess lactate and pyruvate and may not be readily available for fatty acid β-oxidation. 
IR-induced depletion of ATP may result in a decreased ability to utilize β-oxidation 
causing  acetate  production  to  falter.  The  higher  bile  acetate  levels  in  the  IPC+I/R 
treated livers would suggest improved ATP production. The main source of PC in the 
hepatocytes  is  the  cell  membrane.  The  increase  at  2  and  5hrs p o s t -reperfusion 
correlates well with cellular breakdown and membrane lipid peroxidation
524. The first 
peak coincides with hepatocellular injury during ischaemia and the second peak with 
the  ‘no-reflow  period’
404,520.    PC  levels  at  both  peak  periods  were  reduced  in  the 
IPC+I/R group, this may suggest less cellular breakdown in the IPC+I/R group.  
Hirakawa et al have shown in normal rat liver cytochrome c is released into the cytosol 
by mitochondria during IRI
574. It is a mediator of apoptosis inducing caspase 3 and 9 
activation,  which  mediate  apoptosis.  The  release  of  cytochrome  c a n d  c a s p a s e s  
occurred  during  ischaemia,  yet,  apoptosis  occurred  during  reperfusion  in  normal 
liver
575. The release of cytochrome c is mediated by a membrane pore, known as the 
mitochondrial  permeability  transition  pore  (mPTP).  The  pore  can  be  defined  as  a 
voltage-dependent high-conductance channel of the inner mitochondrial membrane
576. 
The  pore  is  normally  closed, b u t  i s  o p e n e d  a t  t h e  o n s e t  o f  r e p e r f u s i o n .  W h e n  
cytochrome c is released there is no substrate for COX resulting in a decrease in ATP 
synthesis  and  mitochondrial  function.  COX  directly  binds  to  oxygen  and  its  activity  
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results in ATP synthesis. The rate of ATP synthesis is directly dependent on redox 
state of mitochondria. There is only a shortage in cytochrome c if the mPTP in the 
membrane remains open. The mPTP may remain open in the fatty liver leading to 
necrosis. IPC of the heart prevents the mPTP opening; it is possible that a similar 
situation occurs in fatty liver
577.  
The presence of non-esterified fatty acids in fatty liver is associated with the decrease 
in ATP as compared to a normal liver under normal conditions. It has been proposed 
that the reason fatty liver chooses to undergo necrosis rather than apoptosis is due to 
a decrease in ATP
256,265. ATP is essential for apoptosis. Selzner et al have proved that 
IPC protects fatty liver against necrosis
265. This may be because IPC maintains ATP 
levels in fatty liver. This is supported by the results of this experiment that suggest that 
the IPC+I/R group was in a more “oxidized” state than the I/R group. 
During  ischaemia t h e r e  i s  v e r y  l i t t l e  H b O 2 a n d  t o t a l  H b ,  t h i s  i s  a s s o c i a t e d  w i t h  a  
decrease in COX activity. Chandel et al studied whether hypoxia leads to suppression 
of electron transport chain and whether COX was involved in this process
578. They 
showed that oxygen availability determines COX activity. Chandel et al support the 
reversible two transition state COX model proposed by Wilson et al
579. Wilson et al 
proposed that COX switches reversibly between two states of activity, suggesting that 
COX  may  possess  two  different  binding  sites  for  oxygen
579.  One  binding  site 
decreased whereas the other increased ATP production. The switch between the two 
states of activity is said to be faster from low activity, in low oxygen states, to high 
activity when oxygen levels return to normal. This phenomenon is seen during the 
transition from baseline to end of ischaemia in the results, it takes time for activity to 
drop along with a decrease in oxygen. The faster change is seen in figure 47 because 
on reperfusion after extended ischaemia the IPC+I/R group shows a surge in COX 
activity, which is higher than the initial baseline value. This is also seen in the IPC+I/R 
group after a brief period of 5 minutes of ischaemia, on reperfusion there is a much  
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higher COX activity than baseline. Suggesting oxygen supply is sufficient for Complex 
IV  of  the  electron  transport  chain, A T P  g e n e r a t i o n  a n d  C O X  f u n c t i o n  i s  n o r m a l .  
Improved extracellular oxygenation in IPC+I/R compared to I/R may be the main way 
in  which  IPC  works  to  preserve  mitochondrial  function  and  blood  flow  preventing 
inflammation. 
This experiment shows there is in vivo and in vitro preservation of COX activity in fatty 
livers, which are preconditioned in comparison to those that are not. This suggests that 
the  mPTP  may  close  after  opening  briefly  on  reperfusion  and  cytochrome  c a n d  
oxygen are available as substrates for COX, as in normal liver. It is likely that ATP 
synthesis continues and if cell death were to occur, apoptosis may be more likely to be 
triggered than necrosis, i.e. there is a switch to the apoptotic pathway.  
A  switch  away  from  necrosis  in  fatty  liver  means  there  is  less  necrosis-induced 
inflammation, release of inflammatory mediators, activation of KCs and leukocytes and 
leukocyte  and  platelet  adhesion  to  sinusoidal  epithelial  cells.  The  hepatic 
microcirculation  and  tissue  perfusion  would  be  maintained.  This  would  lead  to 
sustained oxygen delivery to mitochondria and would therefore maintain COX activity. 
Continued  oxygen  supply  means  that  COX  would  probably  be  in  a  high  active 
transition state with high ATP turnover, whereas a low active state may be related to 
necrotic pathway. A high active COX state may induce the mPTP to close
580. A higher 
COX activity state is less likely to follow the necrotic pathway due to increased ATP 
production. 
During ischaemia COX activity decreased in I/R and IPC+I/R groups, on reperfusion 
COX activity in both groups increased suggesting that COX activity is affected by lack 
of oxygen and may be in a low activity state during ischaemia. COX activity in the I/R 
group on reperfusion was not as high as IPC+I/R group suggesting that COX activity 
may be used as a marker for IRI damage and can be attenuated by IPC in fatty liver.   
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In summary, this experiment shows that IPC protects fatty liver from IRI and maintains 
hepatic oxygenation, tissue perfusion and mitochondrial redox state. Most importantly 
it has proved that COX activity is compromised by IRI in the fatty liver, but can be 
protected by IPC. Damage is mostly confined to the period between baseline and 2hrs 
reperfusion (i.e. the early phase of reperfusion). The data suggests that IRI may be 
reversible in fatty liver if IPC is employed during liver transplantation, however this 
would need to be the subject of further research. The data from this experiment also 
suggests that IPC improves hepatic intracellular tissue oxygenation during beginning 
of the late phase of IRI.  
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9  Thesis discussion 
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Chapter four was intended as a pilot study. It provided a proof of principle, that there 
was a detectable change in bile acid composition using 
1HNMR. It was repeated with 
the addition of an intervention group to form the basis of chapter five. In chapter five 
NAC administration resulted in decreased levels of bile lactate and PC and increased 
levels of acetate following I/R. In chapter five the changes in bile constituents became 
more  apparent.  There w e r e  s e v e r a l  differences  in  bile  composition b e t w e e n  t h e  
experiments  in  this  chapter  five  and  four.  In  chapter  five  the  monitoring  of  the 
haemodynamic  data  was  through  the  ear  artery  and  vein, r a t h e r  t h a n  t h e  f e m o r a l  
artery and vein, which lead to a more stable experimental model
401.  
There  were  clear  differences i n  both I / R  and  I/R+NAC  groups  when  compared  to 
shams. There were no significant differences between the groups in conjugated bile 
acids, this was both disappointing and interesting. Due to active nature of conjugation 
of bile acids, this was initially thought to be an area where a clear difference between 
the  groups  would  be  found.  It  was  one  of  the  aims  of  this  thesis  to  identify  MRS 
markers of IRI. This was an early challenge to the hypothesis, that a bile marker might 
be found through 
1HNMR. Consequently, in subsequent experiments, the search for 
other  metabolites  was  expanded,  and  conjugated  bile  acids  were  discarded  as  a 
candidate  marker.  The  search  for  the  best  predictive  marker,  validating  it  through 
repeated  experiments,  comparing  it  with  other  published  observations,  and  putting 
forward an explanation for these changes is a constant theme that runs through the 
following chapters. 
In chapter five, BF in both the I/R and I/R+NAC groups fell sharply in response to 
ischaemia, and recovered after reperfusion. However, despite this consistent pattern 
of BF, 
1HNMR spectroscopy of bile revealed fluctuations in the concentration of some 
bile constituents.  
Lactate in particular shows a large peak at 5hrs postreperfusion, this corresponds to a  
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large  burst  of  PMN a c t i v i t y  t h a t  c o n s t i t u t e s  t h e  b e g i n n i n g  o f  t h e  l a t e  p h a s e  o f  
ischaemia-reperfusion injury
532. It has been observed that the injury produced during 
the initial part of the late phase is a more extensive hepatocellular injury in comparison 
to  the  early  phase
546,547.  Interestingly,  NAC  administration  abolished  this  peak  in 
lactate, as it lowered the levels of ALT.  
Acetate was observed to drop continuously from baseline throughout the experiment; 
however, it correlated strongly to COX activity. The I/R-induced reduction in ATP may 
result in decreased β-oxidation causing acetate production to falter; this could also 
explain its strong association with the change in COX.   
In chapter six, for the first time, bile constituents were quantified as explained in the 
appendix (section 10.1). They are expressed in micromolar concentrations. 
The  I/R+Glycine  group  was  associated  with  increased  synthetic  functional  markers 
(BF and bile acid synthesis), decreased injury markers (lactate and PC levels) and 
enhanced metabolic indicators (acetate, pyruvate, glucose and acetoacetate).  
The recovery of BF and a rise in bile acid secretion following I/R in the I/R+glycine 
group suggests an early recovery of metabolic activity in the glycine-treated livers, 
which is supported by observations that total serum bile acids were found to be early 
markers of liver function in porcine
521,522 and canine
523 liver transplants.  
Lactate levels were elevated with I/R and were higher than the sham and I/R+glycine 
groups. They were elevated at a time point similar to the previous two experiments 
that corresponds to a large burst of PMN activity at the beginning of the late phase of 
IRI
512,516. PC was observed to be similar in sham and I/R+glycine groups, while it was 
raised in the I/R group during the 2
nd and 4
thhr of reperfusion. Increased bile PC levels 
has also been observed in association with poor graft function in liver transplants
369.  
An increase in post-reperfusion levels of biliary glucose and pyruvate were found on  
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reperfusion in the I/R+glycine group compared to I/R, this suggesting an increased 
metabolic  activity  in  the  glycolytic/gluconeogenic  pathway,  which  may  be  due  to 
conserved  cellular  energetics. G l y c i n e -treated  livers  possessed  a  greater  ability  to 
produce acetate than I/R group, suggesting less injury to their metabolic energetics.  
After a reduction in hepatic blood flow, the mitochondrial redox potential is reduced. 
Consequently, there is accelerated production of ketone bodies, to compensate for 
inhibited  glucose  utilization.  Ketone  body  production  is  an  alternative  pathway  to 
supply  ATP  when  there  is  inhibition  of  glucose  oxidation  and  the  Krebs  cycle. 
Recently, higher acetoacetate perfusate levels have been demonstrated in isolated-
perfused rat livers preserved in University of Wisconsin versus Euro-Collins solution
549 
which  has  been  shown t o  c o r r e l a t e  w i t h  N A D
+/NADH  ratio  in  the  hepatocyte 
mitochondria
550.  The  elevated  levels  of  acetoacetate  observed  in  this  study,  during 
ischaemia a n d  r e p e r f u s i o n ,  s u g g e s t  t h a t  g l y c i n e -treated  livers  can  utilize  this 
alternative  source  of  ATP,  again  suggesting  conserved  cellular  energetics  in  this 
group. 
In chapter seven, NAC administration was seen to reduce IRI mainly in the late phase 
in  steatotic  livers.  Liver  steatosis  reduces  flow  in  the  hepatic  microcirculation  and 
mitochondrial ATP generation
244. Fat accumulation in the cytoplasm of the hepatocytes 
causes  compression  or  even  complete  occlusion  of  the  sinusoidal  spaces  with 
shunting of a proportion of total hepatic blood flow
396,402. In moderate steatosis, the 
THBF was reduced by 30% and flow in hepatic microcirculation was 50% of normal I/R 
group
159,168.  
Recent work has also shown beneficial effects of NAC in normal liver following one 
hour of lobar ischaemia
396,560,561. The dose of NAC administered, in chapter seven, is 
that used in clinical practice to treat patients with acute liver failure
532. The beneficial 
effect  of  NAC  was  demonstrated  by  improvement  in  liver  microcirculation,  bile  
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production, associated with reduced hepatocellular injury.  
In the I/R+NAC group hepatic microcirculation returned to baseline values at the end 
of reperfusion suggesting that NAC has reversed the perfusion failure of the late phase 
of IRI. This correlates well with the return of portal blood flow rates towards baseline at 
the  end  of  the  reperfusion  period  in  the  NAC  group.  Spectroscopy  showed  NAC 
administration enhanced the biliary excretion of acetate and pyruvate and reduced the 
excretion of PC. 
The I/R–induced reduction or depletion of ATP may result in a decreased ability to 
utilize β-oxidation causing acetate production to falter. The higher bile acetate levels in 
the  I/R+NAC  group w o u l d  s u g g e s t  i m p r o v e d  A T P  p r o d u c t i o n  a n d  e n e r g e t i c s .  T h e  
increased excretion of pyruvate in the bile of I/R+NAC group is difficult to interpret.  
Steatotic  livers  have  lower  ATP  levels  after  stress  compared  to  normal  livers  and 
mitochondrial  injury  has  been  proposed  as  one  of  the  causes  of  reduced 
hepatocellular ATP stores in steatosis
394. The main source of PC in the hepatocytes is 
the  cell  membrane. T h e  i n c r e a s e  f o llowing  ischaemia  and  again  at  5hr  post-
reperfusion correlates well with the theory of cellular breakdown and membrane lipid 
peroxidation. PC levels were reduced in the I/R+NAC group.  
The administration of NAC, prior to and during reperfusion, reduced the extent of IRI in 
the steatotic liver. This was apparent during the late phase of reperfusion and was 
demonstrated  by  increased  portal  blood  flow  and  liver  parenchymal  perfusion.  Bile 
excretion was increased and acute liver injury was reduced.  
In chapter eight, several strands of previous experiments started to converge. The 
experiment demonstrated that IPC protects fatty liver from IRI and maintains hepatic 
oxygenation,  tissue  perfusion  and  mitochondrial  redox  state.  Most  importantly  it 
suggested t h a t  C O X  a c t i v i t y  i s  c o m p r o m i s e d  b y  IRI i n  t h e  f a t t y  l i v e r , b u t  c a n  b e  
protected by IPC.   
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NIRS in vivo measurements show extracellular tissue oxygenation was improved in 
the  IPC+I/R  group  compared  with  the  I/R  group  during  reperfusion,  this  has  been 
shown  in  normal  livers
34,267,268.  However,  this  experiment s u g g e s t s  t h a t  I P C  a l s o  
protects  fatty  liver  against  microcirculatory  dysfunction,  this  is  supported  by  other 
findings
266,581. This is of importance to fatty liver as it has diminished sinusoidal spaces 
due to fatty infiltration
239.  
There is a fundamental difference between normal and fatty livers, making them more 
susceptible to IRI. Selzner et al noted the mechanism of cell death in fatty liver was 
significantly different to cell death in normal liver
256,257. In fatty liver cell death occurs 
predominantly by necrosis, whilst apoptosis was dominant in normal liver after IRI. 
Necrosis  is  more  damaging  because  it  is  accompanied  by  the  breakdown  of 
organelles,  membranes  and  the  release  of  cytotoxic  cell  contents,  which  induce 
inflammation, whereas, apoptosis does not. This may contribute to making fatty liver 
less tolerant to IRI injury
256. Fatty liver has diminished sinusoidal spaces due to fatty 
infiltration
239 a n d  i n f l a m m a t o r y  m e d i a t o r s  s u c h  a s  T N F -α a n d  l e u k o c y t e s  c a u s e  a  
further decrease in sinusoidal space and impairs microcirculation which reduces blood 
flow to certain areas resulting in prolonged periods of ischaemia to certain areas of the 
liver. This causing activation of KC and other mechanisms of IRI
569.  
Glanemann et al have shown that IPC protects normal liver from IRI by maintaining 
hepatic microcirculation and reducing inflammatory response by preventing activation 
of  KC  and  maintaining  mitochondrial  redox  state  which  is  dependent  upon  oxygen 
availability
34.  
In chapter eight, a deeper understanding of the use of 
1HNMR in emerged through the 
use  of  bile  redox  ratios  instead  of  measuring  separate  constituents.  The  energetic 
balance  and  redox  status  of  hepatic  tissue  are  intimately  connected  by  substrate 
oxidation/reduction  reactions  via  oxidized  nicotinamide  adenine  dinucleotide  
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(phosphate) (NAD(P)) at several key points, such as pyruvate/lactate interconversion 
in  the  cytosol  or  βHb/AcAc i n t e r c o n v e r s i o n  i n  t h e  m i t o c h o n d r i a  a l s o  k n o w n  a s  t h e 
ketone body ratio.  
βHb and AcAc are a redox pair coupled by interconversion from AcAc (with oxidation 
of  NADH)  to  βHb  and  the  βHb/AcAc  ratio  is  an  indicator  of  mitochondrial  redox 
status
570. βHb/AcAc equilibrates with hepatic mitochondrial NADH/NAD
+ because the 
enzyme, β-hydroxybutyrate dehydrogenase, resides in mitochondrial cristae
571 (figure 
3b). In the IPC+I/R group more of the “oxidized” half of the couplet (AcAc) could be 
detected  in  bile,  this  suggests  a  shift  toward  more  aerobic  conditions  in  the 
mitochondria. This could lead to more aerobic conditions within the cytosol and, thus, 
the reconversion of lactate to pyruvate during reperfusion, lactate and pyruvate being 
a redox pair that is an indicator of the cytosolic redox state. This is supported by our 
findings of decreased lactate/pyruvate ratio in the IPC+I/R group during reperfusion. 
Hirakawa et al have shown in normal rat liver cytochrome c is released into the cytosol 
by mitochondria during IRI
574. It is a mediator of apoptosis inducing caspase 3 and 9 
activation,  which  mediate  apoptosis.  The  release  of  cytochrome  c a n d  c a s p a s e s  
occurred  during  ischaemia,  yet,  apoptosis  occurred  during  reperfusion  in  normal 
liver
575. The release of cytochrome c is mediated by the mPTP, a voltage-dependent 
high-conductance  channel  of  the  inner  mitochondrial  membrane
576.  The  pore  is 
normally closed, but  i s opened at  t he onset  of  r eper f usi on.  When cyt ochr ome c i s 
released there is no substrate for COX resulting in a decrease in ATP synthesis and 
mitochondrial function. COX directly binds to oxygen and its activity results in ATP 
synthesis.  The  rate  of  ATP  synthesis  is  directly  dependent  on  redox  state  of 
mitochondria. There is only a shortage in cytochrome c if the mPTP in the membrane 
remains open. The mPTP may remain open in the fatty liver leading to necrosis. IPC of 
the heart prevents the mPTP opening; it is possible that a similar situation occurs in  
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fatty liver
577.  
The presence of non-esterified fatty acids in fatty liver is associated with the decrease 
in ATP as compared to a normal liver under normal conditions. It has been proposed 
that the reason fatty liver chooses to undergo necrosis rather than apoptosis is due to 
a decrease in ATP
256,265. ATP is essential for apoptosis. Selzner et al have proved that 
IPC protects fatty liver against necrosis
265. This may be because IPC maintains ATP 
levels in fatty liver. This is supported by the results of this experiment that suggest that 
the IPC+I/R group was in a more “oxidized” state than the I/R group. 
Chandel et al studied whether hypoxia leads to suppression of electron transport chain 
and  whether  COX  was  involved  in  this  process
578.  They  showed  that  oxygen 
availability determines COX activity. Chandel et al support the reversible two transition 
state  COX m o d e l  proposed  by  Wilson  et  al
579.  Wilson  et  al p r o p o s e d  t h a t  C O X  
switches reversibly between two states of activity, suggesting that COX may possess 
two different binding sites for oxygen
579. One binding site decreased whereas the other 
increased ATP production. The switch between the two states of activity is said to be 
faster from low activity, in low oxygen states, to high activity when oxygen levels return 
to  normal.  This  phenomenon  is  seen  during  the  transition  from  baseline  to  end  of 
ischaemia in the results, it takes time for activity to drop along with a decrease in 
oxygen. The faster change is seen in figure 47 because on reperfusion after extended 
ischaemia the IPC+I/R group shows a surge in COX activity, which is higher than the 
initial baseline value. This is also seen in the IPC+I/R group after a brief period of 5 
minutes  of  ischaemia,  on  reperfusion  there  is  a  much  higher  COX  activity  than 
baseline.  Suggesting  oxygen  supply  is  sufficient  for  Complex  IV  of  the  electron 
transport chain, ATP generation and COX function is normal. Improved extracellular 
oxygenation in IPC+I/R compared to I/R may be the main way in which IPC works to 
preserve mitochondrial function and blood flow preventing inflammation.  
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This experiment shows there is in vivo and in vitro preservation of COX activity in fatty 
livers, which are preconditioned in comparison to those that are not. This suggests that 
the  mPTP  may  close  after  opening  briefly  on  reperfusion  and  cytochrome  c a n d  
oxygen are available as substrates for COX, as in normal liver. It is likely that ATP 
synthesis continues and if cell death were to occur, apoptosis may be more likely to be 
triggered than necrosis, i.e. there is a switch to the apoptotic pathway. A switch away 
from necrosis in fatty liver means there is less necrosis-induced inflammation, release 
of  inflammatory  mediators,  activation  of  KCs  and  leukocytes  and  leukocyte  and 
platelet adhesion to sinusoidal epithelial cells. The hepatic microcirculation and tissue 
perfusion  would  be  maintained.  This  would  lead t o  s u s t a i n e d  o x y g e n  d e l i v e r y  t o  
mitochondria  and  would  therefore  maintain  COX  activity.  Continued  oxygen  supply 
means that COX would probably be in a high active transition state with high ATP 
turnover, whereas a low active state may be related to necrotic pathway. A high active 
COX state may induce the mPTP to close
580. A higher COX activity state is less likely 
to follow the necrotic pathway due to increased ATP production. 
In conclusion, these experiments set out to discover if bile composition changed during 
IRI and its modulation, through 1HNMR analysis, and find a biomarker through that 
could  effectively  indicate  IRI,  particularly  in  steatotic  livers,  as  well  as  exploring 
methods  of  modulating  IRI  in  steatotic  livers,  that  are  increasingly  being  used  in 
transplantation. The results have shown a consistent set of changes in composition, 
throughout  several  experiments,  and  use  of  redox  ratios  more  closely  mirrors  liver 
energetic than any one particular marker.  
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10.1 Quantification of biliary constituents in micromolar concentrations  
 
10.1.1  Introduction 
In  chapters  four  and  five,  one  of  the  limitations  that  were  faced  was  the  lack  of 
quantification of bile constituents. Bile composition was expressed as a percentage of 
baseline values, in accordance with previously published reports
18. Through a valid 
technique, we sought to quantify the constituents to gain a more accurate insight into 
the changes that developed during I/R. 
10.1.2  Materials and Methods 
A series of ascending known concentrations of taurocholic acid (TCA; Sigma-Aldrich, 
St  Louis,  Missouri,  USA)  in  distilled  water  were  analysed  from  0.1-100  mMols.  A 
methyl peak at 0.665 ppm was identified and the area under the curve integrated for 
each  concentration. 
1HNMR  analysis  was  performed  on  an  11.7  T  (500  MHz  for 
protons)  spectrometer  (Varian  Unity+;  Varian,  Palo  Alto,  CA,  USA)  at  25°C.  For  a 
field/frequency lock a coaxial capillary insert was used (Wilmad, Buena, NJ, USA). 
This  capillary  insert  was  filled  with  a  deuterium  oxide  solution  of  sodium  TSP t h at 
acted as a chemical shift reference. One dimensional NMR spectra were obtained at 
500MHz with a sweep width of 6kHz. The spectra were analysed using software from 
MestRe-C version 3.1.1 (Universidade de Santiage de Compostela, Spain).  
10.1.3  Results 
A taurocholic acid spectrum is shown in figure 52. The results of integration of the area 
under the curve of a C-18 methyl proton peak
12 at 0.7 ppm are shown in figure 53. This 
standard curve was then used to calculate concentrations of other peaks.   
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Figure 52: 
1HNMR spectra of taurocholic acid 
 
 
 
 
 
Figure 53: Standard curve for quantification 
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10.2 Localization of overlapping peaks acetoacetate and pyruvate  
 
10.2.1  Introduction 
In  chapters  eight,  one of the limitations  that were faced was overlapping peaks of 
pyruvate (2.38 ppm, CH3 singlet) and acetoacetate (2.29 ppm, CH3 singlet) that made 
it difficult to identify acetoacetate. At this region in the bile spectra, there were multiple 
small peaks, and it was not entirely clear, which could be attributed to which (figure 
55a).  
10.2.2  Materials and Methods 
A 300µL sample of control bile was analysed initially as below, then augmented with 
100µL of molar pyruvic acid (Sigma-Aldrich, St Louis, Missouri, USA). This sample 
was analysed as below, then a further 100µL of molar acetoacetic acid ethyl ester 
(Sigma-Aldrich,  St  Louis,  Missouri,  USA)  was  added  and  then  reanalysed.
 1 HNMR 
analysis  was  performed  on  an  11.7T  (500  MHz  for  protons)  spectrometer  (Varian 
Unity+;  Varian,  Palo  Alto,  CA, U S A )  a t  2 5 ° C .  F o r  a  f i e l d / f r e q u e n c y  l o c k  a  c o a x i a l  
capillary insert was used (Wilmad, Buena, NJ, USA). This capillary insert was filled 
with  a  deuterium  oxide  solution  of  sodium  TSP t h a t  a c t e d  a s  a  c h e m i c a l  s h i f t  
reference.  One  dimensional  NMR spectra were  obtained  at  500MHz  with  a  sweep 
width  of  6kHz.  The  spectra  were  analysed  using  software  from  MestRe-C 
(Universidade de Santiage de Compostela, Santiage de Compostela, Spain).  
10.2.3  Results 
A  normal  bile  sample  is  shown  in  figure  54a,  and  when  it  was  augmented w i t h  
pyruvate,  there  was  a  clear  increase  in  one  of  the  peaks  shown  in  figure  54b.  A 
pyruvate-augmented  sample i s  s h o w n  i n  figure  55a.  While  the  pyruvate  and 
acetoacetate-augmented  sample  is  shown  in  figure  55b.  A  clearer  difference  was 
discernable after augmentation, and peak assignments for pyruvate (2.38 ppm) and 
acetoacetate (3.45 ppm) were used.   
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Figure 54: 
1HNMR spectra of normal and pyruvate-augmented bile 
(a)            (b) 
    
1HNMR spectra scaled to TSP of (a) a normal bile sample and (b) augmented with 
pyruvate (scale in ppm). 
 
Figure 55: 
1HNMR spectra of pyruvate- and acetoacetate-augmented bile 
(a)            (b) 
 
 
1HNMR spectra scaled to TSP of (a) a pyruvate-augmented bile sample and (b) a bile 
sample augmented with pyruvate and acetoacetate (scale in ppm). 
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10.3 Presentations and publications arising from this thesis 
10.3.1  Conference presentations 
1.  Sheth H, Hafez T, Glantzounis G, Parkes HG, Seifalian A, Fuller B, Davidson BR: 
Intravenous glycine improves bile flow and modulates bile composition in a in-vivo 
warm liver ischaemia reperfusion injury model. Annual Meeting of the Society of 
Academic and Research Surgery (SARS), Edinburgh, UK, 11-13/1/2006 
2.  Hafez T,  Sheth  H,  Glantzounis  G,  Yang  W,  Parkes  HG,  Seifalian  A,  Fuller  B, 
Davidson BR: Bile flow and composition are modulated by intravenous glycine in 
an in-vivo warm ischaemia-reperfusion injury model. Annual Meeting of the British 
Society of Gastroentrology (BSG), Glasgow, Scotland, 21-24/3/2004  
3.  Sheth H, Hafez T, Glantzounis G, Sales KM, Seifalian A, Fuller B, Davidson BR: 
Glycine ameliorates the early phase of liver warm ischaemia reperfusion injury in 
a rabbit model. Annual Meeting of the British Society of Gastroentrology, (BSG), 
Glasgow, Scotland, 21-24/3/2004 
4.  Hafez  T,
  Fusai  G,  Glantzounis  G,  Yang  W,  Sheth  H,  Kanoria  S,  Parks  HG, 
Seifalian  AM,  Davidson  BR:  N-Acetylcysteine  modulates  bile  composition 
following  liver  ischaemia-reperfusion  injury  in  an  experimental  model  with  fatty 
liver. S o c i e t y  o f  A c a d e m i c  a n d  R e s e a r c h  S u r g e r y  (SARS),  Belfast,  UK,  14-
16/1/2004  
5.  Glantzounis GK, Hafez TS,  Cox IJ, Sheth H,
 Yang W, Seifalian AM, Fuller BJ, 
Davidson BR: The use of   magnetic spectroscopy bile analysis  as a tool for the 
assessment  of antioxidant therapy in liver ischaemia-reperfusion injury. 13th Pan-
Hellenic Congress of Transplantation, Athens, Greece, 11-13/12/2003  
6.  Hafez  T,  Glantzounis  GK,  Cox  IJ,  Sheth  H,  Yang  W,
  Seifalian  AM,  Fuller  B, 
Davidson  BR:  N-acetylcysteine  (NAC)  and  liver  warm  ischaemia r e p e r f u s i o n  
injury: alterations to bile composition demonstrated by proton nuclear magnetic  
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resonance spectroscopy (MRS). 38
th Annual Meeting of the European Association 
for the Study of the Liver (EASL), Geneva, Switzerland 2-6/7/2003  
7.  Hafez T, Glantzounis GK, Cox IJ, Yang W, Seifalian AM, Fuller B, Davidson BR: 
N-acetylcysteine and liver warm ischaemia reperfusion injury: alterations to bile 
composition demonstrated by proton nuclear magnetic resonance spectroscopy. 
Society of Academic and Research Surgery (SARS), Leeds, UK, 9-10/1/2003  
10.3.2  Abstracts 
1.  Sheth  H,  Glantzounis  G,  Hafez  T, Q u a g l i a  A ,  D u n c a n  J ,  D a v i d s o n  B R .  D o e s  
perioperative  N-acetylcysteine  prevents  ischaemia-reperfusion  injury  during  liver 
resection? A prospective randomised double blind clinical trial. Gut 2005;54(Suppl 
2):148. 
2.  Hafez  T,  Sheth  H,  Glantzounis  G,  Yang  W,  Parkes  HG,  Seifalian  A,  Fuller  B, 
Davidson BR: Bile flow and composition are modulated by intravenous glycine in 
an in-vivo warm ischaemia-reperfusion injury model. Gut 2004;53 (Suppl 3):A36  
3.  Sheth H, Hafez T, Glantzounis G, Sales KM, Seifalian A, Fuller B, Davidson BR: 
Glycine ameliorates the early phase of liver warm ischaemia reperfusion injury in a 
rabbit model. Gut 2004;53 (Suppl 3):A92  
4.  Hafez  TS,  Glantzounis  GK,  Cox  IJ,  Sheth  H,  Yang  W,
  Seifalian  AM,  Fuller  B, 
Davidson  BR:  N-acetylcysteine  and  liver  warm  ischaemia r e p e r f u s i o n  i n j u r y :  
alterations  to  bile  composition  demonstrated  by  proton  nuclear  magnetic 
resonance spectroscopy. Journal of Hepatology 2003;38(Suppl 2):39 
5.  Hafez T, Glantzounis GK, Cox IJ, Yang W, Seifalian AM, Fuller B, Davidson BR: 
N-acetylcysteine and liver warm ischaemia reperf usi on i nj ury:  al t erat i ons t o bi l e 
composition demonstrated by proton nuclear magnetic resonance spectroscopy. 
British Journal of Surgery 2003;90:604  
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10.3.3  Original articles 
1.  Tariq  Hafez,  Georgios  Glantzounis,  I  Jane  Cox,  Hemant  Sheth,  Alexander  
Seifalian, Barry Fuller, Brian Davidson: Bile composition is modified by ischaemia 
reperfusion injury and attenuated by N-acetylcysteine: a proton nuclear magnetic 
resonance study. Journal of Gastroenterology and Hepatology (submitted) 
2.  Tariq S. Hafez, George K. Glantzounis, Guiseppe Fusai, Jan-Willem Taanman, 
Primeera Wignarajah, Harry Parkes, Barry Fuller, Brian R. Davidson, Alexander M. 
Seifalian: Intracellular oxygenation and cytochrome oxidase C activity in ischemic 
preconditioning  of  steatotic  rabbit  liver. T h e  A m e r i c a n  J o u r n a l  o f  S u r g e r y  
2010;200(4):507–18 
3.  Glantzounis G, Sheth H, Thompson C, Hafez T, Kanoria S, Pamecha V, Davies S, 
Mikhailidis D, Seifalian A, Davidson B: Acute limb ischaemia caused by femoral 
arterial  line  induces  remote  liver  injury  in  a  rabbit  model  of  liver 
ischaemia/reperfusion injury Angiology 2009;60(5):554-61 
4.  Hafez T, Sheth H, Glantzounis G, Parkes H, Seifalian A, Fuller B, Davidson B: 
Glycine  protects  bile  physiology  and  biliary-specific  liver  cell  metabolism  from 
ischaemia-reperfusion  injury:  A 
1HNMR S t u d y   Cell  Preservation  Technology 
2008;6:173–180 
5.  Fusai G, Glantzounis G, Hafez T, Yang W, Quaglia A, Sheth H, Kanoria S, Parkes 
H, Seifalian A, Davidson BR: N-acetylcysteine ameliorates the late phase of liver 
ischaemia-reperfusion injury in the rabbit with hepatic steatosis Clinical Science 
(London) 2005;109:465-73 
6.  Hafez TS, Habib M, Seifalian A, Fuller B, Davidson B: Near infrared spectroscopic 
assessment of mitochondrial oxygenation status: comparison during normothermic 
extracorporeal liver perfusion by buffer only or buffer fortified with red blood cells 
Transplantation Proceedings 2004;36:1265–1267  
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7.  Habib  MM,  Hafez  TS,  Parkes  HG,  Seifalian  AM,  Fuller  BJ,  Davidson  BR.  A 
comparison  of  bile  composition  from  heart-beating  and  non-heart-beating  rabbit 
organ  donors  during  normothermic  extracorporeal  liver  perfusion:  experimental 
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Book chapters: 
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